[{"role": "model", "parts": [{"text": "You are a specialized assistant, and given a publication you can identify which are the mentioned datasets the study is based on. You will retrieve this information and create a summary of the publication datasets for non-specialists. You must output a JSON array of objects, where each object has the following keys: 'dataset_identifier', 'repository_reference'."}]}, {"role": "model", "parts": [{"text": "Dataset Identifiers are any alphanumeric strings (they can also contain punctuation marks) that uniquely identify and/or provide access to a dataset\n.Here are some examples for reference:\n\n[\n'dataset_identifier'=> 'EGAS00001000925', 'repository_reference'=> 'https://ega-archive.org/datasets/EGAS00001000925',\n 'dataset_identifier'=> 'GSE69091', 'repository_reference'=> 'https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE69091',\n  'dataset_identifier'=> 'PRJNA306801', 'repository_reference'=> 'https://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA306801',\n  'dataset_identifier'=> 'phs003416.v1.p1', 'repository_reference'=> 'dbGaP',\n  'dataset_identifier'=> 'PXD049309', 'repository_reference'=> 'https://www.ebi.ac.uk/pride/archive/projects/PXD049309',\n  'dataset_identifier'=> 'IPX0004230000', 'repository_reference'=> 'http://www.iprox.org',\n  'dataset_identifier'=> 'MSV000092944', 'repository_reference'=> 'https://massive.ucsd.edu/',\n  'dataset_identifier'=> 'n/a', 'repository_reference'=> 'https://data.broadinstitute.org/ccle_legacy_data/mRNA_expression/'\n]"}]}, {"role": "user", "parts": [{"text": "Given the following webpage HTML:\n<html class=\"\" lang=\"en\"> <head> <link href=\"/static/assets/style-b3a36f11.css\" rel=\"stylesheet\"/> <link href=\"/static/assets/style-ef962842.css\" rel=\"stylesheet\"/> <link href=\"/static/assets/style-3ade8b5c.css\" rel=\"stylesheet\"/> <link href=\"/static/img/favicons/apple-touch-icon.png\" rel=\"apple-touch-icon\" sizes=\"180x180\"/> <link href=\"/static/img/favicons/favicon-48x48.png\" rel=\"icon\" sizes=\"48x48\" type=\"image/png\"/> <link href=\"/static/img/favicons/favicon-32x32.png\" rel=\"icon\" sizes=\"32x32\" type=\"image/png\"/> <link href=\"/static/img/favicons/favicon-16x16.png\" rel=\"icon\" sizes=\"16x16\" type=\"image/png\"/> <link href=\"/static/img/favicons/site.webmanifest\" rel=\"manifest\"/> <link color=\"#0071bc\" href=\"/static/img/favicons/safari-pinned-tab.svg\" rel=\"mask-icon\"/> <title> Tumor- and circulating-free DNA methylation identifies clinically relevant small cell lung cancer subtypes - PMC </title> <link href=\"https://www.google-analytics.com\" rel=\"preconnect\"/> <link href=\"https://cdn.ncbi.nlm.nih.gov\" rel=\"preconnect\"/> <link href=\"https://pmc.ncbi.nlm.nih.gov/articles/PMC10982990/\" rel=\"canonical\"/> </head> <body> <a class=\"usa-skipnav\" href=\"#main-content\"> Skip to main content </a> <section aria-label=\"Official website of the United States government\" class=\"usa-banner\"> <div class=\"usa-accordion\"> <header class=\"usa-banner__header\"> <div class=\"usa-banner__inner\"> <div class=\"grid-col-auto\"> <img alt=\"\" aria-hidden=\"true\" class=\"usa-banner__header-flag\" src=\"/static/img/us_flag.svg\"/> </div> <div aria-hidden=\"true\" class=\"grid-col-fill tablet:grid-col-auto\"> <p class=\"usa-banner__header-text\"> An official website of the United States government </p> <span class=\"usa-banner__header-action\"> Here's how you know </span> </div> <button aria-controls=\"gov-banner-default\" aria-expanded=\"false\" class=\"usa-accordion__button usa-banner__button\" type=\"button\"> <span class=\"usa-banner__button-text\"> Here's how you know </span> </button> </div> </header> <div class=\"usa-banner__content usa-accordion__content\" hidden=\"\" id=\"gov-banner-default\"> <div class=\"grid-row grid-gap-lg\"> <div class=\"usa-banner__guidance tablet:grid-col-6\"> <img alt=\"\" aria-hidden=\"true\" class=\"usa-banner__icon usa-media-block__img\" src=\"/static/img/icon-dot-gov.svg\"/> <div class=\"usa-media-block__body\"> <p> <strong> Official websites use .gov </strong> <br/> A <strong> .gov </strong> website belongs to an official government organization in the United States. </p> </div> </div> <div class=\"usa-banner__guidance tablet:grid-col-6\"> <img alt=\"\" aria-hidden=\"true\" class=\"usa-banner__icon usa-media-block__img\" src=\"/static/img/icon-https.svg\"/> <div class=\"usa-media-block__body\"> <p> <strong> Secure .gov websites use HTTPS </strong> <br/> A <strong> lock </strong> ( <span class=\"icon-lock\"> <svg aria-labelledby=\"banner-lock-description\" class=\"usa-banner__lock-image\" focusable=\"false\" height=\"64\" role=\"graphics-symbol\" viewbox=\"0 0 52 64\" width=\"52\" xmlns=\"http://www.w3.org/2000/svg\"> <title id=\"banner-lock-title\"> Lock </title> <desc id=\"banner-lock-description\"> Locked padlock icon </desc> <path d=\"M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z\" fill=\"#000000\" fill-rule=\"evenodd\"> </path> </svg> </span> ) or <strong> https:// </strong> means you've safely connected to the .gov website. Share sensitive information only on official, secure websites. </p> </div> </div> </div> </div> </div> </section> <div class=\"usa-overlay\"> </div> <header class=\"usa-header usa-header--extended usa-header--wide\"> <div class=\"ncbi-header\"> <div class=\"ncbi-header__container\"> <a class=\"ncbi-header__logo-container\" href=\"https://www.ncbi.nlm.nih.gov/\"> <img alt=\" NCBI home page \" class=\"ncbi-header__logo-image\" src=\"/static/img/ncbi-logos/nih-nlm-ncbi--white.svg\"/> </a> <button aria-label=\"Show menu\" class=\"usa-menu-btn ncbi-header__hamburger-button\" type=\"button\"> <svg aria-hidden=\"true\" class=\"ncbi-hamburger-icon\" fill=\"none\" focusable=\"false\" height=\"21\" viewbox=\"0 0 31 21\" width=\"31\" xmlns=\"http://www.w3.org/2000/svg\"> <path clip-rule=\"evenodd\" d=\"M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z\" fill=\"#F1F1F1\" fill-rule=\"evenodd\"> </path> </svg> </button> <div class=\"ncbi-header__desktop-buttons\"> <button aria-controls=\"search-field-desktop-navigation\" aria-expanded=\"false\" aria-label=\"Show search overlay\" class=\"usa-button usa-button--unstyled ncbi-header__desktop-button\" type=\"button\"> <svg aria-hidden=\"true\" class=\"usa-icon\" role=\"graphics-symbol\"> <use xlink:href=\"/static/img/sprite.svg#search\"> </use> </svg> Search </button> <div class=\"ncbi-header__login-dropdown\"> <button aria-controls=\"login-dropdown-menu\" aria-expanded=\"false\" aria-label=\"Show login menu\" class=\"usa-button usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button\" type=\"button\"> <svg aria-hidden=\"true\" class=\"usa-icon\" role=\"graphics-symbol\"> <use xlink:href=\"/static/img/sprite.svg#person\"> </use> </svg> <span> Log in </span> <svg aria-hidden=\"true\" class=\"usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden\" role=\"graphics-symbol\"> <use xlink:href=\"/static/img/sprite.svg#expand_less\"> </use> </svg> <svg aria-hidden=\"true\" class=\"usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden\" role=\"graphics-symbol\"> <use xlink:href=\"/static/img/sprite.svg#expand_more\"> </use> </svg> </button> <ul class=\"usa-nav__submenu ncbi-header__login-dropdown-menu\" hidden=\"\" id=\"login-dropdown-menu\"> <li class=\"usa-nav__submenu-item\"> <a class=\"usa-link\" href=\"https://www.ncbi.nlm.nih.gov/myncbi/\"> Dashboard </a> </li> <li class=\"usa-nav__submenu-item\"> <a class=\"usa-link\" href=\"https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/\"> Publications </a> </li> <li class=\"usa-nav__submenu-item\"> <a class=\"usa-link\" href=\"https://www.ncbi.nlm.nih.gov/account/settings/\"> Account settings </a> </li> <li class=\"usa-nav__submenu-item\"> <button class=\"usa-button usa-button--outline ncbi-header__login-dropdown-logout-button\" type=\"button\"> Log out </button> </li> </ul> </div> </div> </div> </div> <div class=\"ncbi-search-panel ncbi--show-only-at-desktop\" hidden=\"\"> <div class=\"ncbi-search-panel__container\"> <form action=\"https://www.ncbi.nlm.nih.gov/search/all/\" aria-describedby=\"search-field-desktop-navigation-help-text\" autocomplete=\"off\" class=\"usa-search usa-search--big ncbi-search-panel__form\" method=\"GET\" role=\"search\"> <label class=\"usa-sr-only\" for=\"search-field-desktop-navigation\"> Search\u2026 </label> <input class=\"usa-input\" id=\"search-field-desktop-navigation\" name=\"term\" placeholder=\"Search NCBI\" type=\"search\" value=\"\"/> <button class=\"usa-button\" type=\"submit\"> <span class=\"usa-search__submit-text\"> Search NCBI </span> </button> </form> </div> </div> <nav aria-label=\"Primary navigation\" class=\"usa-nav\"> <p class=\"usa-sr-only\" id=\"primary-navigation-sr-only-title\"> Primary site navigation </p> <button aria-label=\"Close navigation menu\" class=\"usa-nav__close ncbi-nav__close-button\" type=\"button\"> <img alt=\"Close\" src=\"/static/img/usa-icons/close.svg\"/> </button> <form class=\"usa-search usa-search--small ncbi--hide-at-desktop margin-top-6\" role=\"search\"> <label class=\"usa-sr-only\" for=\"search-field\"> Search </label> <input class=\"usa-input\" id=\"search-field-mobile-navigation\" name=\"search\" placeholder=\"Search NCBI\" type=\"search\"/> <button class=\"usa-button\" type=\"submit\"> <img alt=\"Search\" class=\"usa-search__submit-icon\" src=\"data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg==\"/> </button> </form> <div class=\"ncbi-nav__mobile-login-menu ncbi--hide-at-desktop\" hidden=\"\"> <p class=\"ncbi-nav__mobile-login-menu-status\"> Logged in as: <strong class=\"ncbi-nav__mobile-login-menu-email\"> </strong> </p> <ul class=\"usa-nav__primary usa-accordion\"> <li class=\"usa-nav__primary-item\"> <a class=\"usa-link\" href=\"https://www.ncbi.nlm.nih.gov/myncbi/\"> Dashboard </a> </li> <li class=\"usa-nav__primary-item\"> <a class=\"usa-link\" href=\"https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/\"> Publications </a> </li> <li class=\"usa-nav__primary-item\"> <a class=\"usa-link\" href=\"https://www.ncbi.nlm.nih.gov/account/settings/\"> Account settings </a> </li> </ul> </div> <button class=\"usa-button ncbi-nav__mobile-login-button ncbi--hide-at-desktop\" type=\"button\"> Log in </button> </nav> </header> <section aria-label=\"PMC Header with search box\" class=\"pmc-header pmc-header--basic\"> <div class=\"pmc-nav-container\"> <div class=\"pmc-header__bar\"> <div class=\"pmc-header__logo\"> <a aria-label=\"PMC Home\" href=\"/\" title=\"Home\"> </a> </div> <button aria-label=\"Open search\" class=\"usa-button usa-button--unstyled pmc-header__search__button\" type=\"button\"> <svg aria-hidden=\"true\" class=\"usa-icon width-4 height-4 pmc-icon__open\" focusable=\"false\" role=\"img\"> <use xlink:href=\"/static/img/sprite.svg#search\"> </use> </svg> <svg aria-hidden=\"true\" class=\"usa-icon width-4 height-4 pmc-icon__close\" focusable=\"false\" role=\"img\"> <use xlink:href=\"/static/img/sprite.svg#close\"> </use> </svg> </button> </div> <div class=\"pmc-header__search\"> <form autocomplete=\"off\" class=\"usa-search usa-search--extra usa-search--article-right-column pmc-header__search__form\" role=\"search\"> <label class=\"usa-sr-only\" for=\"pmc-search\"> Search PMC Full-Text Archive </label> <span class=\"autoComplete_wrapper flex-1\"> <input aria-autocomplete=\"both\" aria-controls=\"autoComplete_list_1\" aria-expanded=\"false\" aria-haspopup=\"true\" aria-owns=\"autoComplete_list_1\" class=\"usa-input width-full maxw-none\" id=\"pmc-search\" name=\"term\" placeholder=\"Search PMC Full-Text Archive\" required=\"required\" role=\"combobox\" type=\"search\"/> <ul aria-label=\"Suggestions\" hidden=\"\" id=\"autoComplete_list_1\" role=\"listbox\"> </ul> </span> <button class=\"usa-button\" formaction=\"https://www.ncbi.nlm.nih.gov/pmc/\" type=\"submit\"> <span class=\"usa-search__submit-text\"> Search in PMC </span> <img alt=\"Search\" class=\"usa-search__submit-icon\" src=\"/static/img/usa-icons-bg/search--white.svg\"/> </button> </form> <ul class=\"pmc-header__search__menu\"> <li> <a class=\"usa-link\" href=\"https://www.ncbi.nlm.nih.gov/pmc/advanced/\"> Advanced Search </a> </li> <li> <a class=\"usa-link\" href=\"/journals/\"> Journal List </a> </li> <li> <a class=\"usa-link\" href=\"/about/userguide/\"> User Guide </a> </li> </ul> </div> </div> </section> <div class=\"usa-section padding-top-0 desktop:padding-top-6 pmc-article-section\"> <div aria-label=\"Actions bar\" class=\"grid-container pmc-actions-bar is-not-intersecting\" role=\"complementary\"> <div class=\"grid-row\"> <div class=\"grid-col-fill display-flex\"> <div class=\"display-flex\"> <ul class=\"usa-list usa-list--unstyled usa-list--horizontal\"> <li class=\"margin-right-2 mobile-lg:margin-right-4 display-flex mob\"> <button aria-label=\"Open resources\" class=\"usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex\" type=\"button\"> <svg aria-hidden=\"true\" class=\"usa-icon width-4 height-4\" focusable=\"false\" role=\"img\"> <use xlink:href=\"/static/img/sprite.svg#more_vert\"> </use> </svg> </button> </li> <li class=\"margin-right-2 mobile-lg:margin-right-4 display-flex mob\"> <span class=\"usa-tooltip\"> <a aria-label=\"View on publisher site\" class=\"usa-link display-flex usa-tooltip__trigger\" href=\"https://doi.org/10.1016/j.ccell.2024.01.001\" rel=\"noreferrer noopener\" role=\"button\" tabindex=\"0\" target=\"_blank\"> <svg aria-hidden=\"true\" class=\"usa-icon width-4 height-4\" focusable=\"false\" role=\"img\"> <use xlink:href=\"/static/img/sprite.svg#launch\"> </use> </svg> </a> <span aria-hidden=\"true\" class=\"usa-tooltip__body\" role=\"tooltip\"> View on publisher site </span> </span> </li> <li class=\"margin-right-2 mobile-lg:margin-right-4 display-flex\"> <span class=\"usa-tooltip\"> <a aria-label=\"Download PDF\" class=\"usa-link display-flex usa-tooltip__trigger\" href=\"pdf/EMS195999.pdf\" role=\"button\" tabindex=\"0\"> <svg aria-hidden=\"true\" class=\"usa-icon width-4 height-4\" focusable=\"false\" role=\"img\"> <use xlink:href=\"/static/img/sprite.svg#file_download\"> </use> </svg> </a> <span aria-hidden=\"true\" class=\"usa-tooltip__body\" role=\"tooltip\"> Download PDF </span> </span> </li> <li class=\"margin-right-2 mobile-lg:margin-right-4 display-flex\"> <span class=\"usa-tooltip\"> <button aria-label=\"Save article in MyNCBI collections.\" class=\"usa-button usa-button--unstyled collections-dialog-trigger collections-button display-flex collections-button-empty usa-tooltip__trigger\" tabindex=\"0\"> <svg aria-hidden=\"true\" class=\"usa-icon width-4 height-4 usa-icon--bookmark-full\" focusable=\"false\" hidden=\"\" role=\"img\"> <use xlink:href=\"/static/img/action-bookmark-full.svg#icon\"> </use> </svg> <svg aria-hidden=\"true\" class=\"usa-icon width-4 height-4 usa-icon--bookmark-empty\" focusable=\"false\" hidden=\"\" role=\"img\"> <use xlink:href=\"/static/img/action-bookmark-empty.svg#icon\"> </use> </svg> </button> <span aria-hidden=\"true\" class=\"usa-tooltip__body\" role=\"tooltip\"> Add to Collections </span> </span> </li> <li class=\"margin-right-2 mobile-lg:margin-right-4 display-flex\"> <span class=\"usa-tooltip\"> <button aria-label=\"Open dialog with citation text in different styles\" class=\"usa-button usa-button--unstyled citation-dialog-trigger display-flex usa-tooltip__trigger\" role=\"button\" tabindex=\"0\"> <svg aria-hidden=\"true\" class=\"usa-icon width-4 height-4 usa-icon--bookmark-empty\" focusable=\"false\" hidden=\"\" role=\"img\"> <use xlink:href=\"/static/img/sprite.svg#format_quote\"> </use> </svg> </button> <span aria-hidden=\"true\" class=\"usa-tooltip__body\" role=\"tooltip\"> Cite </span> </span> </li> <li class=\"pmc-permalink display-flex\"> <span class=\"usa-tooltip\"> <button aria-expanded=\"false\" aria-haspopup=\"true\" aria-label=\"Show article permalink\" class=\"usa-button usa-button--unstyled display-flex usa-tooltip__trigger\" tabindex=\"0\" type=\"button\"> <svg aria-hidden=\"true\" class=\"usa-icon width-4 height-4\" focusable=\"false\" role=\"img\"> <use xlink:href=\"/static/img/sprite.svg#share\"> </use> </svg> </button> <span aria-hidden=\"true\" class=\"usa-tooltip__body\" role=\"tooltip\"> Permalink </span> </span> <div class=\"pmc-permalink__dropdown\" hidden=\"\"> <div class=\"pmc-permalink__dropdown__container\"> <h2 class=\"usa-modal__heading margin-top-0 margin-bottom-2\"> PERMALINK </h2> <div class=\"pmc-permalink__dropdown__content\"> <input aria-label=\"Article permalink\" class=\"usa-input\" type=\"text\" value=\"https://pmc.ncbi.nlm.nih.gov/articles/PMC10982990/\"/> <button aria-expanded=\"false\" class=\"usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0\" title=\"Copy article permalink\"> <svg aria-hidden=\"true\" class=\"usa-icon\" focusable=\"false\" role=\"img\"> <use xlink:href=\"/static/img/sprite.svg#content_copy\"> </use> </svg> <span class=\"margin-left-1\"> Copy </span> </button> </div> </div> </div> </li> </ul> </div> <button aria-label=\"Open article navigation\" class=\"usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex\" type=\"button\"> <svg aria-hidden=\"true\" class=\"usa-icon width-4 height-4\" focusable=\"false\" role=\"img\"> <use xlink:href=\"/static/img/sprite.svg#list\"> </use> </svg> </button> </div> </div> </div> <div class=\"grid-container desktop:padding-left-6\"> <div class=\"grid-row grid-gap\" id=\"article-container\"> <div class=\"grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content\"> <div class=\"grid-container padding-left-0 padding-right-0\"> <div class=\"grid-row desktop:margin-left-neg-6\"> <div class=\"grid-col-12\"> <div aria-label=\"Disclaimer note\" class=\"pmc-layout__disclaimer\" role=\"complementary\"> As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. <br/> Learn more: <a class=\"usa-link\" href=\"/about/disclaimer/\"> PMC Disclaimer </a> | <a class=\"usa-link\" href=\"/about/copyright/\"> PMC Copyright Notice </a> </div> </div> </div> <div class=\"grid-row pmc-wm desktop:margin-left-neg-6\"> <main class=\"usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0\" id=\"main-content\"> <section aria-label=\"Journal banner\" class=\"pmc-journal-banner text-center line-height-none\"> <img alt=\"UKPMC Funders Author Manuscripts logo\" height=\"75\" src=\"https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-wtpa2.gif\" usemap=\"#pmc-banner-imagemap\" width=\"500\"/> <map name=\"pmc-banner-imagemap\"> <area alt=\"Link to UKPMC Funders Author Manuscripts\" href=\"http://europepmc.org/\" rel=\"noopener noreferrer\" shape=\"default\" target=\"_blank\" title=\"Link to UKPMC Funders Author Manuscripts\"/> </map> </section> <article lang=\"en\"> <section aria-label=\"Article citation and metadata\"> <section class=\"pmc-layout__citation font-secondary font-xs\"> <div> <div class=\"display-inline-block\"> <button aria-controls=\"journal_context_menu\" aria-expanded=\"false\" class=\"cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary\" type=\"button\"> Cancer Cell </button> </div> . Author manuscript; available in PMC: 2024 Jun 14. </div> <div> <em> Published in final edited form as: </em> Cancer Cell. 2024 Jan 25;42(2):225\u2013237.e5. doi: <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1016/j.ccell.2024.01.001\" rel=\"noopener noreferrer\" target=\"_blank\"> 10.1016/j.ccell.2024.01.001 </a> </div> <nav hidden=\"hidden\" id=\"journal_context_menu\"> <ul class=\"menu-list font-family-ui\" role=\"menu\"> <li role=\"presentation\"> <a class=\"usa-link\" href=\"https://www.ncbi.nlm.nih.gov/pmc/?term=%22Cancer%20Cell%22%5Bjour%5D\" role=\"menuitem\"> Search in PMC </a> </li> <li role=\"presentation\"> <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Cancer%20Cell%22%5Bjour%5D\" lang=\"en\" role=\"menuitem\"> Search in PubMed </a> </li> <li role=\"presentation\"> <a class=\"usa-link\" href=\"https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Cancer%20Cell%22%5BTitle%20Abbreviation%5D\" role=\"menuitem\"> View in NLM Catalog </a> </li> <li role=\"presentation\"> <a class=\"usa-link\" href=\"?term=%22Cancer%20Cell%22%5Bjour%5D\" role=\"menuitem\"> Add to search </a> </li> </ul> </nav> </section> <section class=\"front-matter\"> <div class=\"ameta p font-secondary font-xs\"> <hgroup> <h1> Tumor- and circulating-free DNA methylation identifies clinically relevant small cell lung cancer subtypes </h1> </hgroup> <div class=\"cg p\"> <a aria-describedby=\"id1\" aria-expanded=\"false\" class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Heeke%20S%22%5BAuthor%5D\"> <span class=\"name western\"> Simon Heeke </span> </a> <div hidden=\"hidden\" id=\"id1\"> <h3> <span class=\"name western\"> Simon Heeke </span> </h3> <div class=\"p\"> <sup> 1 </sup> Department of Thoracic/Head &amp; Neck Medical Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX, USA </div> <div class=\"p\"> Find articles by <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Heeke%20S%22%5BAuthor%5D\"> <span class=\"name western\"> Simon Heeke </span> </a> </div> </div> <sup> 1 </sup> , <a aria-describedby=\"id2\" aria-expanded=\"false\" class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Gay%20CM%22%5BAuthor%5D\"> <span class=\"name western\"> Carl M Gay </span> </a> <div hidden=\"hidden\" id=\"id2\"> <h3> <span class=\"name western\"> Carl M Gay </span> </h3> <div class=\"p\"> <sup> 1 </sup> Department of Thoracic/Head &amp; Neck Medical Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX, USA </div> <div class=\"p\"> Find articles by <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Gay%20CM%22%5BAuthor%5D\"> <span class=\"name western\"> Carl M Gay </span> </a> </div> </div> <sup> 1 </sup> , <a aria-describedby=\"id3\" aria-expanded=\"false\" class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Estecio%20MR%22%5BAuthor%5D\"> <span class=\"name western\"> Marcos R Estecio </span> </a> <div hidden=\"hidden\" id=\"id3\"> <h3> <span class=\"name western\"> Marcos R Estecio </span> </h3> <div class=\"p\"> <sup> 2 </sup> Epigenetic and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, USA </div> <div class=\"p\"> Find articles by <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Estecio%20MR%22%5BAuthor%5D\"> <span class=\"name western\"> Marcos R Estecio </span> </a> </div> </div> <sup> 2 </sup> , <a aria-describedby=\"id4\" aria-expanded=\"false\" class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Tran%20H%22%5BAuthor%5D\"> <span class=\"name western\"> Hai Tran </span> </a> <div hidden=\"hidden\" id=\"id4\"> <h3> <span class=\"name western\"> Hai Tran </span> </h3> <div class=\"p\"> <sup> 1 </sup> Department of Thoracic/Head &amp; Neck Medical Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX, USA </div> <div class=\"p\"> Find articles by <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Tran%20H%22%5BAuthor%5D\"> <span class=\"name western\"> Hai Tran </span> </a> </div> </div> <sup> 1 </sup> , <a aria-describedby=\"id5\" aria-expanded=\"false\" class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Morris%20BB%22%5BAuthor%5D\"> <span class=\"name western\"> Benjamin B Morris </span> </a> <div hidden=\"hidden\" id=\"id5\"> <h3> <span class=\"name western\"> Benjamin B Morris </span> </h3> <div class=\"p\"> <sup> 1 </sup> Department of Thoracic/Head &amp; Neck Medical Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX, USA </div> <div class=\"p\"> Find articles by <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Morris%20BB%22%5BAuthor%5D\"> <span class=\"name western\"> Benjamin B Morris </span> </a> </div> </div> <sup> 1 </sup> , <a aria-describedby=\"id6\" aria-expanded=\"false\" class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20B%22%5BAuthor%5D\"> <span class=\"name western\"> Bingnan Zhang </span> </a> <div hidden=\"hidden\" id=\"id6\"> <h3> <span class=\"name western\"> Bingnan Zhang </span> </h3> <div class=\"p\"> <sup> 1 </sup> Department of Thoracic/Head &amp; Neck Medical Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX, USA </div> <div class=\"p\"> Find articles by <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20B%22%5BAuthor%5D\"> <span class=\"name western\"> Bingnan Zhang </span> </a> </div> </div> <sup> 1 </sup> , <a aria-describedby=\"id7\" aria-expanded=\"false\" class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Tang%20X%22%5BAuthor%5D\"> <span class=\"name western\"> Ximing Tang </span> </a> <div hidden=\"hidden\" id=\"id7\"> <h3> <span class=\"name western\"> Ximing Tang </span> </h3> <div class=\"p\"> <sup> 3 </sup> Department of Translational Molecular Pathology, the University of Texas MD Anderson Cancer Center, Houston, TX, USA </div> <div class=\"p\"> Find articles by <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Tang%20X%22%5BAuthor%5D\"> <span class=\"name western\"> Ximing Tang </span> </a> </div> </div> <sup> 3 </sup> , <a aria-describedby=\"id8\" aria-expanded=\"false\" class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Raso%20MG%22%5BAuthor%5D\"> <span class=\"name western\"> Maria Gabriela Raso </span> </a> <div hidden=\"hidden\" id=\"id8\"> <h3> <span class=\"name western\"> Maria Gabriela Raso </span> </h3> <div class=\"p\"> <sup> 3 </sup> Department of Translational Molecular Pathology, the University of Texas MD Anderson Cancer Center, Houston, TX, USA </div> <div class=\"p\"> Find articles by <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Raso%20MG%22%5BAuthor%5D\"> <span class=\"name western\"> Maria Gabriela Raso </span> </a> </div> </div> <sup> 3 </sup> , <a aria-describedby=\"id9\" aria-expanded=\"false\" class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Rocha%20P%22%5BAuthor%5D\"> <span class=\"name western\"> Pedro Rocha </span> </a> <div hidden=\"hidden\" id=\"id9\"> <h3> <span class=\"name western\"> Pedro Rocha </span> </h3> <div class=\"p\"> <sup> 4 </sup> Medical Oncology Department, Hospital del Mar, Barcelona, Spain </div> <div class=\"p\"> Find articles by <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Rocha%20P%22%5BAuthor%5D\"> <span class=\"name western\"> Pedro Rocha </span> </a> </div> </div> <sup> 4 </sup> , <a aria-describedby=\"id10\" aria-expanded=\"false\" class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Lai%20S%22%5BAuthor%5D\"> <span class=\"name western\"> Siqi Lai </span> </a> <div hidden=\"hidden\" id=\"id10\"> <h3> <span class=\"name western\"> Siqi Lai </span> </h3> <div class=\"p\"> <sup> 5 </sup> Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA </div> <div class=\"p\"> <sup> 6 </sup> Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center UTHealth Houston, Houston, TX, USA </div> <div class=\"p\"> Find articles by <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Lai%20S%22%5BAuthor%5D\"> <span class=\"name western\"> Siqi Lai </span> </a> </div> </div> <sup> 5, </sup> <sup> 6 </sup> , <a aria-describedby=\"id11\" aria-expanded=\"false\" class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Arriola%20E%22%5BAuthor%5D\"> <span class=\"name western\"> Edurne Arriola </span> </a> <div hidden=\"hidden\" id=\"id11\"> <h3> <span class=\"name western\"> Edurne Arriola </span> </h3> <div class=\"p\"> <sup> 4 </sup> Medical Oncology Department, Hospital del Mar, Barcelona, Spain </div> <div class=\"p\"> Find articles by <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Arriola%20E%22%5BAuthor%5D\"> <span class=\"name western\"> Edurne Arriola </span> </a> </div> </div> <sup> 4 </sup> , <a aria-describedby=\"id12\" aria-expanded=\"false\" class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Hofman%20P%22%5BAuthor%5D\"> <span class=\"name western\"> Paul Hofman </span> </a> <div hidden=\"hidden\" id=\"id12\"> <h3> <span class=\"name western\"> Paul Hofman </span> </h3> <div class=\"p\"> <sup> 7 </sup> Laboratory of Clinical and Experimental Pathology, IHU RespirERA, Nice Hospital, University C\u00f4te d\u2019Azur, Nice, France </div> <div class=\"p\"> Find articles by <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Hofman%20P%22%5BAuthor%5D\"> <span class=\"name western\"> Paul Hofman </span> </a> </div> </div> <sup> 7 </sup> , <a aria-describedby=\"id13\" aria-expanded=\"false\" class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Hofman%20V%22%5BAuthor%5D\"> <span class=\"name western\"> Veronique Hofman </span> </a> <div hidden=\"hidden\" id=\"id13\"> <h3> <span class=\"name western\"> Veronique Hofman </span> </h3> <div class=\"p\"> <sup> 7 </sup> Laboratory of Clinical and Experimental Pathology, IHU RespirERA, Nice Hospital, University C\u00f4te d\u2019Azur, Nice, France </div> <div class=\"p\"> Find articles by <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Hofman%20V%22%5BAuthor%5D\"> <span class=\"name western\"> Veronique Hofman </span> </a> </div> </div> <sup> 7 </sup> , <a aria-describedby=\"id14\" aria-expanded=\"false\" class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Kopparapu%20P%22%5BAuthor%5D\"> <span class=\"name western\"> Prasad Kopparapu </span> </a> <div hidden=\"hidden\" id=\"id14\"> <h3> <span class=\"name western\"> Prasad Kopparapu </span> </h3> <div class=\"p\"> <sup> 8 </sup> Department of Medicine, Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, TN, USA </div> <div class=\"p\"> Find articles by <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Kopparapu%20P%22%5BAuthor%5D\"> <span class=\"name western\"> Prasad Kopparapu </span> </a> </div> </div> <sup> 8 </sup> , <a aria-describedby=\"id15\" aria-expanded=\"false\" class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Lovly%20CM%22%5BAuthor%5D\"> <span class=\"name western\"> Christine M Lovly </span> </a> <div hidden=\"hidden\" id=\"id15\"> <h3> <span class=\"name western\"> Christine M Lovly </span> </h3> <div class=\"p\"> <sup> 8 </sup> Department of Medicine, Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, TN, USA </div> <div class=\"p\"> Find articles by <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Lovly%20CM%22%5BAuthor%5D\"> <span class=\"name western\"> Christine M Lovly </span> </a> </div> </div> <sup> 8 </sup> , <a aria-describedby=\"id16\" aria-expanded=\"false\" class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Concannon%20K%22%5BAuthor%5D\"> <span class=\"name western\"> Kyle Concannon </span> </a> <div hidden=\"hidden\" id=\"id16\"> <h3> <span class=\"name western\"> Kyle Concannon </span> </h3> <div class=\"p\"> <sup> 1 </sup> Department of Thoracic/Head &amp; Neck Medical Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX, USA </div> <div class=\"p\"> Find articles by <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Concannon%20K%22%5BAuthor%5D\"> <span class=\"name western\"> Kyle Concannon </span> </a> </div> </div> <sup> 1 </sup> , <a aria-describedby=\"id17\" aria-expanded=\"false\" class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22De%20Sousa%20LG%22%5BAuthor%5D\"> <span class=\"name western\"> Luana Guimaraes De Sousa </span> </a> <div hidden=\"hidden\" id=\"id17\"> <h3> <span class=\"name western\"> Luana Guimaraes De Sousa </span> </h3> <div class=\"p\"> <sup> 1 </sup> Department of Thoracic/Head &amp; Neck Medical Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX, USA </div> <div class=\"p\"> Find articles by <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22De%20Sousa%20LG%22%5BAuthor%5D\"> <span class=\"name western\"> Luana Guimaraes De Sousa </span> </a> </div> </div> <sup> 1 </sup> , <a aria-describedby=\"id18\" aria-expanded=\"false\" class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Lewis%20WE%22%5BAuthor%5D\"> <span class=\"name western\"> Whitney Elisabeth Lewis </span> </a> <div hidden=\"hidden\" id=\"id18\"> <h3> <span class=\"name western\"> Whitney Elisabeth Lewis </span> </h3> <div class=\"p\"> <sup> 1 </sup> Department of Thoracic/Head &amp; Neck Medical Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX, USA </div> <div class=\"p\"> Find articles by <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Lewis%20WE%22%5BAuthor%5D\"> <span class=\"name western\"> Whitney Elisabeth Lewis </span> </a> </div> </div> <sup> 1 </sup> , <a aria-describedby=\"id19\" aria-expanded=\"false\" class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Kondo%20K%22%5BAuthor%5D\"> <span class=\"name western\"> Kimie Kondo </span> </a> <div hidden=\"hidden\" id=\"id19\"> <h3> <span class=\"name western\"> Kimie Kondo </span> </h3> <div class=\"p\"> <sup> 2 </sup> Epigenetic and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, USA </div> <div class=\"p\"> Find articles by <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Kondo%20K%22%5BAuthor%5D\"> <span class=\"name western\"> Kimie Kondo </span> </a> </div> </div> <sup> 2 </sup> , <a aria-describedby=\"id20\" aria-expanded=\"false\" class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Hu%20X%22%5BAuthor%5D\"> <span class=\"name western\"> Xin Hu </span> </a> <div hidden=\"hidden\" id=\"id20\"> <h3> <span class=\"name western\"> Xin Hu </span> </h3> <div class=\"p\"> <sup> 9 </sup> Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA </div> <div class=\"p\"> Find articles by <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Hu%20X%22%5BAuthor%5D\"> <span class=\"name western\"> Xin Hu </span> </a> </div> </div> <sup> 9 </sup> , <a aria-describedby=\"id21\" aria-expanded=\"false\" class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Tanimoto%20A%22%5BAuthor%5D\"> <span class=\"name western\"> Azusa Tanimoto </span> </a> <div hidden=\"hidden\" id=\"id21\"> <h3> <span class=\"name western\"> Azusa Tanimoto </span> </h3> <div class=\"p\"> <sup> 1 </sup> Department of Thoracic/Head &amp; Neck Medical Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX, USA </div> <div class=\"p\"> Find articles by <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Tanimoto%20A%22%5BAuthor%5D\"> <span class=\"name western\"> Azusa Tanimoto </span> </a> </div> </div> <sup> 1 </sup> , <a aria-describedby=\"id22\" aria-expanded=\"false\" class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Vokes%20NI%22%5BAuthor%5D\"> <span class=\"name western\"> Natalie I Vokes </span> </a> <div hidden=\"hidden\" id=\"id22\"> <h3> <span class=\"name western\"> Natalie I Vokes </span> </h3> <div class=\"p\"> <sup> 1 </sup> Department of Thoracic/Head &amp; Neck Medical Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX, USA </div> <div class=\"p\"> Find articles by <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Vokes%20NI%22%5BAuthor%5D\"> <span class=\"name western\"> Natalie I Vokes </span> </a> </div> </div> <sup> 1 </sup> , <a aria-describedby=\"id23\" aria-expanded=\"false\" class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Nilsson%20MB%22%5BAuthor%5D\"> <span class=\"name western\"> Monique B Nilsson </span> </a> <div hidden=\"hidden\" id=\"id23\"> <h3> <span class=\"name western\"> Monique B Nilsson </span> </h3> <div class=\"p\"> <sup> 1 </sup> Department of Thoracic/Head &amp; Neck Medical Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX, USA </div> <div class=\"p\"> Find articles by <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Nilsson%20MB%22%5BAuthor%5D\"> <span class=\"name western\"> Monique B Nilsson </span> </a> </div> </div> <sup> 1 </sup> , <a aria-describedby=\"id24\" aria-expanded=\"false\" class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Stewart%20A%22%5BAuthor%5D\"> <span class=\"name western\"> Allison Stewart </span> </a> <div hidden=\"hidden\" id=\"id24\"> <h3> <span class=\"name western\"> Allison Stewart </span> </h3> <div class=\"p\"> <sup> 1 </sup> Department of Thoracic/Head &amp; Neck Medical Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX, USA </div> <div class=\"p\"> Find articles by <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Stewart%20A%22%5BAuthor%5D\"> <span class=\"name western\"> Allison Stewart </span> </a> </div> </div> <sup> 1 </sup> , <a aria-describedby=\"id25\" aria-expanded=\"false\" class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Jansen%20M%22%5BAuthor%5D\"> <span class=\"name western\"> Maarten Jansen </span> </a> <div hidden=\"hidden\" id=\"id25\"> <h3> <span class=\"name western\"> Maarten Jansen </span> </h3> <div class=\"p\"> <sup> 10 </sup> Pulmonary Dept, Ziekenhuisgroep Twente, Hengelo, The Netherlands </div> <div class=\"p\"> Find articles by <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Jansen%20M%22%5BAuthor%5D\"> <span class=\"name western\"> Maarten Jansen </span> </a> </div> </div> <sup> 10 </sup> , <a aria-describedby=\"id26\" aria-expanded=\"false\" class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Horv%C3%A1th%20I%22%5BAuthor%5D\"> <span class=\"name western\"> Ildik\u00f3 Horv\u00e1th </span> </a> <div hidden=\"hidden\" id=\"id26\"> <h3> <span class=\"name western\"> Ildik\u00f3 Horv\u00e1th </span> </h3> <div class=\"p\"> <sup> 11 </sup> National Kor\u00e1nyi Institute of Pulmonology, Budapest, Hungary </div> <div class=\"p\"> Find articles by <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Horv%C3%A1th%20I%22%5BAuthor%5D\"> <span class=\"name western\"> Ildik\u00f3 Horv\u00e1th </span> </a> </div> </div> <sup> 11 </sup> , <a aria-describedby=\"id27\" aria-expanded=\"false\" class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Gaga%20M%22%5BAuthor%5D\"> <span class=\"name western\"> Mina Gaga </span> </a> <div hidden=\"hidden\" id=\"id27\"> <h3> <span class=\"name western\"> Mina Gaga </span> </h3> <div class=\"p\"> <sup> 12 </sup> 7th Respiratory Medicine Dept, Athens Chest Hospital, Athens, Greece </div> <div class=\"p\"> Find articles by <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Gaga%20M%22%5BAuthor%5D\"> <span class=\"name western\"> Mina Gaga </span> </a> </div> </div> <sup> 12 </sup> , <a aria-describedby=\"id28\" aria-expanded=\"false\" class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Panagoulias%20V%22%5BAuthor%5D\"> <span class=\"name western\"> Vasileios Panagoulias </span> </a> <div hidden=\"hidden\" id=\"id28\"> <h3> <span class=\"name western\"> Vasileios Panagoulias </span> </h3> <div class=\"p\"> <sup> 13 </sup> 2nd Respiratory Medicine Dept, Athens Chest Hospital, Athens, Greece </div> <div class=\"p\"> Find articles by <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Panagoulias%20V%22%5BAuthor%5D\"> <span class=\"name western\"> Vasileios Panagoulias </span> </a> </div> </div> <sup> 13 </sup> , <a aria-describedby=\"id29\" aria-expanded=\"false\" class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Raviv%20Y%22%5BAuthor%5D\"> <span class=\"name western\"> Yael Raviv </span> </a> <div hidden=\"hidden\" id=\"id29\"> <h3> <span class=\"name western\"> Yael Raviv </span> </h3> <div class=\"p\"> <sup> 14 </sup> Dept of Medicine, Pulmonology, Institute, Soroka Medical Center, Ben-Gurion University, Beer-Sheva, Israel </div> <div class=\"p\"> Find articles by <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Raviv%20Y%22%5BAuthor%5D\"> <span class=\"name western\"> Yael Raviv </span> </a> </div> </div> <sup> 14 </sup> , <a aria-describedby=\"id30\" aria-expanded=\"false\" class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Frumkin%20D%22%5BAuthor%5D\"> <span class=\"name western\"> Danny Frumkin </span> </a> <div hidden=\"hidden\" id=\"id30\"> <h3> <span class=\"name western\"> Danny Frumkin </span> </h3> <div class=\"p\"> <sup> 15 </sup> Nucleix Ltd. Rehovot, Israel </div> <div class=\"p\"> Find articles by <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Frumkin%20D%22%5BAuthor%5D\"> <span class=\"name western\"> Danny Frumkin </span> </a> </div> </div> <sup> 15 </sup> , <a aria-describedby=\"id31\" aria-expanded=\"false\" class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Wasserstrom%20A%22%5BAuthor%5D\"> <span class=\"name western\"> Adam Wasserstrom </span> </a> <div hidden=\"hidden\" id=\"id31\"> <h3> <span class=\"name western\"> Adam Wasserstrom </span> </h3> <div class=\"p\"> <sup> 15 </sup> Nucleix Ltd. Rehovot, Israel </div> <div class=\"p\"> Find articles by <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Wasserstrom%20A%22%5BAuthor%5D\"> <span class=\"name western\"> Adam Wasserstrom </span> </a> </div> </div> <sup> 15 </sup> , <a aria-describedby=\"id32\" aria-expanded=\"false\" class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Shuali%20A%22%5BAuthor%5D\"> <span class=\"name western\"> Aharona Shuali </span> </a> <div hidden=\"hidden\" id=\"id32\"> <h3> <span class=\"name western\"> Aharona Shuali </span> </h3> <div class=\"p\"> <sup> 15 </sup> Nucleix Ltd. Rehovot, Israel </div> <div class=\"p\"> Find articles by <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Shuali%20A%22%5BAuthor%5D\"> <span class=\"name western\"> Aharona Shuali </span> </a> </div> </div> <sup> 15 </sup> , <a aria-describedby=\"id33\" aria-expanded=\"false\" class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Schnabel%20CA%22%5BAuthor%5D\"> <span class=\"name western\"> Catherine A Schnabel </span> </a> <div hidden=\"hidden\" id=\"id33\"> <h3> <span class=\"name western\"> Catherine A Schnabel </span> </h3> <div class=\"p\"> <sup> 16 </sup> Nucleix Inc. San Diego, CA, USA </div> <div class=\"p\"> Find articles by <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Schnabel%20CA%22%5BAuthor%5D\"> <span class=\"name western\"> Catherine A Schnabel </span> </a> </div> </div> <sup> 16 </sup> , <a aria-describedby=\"id34\" aria-expanded=\"false\" class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Xi%20Y%22%5BAuthor%5D\"> <span class=\"name western\"> Yuanxin Xi </span> </a> <div hidden=\"hidden\" id=\"id34\"> <h3> <span class=\"name western\"> Yuanxin Xi </span> </h3> <div class=\"p\"> <sup> 17 </sup> Department of Bioinformatics and Computational Biology, the University of Texas MD Anderson Cancer Center, Houston, TX, USA </div> <div class=\"p\"> Find articles by <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Xi%20Y%22%5BAuthor%5D\"> <span class=\"name western\"> Yuanxin Xi </span> </a> </div> </div> <sup> 17 </sup> , <a aria-describedby=\"id35\" aria-expanded=\"false\" class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Diao%20L%22%5BAuthor%5D\"> <span class=\"name western\"> Lixia Diao </span> </a> <div hidden=\"hidden\" id=\"id35\"> <h3> <span class=\"name western\"> Lixia Diao </span> </h3> <div class=\"p\"> <sup> 17 </sup> Department of Bioinformatics and Computational Biology, the University of Texas MD Anderson Cancer Center, Houston, TX, USA </div> <div class=\"p\"> Find articles by <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Diao%20L%22%5BAuthor%5D\"> <span class=\"name western\"> Lixia Diao </span> </a> </div> </div> <sup> 17 </sup> , <a aria-describedby=\"id36\" aria-expanded=\"false\" class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20Q%22%5BAuthor%5D\"> <span class=\"name western\"> Qi Wang </span> </a> <div hidden=\"hidden\" id=\"id36\"> <h3> <span class=\"name western\"> Qi Wang </span> </h3> <div class=\"p\"> <sup> 17 </sup> Department of Bioinformatics and Computational Biology, the University of Texas MD Anderson Cancer Center, Houston, TX, USA </div> <div class=\"p\"> Find articles by <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20Q%22%5BAuthor%5D\"> <span class=\"name western\"> Qi Wang </span> </a> </div> </div> <sup> 17 </sup> , <a aria-describedby=\"id37\" aria-expanded=\"false\" class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20J%22%5BAuthor%5D\"> <span class=\"name western\"> Jianjun Zhang </span> </a> <div hidden=\"hidden\" id=\"id37\"> <h3> <span class=\"name western\"> Jianjun Zhang </span> </h3> <div class=\"p\"> <sup> 1 </sup> Department of Thoracic/Head &amp; Neck Medical Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX, USA </div> <div class=\"p\"> <sup> 9 </sup> Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA </div> <div class=\"p\"> Find articles by <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20J%22%5BAuthor%5D\"> <span class=\"name western\"> Jianjun Zhang </span> </a> </div> </div> <sup> 1, </sup> <sup> 9 </sup> , <a aria-describedby=\"id38\" aria-expanded=\"false\" class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Van%20Loo%20P%22%5BAuthor%5D\"> <span class=\"name western\"> Peter Van Loo </span> </a> <div hidden=\"hidden\" id=\"id38\"> <h3> <span class=\"name western\"> Peter Van Loo </span> </h3> <div class=\"p\"> <sup> 5 </sup> Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA </div> <div class=\"p\"> <sup> 9 </sup> Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA </div> <div class=\"p\"> <sup> 18 </sup> The Francis Crick Institute, London, UK </div> <div class=\"p\"> Find articles by <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Van%20Loo%20P%22%5BAuthor%5D\"> <span class=\"name western\"> Peter Van Loo </span> </a> </div> </div> <sup> 5, </sup> <sup> 9, </sup> <sup> 18 </sup> , <a aria-describedby=\"id39\" aria-expanded=\"false\" class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20J%22%5BAuthor%5D\"> <span class=\"name western\"> Jing Wang </span> </a> <div hidden=\"hidden\" id=\"id39\"> <h3> <span class=\"name western\"> Jing Wang </span> </h3> <div class=\"p\"> <sup> 17 </sup> Department of Bioinformatics and Computational Biology, the University of Texas MD Anderson Cancer Center, Houston, TX, USA </div> <div class=\"p\"> Find articles by <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20J%22%5BAuthor%5D\"> <span class=\"name western\"> Jing Wang </span> </a> </div> </div> <sup> 17 </sup> , <a aria-describedby=\"id40\" aria-expanded=\"false\" class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Wistuba%20II%22%5BAuthor%5D\"> <span class=\"name western\"> Ignacio I Wistuba </span> </a> <div hidden=\"hidden\" id=\"id40\"> <h3> <span class=\"name western\"> Ignacio I Wistuba </span> </h3> <div class=\"p\"> <sup> 3 </sup> Department of Translational Molecular Pathology, the University of Texas MD Anderson Cancer Center, Houston, TX, USA </div> <div class=\"p\"> Find articles by <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Wistuba%20II%22%5BAuthor%5D\"> <span class=\"name western\"> Ignacio I Wistuba </span> </a> </div> </div> <sup> 3 </sup> , <a aria-describedby=\"id41\" aria-expanded=\"false\" class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Byers%20LA%22%5BAuthor%5D\"> <span class=\"name western\"> Lauren A Byers </span> </a> <div hidden=\"hidden\" id=\"id41\"> <h3> <span class=\"name western\"> Lauren A Byers </span> </h3> <div class=\"p\"> <sup> 1 </sup> Department of Thoracic/Head &amp; Neck Medical Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX, USA </div> <div class=\"p\"> Find articles by <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Byers%20LA%22%5BAuthor%5D\"> <span class=\"name western\"> Lauren A Byers </span> </a> </div> </div> <sup> 1, </sup> <sup> \u20b8 </sup> , <a aria-describedby=\"id42\" aria-expanded=\"false\" class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Heymach%20JV%22%5BAuthor%5D\"> <span class=\"name western\"> John V Heymach </span> </a> <div hidden=\"hidden\" id=\"id42\"> <h3> <span class=\"name western\"> John V Heymach </span> </h3> <div class=\"p\"> <sup> 1 </sup> Department of Thoracic/Head &amp; Neck Medical Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX, USA </div> <div class=\"p\"> Find articles by <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Heymach%20JV%22%5BAuthor%5D\"> <span class=\"name western\"> John V Heymach </span> </a> </div> </div> <sup> 1, </sup> <sup> \u20b8 </sup> </div> <ul class=\"d-buttons inline-list\"> <li> <button aria-controls=\"aip_a\" aria-expanded=\"false\" class=\"d-button\"> Author information </button> </li> <li> <button aria-controls=\"anp_a\" aria-expanded=\"false\" class=\"d-button\"> Article notes </button> </li> <li> <button aria-controls=\"clp_a\" aria-expanded=\"false\" class=\"d-button\"> Copyright and License information </button> </li> </ul> <div class=\"d-panels font-secondary-light\"> <div class=\"d-panel p\" id=\"aip_a\"> <div class=\"p\" id=\"A1\"> <sup> 1 </sup> Department of Thoracic/Head &amp; Neck Medical Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX, USA </div> <div id=\"A2\"> <sup> 2 </sup> Epigenetic and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, USA </div> <div id=\"A3\"> <sup> 3 </sup> Department of Translational Molecular Pathology, the University of Texas MD Anderson Cancer Center, Houston, TX, USA </div> <div id=\"A4\"> <sup> 4 </sup> Medical Oncology Department, Hospital del Mar, Barcelona, Spain </div> <div id=\"A5\"> <sup> 5 </sup> Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA </div> <div id=\"A6\"> <sup> 6 </sup> Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center UTHealth Houston, Houston, TX, USA </div> <div id=\"A7\"> <sup> 7 </sup> Laboratory of Clinical and Experimental Pathology, IHU RespirERA, Nice Hospital, University C\u00f4te d\u2019Azur, Nice, France </div> <div id=\"A8\"> <sup> 8 </sup> Department of Medicine, Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, TN, USA </div> <div id=\"A9\"> <sup> 9 </sup> Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA </div> <div id=\"A10\"> <sup> 10 </sup> Pulmonary Dept, Ziekenhuisgroep Twente, Hengelo, The Netherlands </div> <div id=\"A11\"> <sup> 11 </sup> National Kor\u00e1nyi Institute of Pulmonology, Budapest, Hungary </div> <div id=\"A12\"> <sup> 12 </sup> 7th Respiratory Medicine Dept, Athens Chest Hospital, Athens, Greece </div> <div id=\"A13\"> <sup> 13 </sup> 2nd Respiratory Medicine Dept, Athens Chest Hospital, Athens, Greece </div> <div id=\"A14\"> <sup> 14 </sup> Dept of Medicine, Pulmonology, Institute, Soroka Medical Center, Ben-Gurion University, Beer-Sheva, Israel </div> <div id=\"A15\"> <sup> 15 </sup> Nucleix Ltd. Rehovot, Israel </div> <div id=\"A16\"> <sup> 16 </sup> Nucleix Inc. San Diego, CA, USA </div> <div id=\"A17\"> <sup> 17 </sup> Department of Bioinformatics and Computational Biology, the University of Texas MD Anderson Cancer Center, Houston, TX, USA </div> <div id=\"A18\"> <sup> 18 </sup> The Francis Crick Institute, London, UK </div> <div class=\"author-notes p\"> <div class=\"fn\" id=\"CR1\"> <sup> \u20b8 </sup> <p class=\"display-inline\"> Corresponding Authors: John V. Heymach and Lauren A. Byers </p> </div> <div class=\"fn\" id=\"FN1\"> <p id=\"P1\"> Lead contact: John V. Heymach, <span> jheymach@mdanderson.org </span> </p> </div> </div> </div> <div class=\"d-panel p\" id=\"anp_a\"> <div class=\"notes p\"> <section class=\"history\" id=\"historyarticle-meta1\"> <p> Issue date 2024 Feb 12. </p> </section> </div> </div> <div class=\"d-panel p\" id=\"clp_a\"> <p> This work is licensed under a <a class=\"usa-link usa-link--external\" href=\"https://creativecommons.org/licenses/by/4.0/\" rel=\"noopener noreferrer\" target=\"_blank\"> BY 4.0 </a> International license. </p> <div class=\"p\"> <a class=\"usa-link\" href=\"/about/copyright/\"> PMC Copyright notice </a> </div> </div> </div> <div> PMCID: PMC10982990 EMSID: EMS195999 PMID: <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/38278149/\"> 38278149 </a> </div> <div aria-label=\"Related or updated information about this article\" class=\"ra xbox p\" role=\"complementary\"> <div> The publisher's version of this article is available at <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1016/j.ccell.2024.01.001\" rel=\"noopener noreferrer\" target=\"_blank\"> Cancer Cell </a> </div> </div> </div> </section> </section> <section aria-label=\"Article content\"> <section class=\"body main-article-body\"> <section class=\"abstract\" id=\"abstract1\"> <h2> <a class=\"usa-anchor\" id=\"abstract1-anchor\"> </a> Summary </h2> <p id=\"P2\"> Small-cell lung cancer (SCLC) is an aggressive malignancy composed of distinct transcriptional subtypes, but implementing subtyping in the clinic has remained challenging, particularly due to limited tissue availability. Given the known epigenetic regulation of critical SCLC transcriptional programs, we hypothesized that subtype-specific patterns of DNA methylation could be detected in tumor or blood from SCLC patients. Using genomic-wide reduced-representation bisulfite sequencing (RRBS) in two cohorts totallying 179 SCLC patients and using machine learning approaches, we report a highly accurate DNA methylation-based classifier (SCLC-DMC) that can distinguish SCLC subtypes. We further adjust the classifier for circulating-free DNA (cfDNA) to subtype SCLC from plasma. Using the cfDNA classifier (cfDMC) we demonstrate that SCLC phenotypes can evolve during disease progression, highlighting the need for longitudinal tracking of SCLC during clinical treatment. These data establish that tumor and cfDNA methylation can be used to identify SCLC subtypes and might guide precision SCLC therapy. </p> </section> <section id=\"S1\"> <h2 class=\"pmc_sec_title\"> <a class=\"usa-anchor\" id=\"S1-anchor\"> </a> Introduction </h2> <p id=\"P3\"> Small cell lung cancer (SCLC) is a highly aggressive form of lung cancer with limited treatment options and generally poor prognosis. SCLC patient outcomes are only modestly improved with the addition of immunotherapy to frontline platinum-etoposide chemotherapy in an unselected population <sup> <a aria-describedby=\"R1\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R1\"> 1 </a> , <a aria-describedby=\"R2\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R2\"> 2 </a> </sup> . Currently, there are no targeted therapies or predictive biomarkers in routine clinical use for SCLC patients, although several are currently under investigation including DLL3 protein expression for the use of DLL3-directed CAR-T cell <sup> <a aria-describedby=\"R3\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R3\"> 3 </a> </sup> or bispecific-antibody targeting <sup> <a aria-describedby=\"R4\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R4\"> 4 </a> , <a aria-describedby=\"R5\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R5\"> 5 </a> </sup> as well as SLFN11 expression to select patients for PARP-inhibitor treatments <sup> <a aria-describedby=\"R6\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R6\"> 6 </a> </sup> . Despite these efforts, the 2-year survival rate has not changed appreciably during the past decade <sup> <a aria-describedby=\"R7\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R7\"> 7 </a> </sup> . </p> <p id=\"P4\"> Although SCLC has historically been treated as a single disease entity, recent studies have revealed that there are biologically distinct subgroups of SCLC, and that these subgroups have different therapeutic vulnerabilities and hence could be used for tailoring treatment regimens <sup> <a aria-describedby=\"R8\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R8\"> 8 </a> \u2013 <a aria-describedby=\"R11\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R11\"> 11 </a> </sup> . We recently reported on four distinct SCLC subgroups based on mRNA profiling <sup> <a aria-describedby=\"R10\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R10\"> 10 </a> </sup> . Three of the four subtypes are enriched in the predominant expression of specific transcription factors, <em> ASCL1 </em> (SCLC-A), <em> NEUROD1 </em> (SCLC-N), and <em> POU2F3 </em> (SCLC-P) while the fourth is an inflamed subtype (SCLC-I) associated with higher levels of PD-L1 and other checkpoint factors, and higher levels of interferon signaling and epithelial to mesenchymal transition (EMT) based on their transcriptomic signature <sup> <a aria-describedby=\"R10\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R10\"> 10 </a> </sup> . Importantly, in two independent analyses, the SCLC-I subtype is associated with the greatest benefit of the addition of immunotherapy to platinum-etoposide chemotherapy demonstrating the potentially predictive value of SCLC subtyping <sup> <a aria-describedby=\"R10\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R10\"> 10 </a> , <a aria-describedby=\"R12\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R12\"> 12 </a> </sup> . </p> <p id=\"P5\"> Given the growing recognition that SCLC is comprised of subtypes with distinct therapeutic vulnerabilities <sup> <a aria-describedby=\"R10\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R10\"> 10 </a> , <a aria-describedby=\"R13\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R13\"> 13 </a> , <a aria-describedby=\"R14\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R14\"> 14 </a> </sup> , the development of practical biomarkers for identifying patients likely to benefit from those therapies is urgently needed. Unfortunately, development of biomarkers in SCLC is hindered by the lack of access to tissue as diagnostic specimens are often limited to fine needle aspirations and surgery is rarely performed <sup> <a aria-describedby=\"R15\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R15\"> 15 </a> </sup> . Consequently, common subtyping approaches studied for SCLC - such as the use of mRNA expression signatures or multi-marker immunohistochemistry (IHC) - can typically be performed on only a subset of patients. These approaches also have shortcomings limiting their routine clinical adoption, such as mRNA degradation commonly seen in preserved SCLC specimens, and the use of subjective and time-intensive scoring methods used for multi-marker IHC assays. </p> <p id=\"P6\"> In contrast to the tissue limitations, SCLC is often associated with a high shedding of circulating tumor DNA (ctDNA) and circulating tumor cells (CTCs) and consequently, liquid biopsy strategies have been extensively researched in this setting <sup> <a aria-describedby=\"R16\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R16\"> 16 </a> \u2013 <a aria-describedby=\"R18\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R18\"> 18 </a> </sup> . While the development of circulating tumor cell derived xenograft models (CDX) allowed the mechanistic study of SCLC and has become indispensable for the development of novel therapeutic strategies <sup> <a aria-describedby=\"R19\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R19\"> 19 </a> , <a aria-describedby=\"R20\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R20\"> 20 </a> </sup> , liquid biopsies are also used for the development of biomarker approaches. Recently, it has been shown that DNA methylation, as a surrogate to gene expression, can be used for the development of prognostic signatures as well as to differentiate <em> ASCL1 </em> -dominant SCLC and <em> NEUROD1 </em> -dominant SCLC from a third group of SCLC which is highlighted by the absence of <em> ASCL1 </em> or <em> NEUROD1 </em> dominance <sup> <a aria-describedby=\"R21\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R21\"> 21 </a> </sup> . These and other approaches, including profiling of plasma-derived nucleosomes <sup> <a aria-describedby=\"R22\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R22\"> 22 </a> </sup> and fragmentomics analyses <sup> <a aria-describedby=\"R23\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R23\"> 23 </a> </sup> , have opened avenues for using liquid biopsies to guide precision medicine approaches in SCLC. However, previous analyses were limited by the absence of tumor specimens for direct comparison or profound subtyping of patients based on clinically validated gene expression-based subtyping which hampers the routine implementation of SCLC subtyping. Here, we therefore investigate the potential use of DNA methylation from both tumor and ctDNA in a cohort of 179 SCLC patients whose subtypes are assigned based on our recently established classification system <sup> <a aria-describedby=\"R10\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R10\"> 10 </a> </sup> . We develop machine learning approaches to allow the classification of SCLC subtypes using DNA methylation from both tissue and liquid biopsy samples in order to identify SCLC subgroups and enable precision medicine in SCLC. </p> </section> <section id=\"S2\"> <h2 class=\"pmc_sec_title\"> <a class=\"usa-anchor\" id=\"S2-anchor\"> </a> Results </h2> <section id=\"S3\"> <h3 class=\"pmc_sec_title\"> 1. Detection of SCLC using DNA methylation in plasma samples </h3> <p id=\"P7\"> We hypothesized that DNA methylation can be used to detect SCLC in the circulation and to test this we initially utilized a methylation-sensitive digestion PCR assay designed previously to detect lung cancer (EpiCheck assay). Evaluation was based on a cohort of 52 SCLC cases of which 50 (17 Limited Stage SCLC (LS-SCLC) and 33 Extensive Stage SCLC (ES-SCLC)) passed quality control and 398 control cases (395 passed quality control) of which 137 cases have been used in an earlier validation study <sup> <a aria-describedby=\"R24\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R24\"> 24 </a> </sup> . The area under the curve for the detection was 0.988 (95% CI: 0.977-0.999; <a class=\"usa-link\" href=\"#F1\"> Figure 1A </a> ). Two different cut-offs were used for the detection, yielding a sensitivity and specificity of 100.0% (95% CI: 92.9%-100.0%) and 83.8% (95% CI: 79.8%-87.3%) with the low cut-off (EpiScore = 65) and 94.0% (95% CI: 83.5%-98.7%) and 94.9% (95% CI: 92.3%-96.9%) with the high cut-off (EpiScore = 74), respectively ( <a class=\"usa-link\" href=\"#SD1\"> Figure S1A </a> ), with high sensitivity in both LS-SCLC ( <a class=\"usa-link\" href=\"#SD1\"> Figure S1B </a> ) and ES-SCLC ( <a class=\"usa-link\" href=\"#SD1\"> Figure S1C </a> ). Four of the six markers used have also been assessed in the subtyping cohort ( <a class=\"usa-link\" href=\"#T1\"> Table 1 </a> ) with high methylation levels detected across all four subtypes ( <a class=\"usa-link\" href=\"#SD2\"> Table S1 </a> ). </p> <figure class=\"fig xbox font-sm\" id=\"F1\"> <h4 class=\"obj_head\"> Figure 1. Detection and Classification of SCLC. </h4> <p class=\"img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center\"> <a class=\"tileshop\" href=\"https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=11178430_EMS195999-f001.jpg\" target=\"_blank\"> <img alt=\"Figure 1\" class=\"graphic zoom-in\" height=\"634\" loading=\"lazy\" src=\"https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae96/11178430/cdcacdc8211d/EMS195999-f001.jpg\" width=\"800\"/> </a> </p> <div class=\"p text-right font-secondary\"> <a class=\"usa-link\" href=\"figure/F1/\" rel=\"noopener noreferrer\" target=\"_blank\"> Open in a new tab </a> </div> <figcaption> <p> <strong> A </strong> Receiver operator characteristics (ROC) analysis of a DNA methylation-based test for the detection of SCLC from plasma. <strong> B </strong> Predictive models were generated to classify SCLC based on RNA-seq (Gene Ratio Classifier; GRC) and consensus of several combined predictive models is shown. A subtype was called when the consensus <span class=\"text-underline\"> &gt; </span> 0.5, else a sample was called equivocal. In addition, the expression of the three transcription factors ASCL1 (for SCLC-A), NEUROD1 (for SCLC-N) and POU2F3 (for SCLC-P) is shown normalized across the two cohorts. Furthermore, genes involved in neuroendocrine and non-neuroendocrine (Non-NE) as well as in tumor inflammation (TIS) and expression of HLA is shown. <strong> C </strong> Immune infiltration estimation using RNA-seq data (using the ESTIMATE algorithm). Boxplot shows the median as thick line, the box highlighting the first and third quartile with the whiskers highlighting 1.5x the interquartile range. <strong> D </strong> Characterization of SCLC consensus heterogeneity. The consensus agreement value for each subtype is plotted on the axis for each subtype by its consensus fraction of the respective subtype, demonstrating overlaps between SCLC subtypes. The line plot at the axis characterizes the distribution of subtypes across the axis. Wilcoxon test was used to compute p-values between groups. </p> <p> See also <a class=\"usa-link\" href=\"#SD1\"> Figure S1 </a> , <a class=\"usa-link\" href=\"#SD2\"> Table S1 </a> , and Data S1 and S2. </p> </figcaption> </figure> <section class=\"tw xbox font-sm\" id=\"T1\"> <h4 class=\"obj_head\"> Table 1. Overview of included patients for the whole cohort, cohort 1 (C1) and cohort 2 (C2). </h4> <div class=\"tbl-box p\" tabindex=\"0\"> <table class=\"content\" frame=\"box\" rules=\"groups\"> <thead> <tr> <th align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> </th> <th align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Group </th> <th align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> All </th> <th align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> C1 </th> <th align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> C2 </th> </tr> </thead> <tbody> <tr> <td align=\"left\" colspan=\"2\" rowspan=\"1\" valign=\"top\"> N </td> <td align=\"right\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> 179 </td> <td align=\"right\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> 105 </td> <td align=\"right\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> 74 </td> </tr> <tr> <td align=\"left\" colspan=\"2\" rowspan=\"1\" valign=\"top\"> <strong> Age (range) </strong> </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> 66 (26 - 96) </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> 66 (26 - 96) </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> 68 (45 - 82) </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"2\" valign=\"top\"> <strong> Sex (%) </strong> </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> F </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> 72 (40%) </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> 57 (54%) </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> 15 (20%) </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> M </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> 107 (60%) </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> 48 (46%) </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> 59 (80%) </td> </tr> <tr> <td align=\"left\" colspan=\"2\" rowspan=\"1\" valign=\"top\"> <strong> RNA-seq [Yes/No] </strong> </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> 142 (79%) </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> 85 (81%) </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> 57 (77%) </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"5\" valign=\"top\"> <strong> RNA classification (%) </strong> <br/> <strong> SCLC-GRC </strong> </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> SCLC-A </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> 75 (42%) </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> 47 (45%) </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> 28 (38%) </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> SCLC-N </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> 25 (14%) </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> 22 (21%) </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> 3 (4%) </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> SCLC-P </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> 15 (8%) </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> 4 (4%) </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> 11 (15%) </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> SCLC-I </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> 21 (12%) </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> 8 (8%) </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> 13 (18%) </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> equivocal </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> 6 (3%) </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> 4 (4%) </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> 2 (3%) </td> </tr> <tr> <td align=\"left\" colspan=\"2\" rowspan=\"1\" valign=\"top\"> <strong> RRBS [Yes/No] </strong> </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> 124 (69%) </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> 83 (79%) </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> 41 (55%) <sup> <a class=\"usa-link\" href=\"#TFN1\"> \u00a5 </a> </sup> </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"5\" valign=\"top\"> <strong> RRBS classification (%) </strong> <br/> <strong> SCLC-DMC </strong> </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> SCLC-A </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> 78 (44%) </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> 55 (52%) </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> 23 (31%) </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> SCLC-N </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> 23 (13%) </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> 20 (19%) </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> 3 (4%) </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> SCLC-P </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> 11 (6%) </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> 3 (3%) </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> 8 (11%) </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> SCLC-I </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> 11 (6%) </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> 5 (5%) </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> 6 (8%) </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> equivocal </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> 1 (1%) </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> 0 (0%) </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> 1 (1%) </td> </tr> <tr> <td align=\"left\" colspan=\"2\" rowspan=\"1\" valign=\"top\"> <strong> Both [RNA-seq &amp; RRBS] </strong> </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> 100 (56%) </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> 66 (63%) </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> 34 (46%) </td> </tr> </tbody> </table> </div> <div class=\"p text-right font-secondary\"> <a class=\"usa-link\" href=\"table/T1/\" rel=\"noopener noreferrer\" target=\"_blank\"> Open in a new tab </a> </div> <div class=\"tw-foot p\"> <div class=\"fn\" id=\"TFN1\"> <sup> \u00a5 </sup> <p class=\"display-inline\" id=\"P57\"> For 15/74 samples (21%) only previously extracted RNA was available and thus no RRBS could be performed. Excluding those samples, success rate for RRBS was 72% (41/57) for C2 and 76% (124/164) for the complete data set. </p> </div> </div> </section> </section> <section id=\"S4\"> <h3 class=\"pmc_sec_title\"> 2. Cohort of clinical specimens for RNA-seq and DNA methylation profiling </h3> <p id=\"P8\"> Given our finding that DNA methylation was able to detect SCLC from plasma, we next hypothesized that DNA methylation can be exploited as a biomarker to subtype SCLC. To this end we investigated two independent cohorts of 105 and 74 samples respectively ( <a class=\"usa-link\" href=\"#T1\"> Table 1 </a> ). Generation of RNA-seq and RRBS data was feasible in both cohorts, though in C2, only RNA instead of tissue sections was provided for a subset of samples, leading to a lower number of samples with tissue methylation data due to the absence of DNA specimen in this subset. Reasons for unsuccessful analysis were low RNA or DNA content, low DV200 for RNA or unsuccessful library generation. Processed RNA-seq data is shown in <a class=\"usa-link\" href=\"#SD1\"> Supplementary Data 1 </a> (for cohort 1) and <a class=\"usa-link\" href=\"#SD2\"> Supplementary Data 2 </a> (cohort 2). </p> </section> <section id=\"S5\"> <h3 class=\"pmc_sec_title\"> 3. Clinical SCLC can be classified using a reduced machine learning RNA-seq signature </h3> <p id=\"P9\"> We previously reported that SCLC can be classified in four distinct subtypes using a gene expression classifier derived from non-negative matrix factorization (NMF) <sup> <a aria-describedby=\"R10\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R10\"> 10 </a> </sup> and mRNA expression data from <sup> <a aria-describedby=\"R25\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R25\"> 25 </a> </sup> both limited stage and <sup> <a aria-describedby=\"R1\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R1\"> 1 </a> </sup> extensive stage SCLC specimens. However, our previously established NMF method is limited to analyzing cohorts only and thus we aimed to establish a predictive classifier to allow the subtyping of individual samples. Building on this analysis, we therefore developed a gene ratio classifier (SCLC-GRC) in order to reduce the number of genes required to subtype tumors and facilitate the subtype classification using different mRNA profiling methods. Using a consensus classification (see <a class=\"usa-link\" href=\"#S13\"> STAR methods </a> ) incorporating 181 genes, we were able to unambiguously classify the majority of samples into a single subtype, notably independent of the cohort and underlying RNA-seq method used ( <a class=\"usa-link\" href=\"#SD2\"> Table S1 </a> , <a class=\"usa-link\" href=\"#F1\"> Figure 1B </a> ). Across both cohorts, unambiguous subtyping was achieved for 136/142 (96%) of samples with RNA-seq data ( <a class=\"usa-link\" href=\"#SD2\"> Table S1 </a> ). Classification was balanced across the four subtypes with 75/142 (53%), 25/142 (18%), 21/142 (15%), 15/142 (11%) representing the SCLC-A, SCLC-N, SCLC-P an SCLC-I subtypes, respectively. This distribution is comparable to the observed distribution in the IMpower133 study with SCLC-A - 51%, SCLC-N - 23%, SCLC-I \u2013 18%, SCLC-P \u2013 7% <sup> <a aria-describedby=\"R10\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R10\"> 10 </a> </sup> (chi-sq <em> p </em> = 0.4186). Consistent with the prior reports of the four subgroups <sup> <a aria-describedby=\"R10\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R10\"> 10 </a> </sup> , the SCLC-A and SCLC-N samples in our cohort demonstrated a higher expression of neuroendocrine genes compared to SCLC-P and SCLC-I, while the SCLC-P and SCLC-I subgroups were characterized by a higher expression of HLA genes, tumor inflammation genes (TIS) ( <a class=\"usa-link\" href=\"#F1\"> Figure 1B </a> ) as well as a higher percentage of tumor stroma and, hence, a lower percentage of tumor cells ( <a class=\"usa-link\" href=\"#F1\"> Figure 1C </a> ) as calculated using RNA-seq deconvolution <sup> <a aria-describedby=\"R26\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R26\"> 26 </a> </sup> . Furthermore, using CIBERSORT deconvolution <sup> <a aria-describedby=\"R27\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R27\"> 27 </a> </sup> , we identified increased immune cell infiltration in the SCLC-P and SCLC-I subtypes, respectively ( <a class=\"usa-link\" href=\"#SD1\"> Figure S1D </a> . Importantly, the consensus of classification for each of the samples, retrieved from the overlap of 500 machine learning models highlighted certain distributions across the four subtypes, with samples acquiring properties of some of the other subtypes, suggesting that the SCLC-GRC approach is preserving information on the of intratumoral heterogeneity of SCLC subtype properties ( <a class=\"usa-link\" href=\"#F1\"> Figure 1D </a> ). Only few specimens could not be classified (equivocal: 6/142; 4%) due to what appears to be technical limitations and RNA quality ( <a class=\"usa-link\" href=\"#F1\"> Figure 1B </a> ). Consequently, with a success rate of 96%, our classification approach was highly accurate across different cohorts and RNA-seq technologies while comprised of a limited number of 181 genes. Thus, this assessment is technically less challenging than larger gene panels, and enables robust SCLC subtype classification from different cohorts and individual samples. </p> </section> <section id=\"S6\"> <h3 class=\"pmc_sec_title\"> 4. Genome-wide hypomethylation is characteristic of SCLC-P </h3> <p id=\"P10\"> We then analyzed the differences of genome-wide DNA methylation in our dataset. We averaged the methylation level across bins of 100kb width and calculated the mean for those bins per subtype. To determine the genome-wide methylation level, we calculated the rolling average over 500 bins (= 50Mbp). The analysis highlighted profound differences in the global methylation level per subtype, with the SCLC-P subtype presenting with a hypomethylated phenotype and SCLC-N with a hypermethylated phenotype, while SCLC-A and SCLC-I were comparable in cohort 1 ( <a class=\"usa-link\" href=\"#F2\"> Figure 2A </a> ) as well as when filtering for tumor-intrinsic DNA methylation signals using the CAMDAC algorithm <sup> <a aria-describedby=\"R28\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R28\"> 28 </a> </sup> in a subset of samples in cohort 2 ( <a class=\"usa-link\" href=\"#SD1\"> Figure S2A </a> ; see <a class=\"usa-link\" href=\"#S13\"> STAR methods </a> ). The SCLC-P hypomethylation phenotype was also observed in cohort 2 while methylation patterns for the other subtypes appeared to differ between the cohorts ( <a class=\"usa-link\" href=\"#SD1\"> Figure S2B </a> ). We further analyzed 59 SCLC-derived cell lines across all four subtypes as well as two previously published datasets on cell lines. Interestingly, in cell lines, SCLC-P was hypermethylated ( <a class=\"usa-link\" href=\"#SD1\"> Figure S2C </a> ) contrary to tumor methylation analysis, which was confirmed in two independent datasets of cell lines from the NCI SCLC cell miner project <sup> <a aria-describedby=\"R29\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R29\"> 29 </a> </sup> ( <a class=\"usa-link\" href=\"#SD1\"> Figure S2D </a> ) and the GDSC <sup> <a aria-describedby=\"R30\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R30\"> 30 </a> </sup> ( <a class=\"usa-link\" href=\"#SD1\"> Figure S2E </a> ), highlighting limitations when working with cell line derived tumor methylation data. </p> <figure class=\"fig xbox font-sm\" id=\"F2\"> <h4 class=\"obj_head\"> Figure 2. Subtype-specific DNA methylation in SCLC. </h4> <p class=\"img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center\"> <a class=\"tileshop\" href=\"https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=11178430_EMS195999-f002.jpg\" target=\"_blank\"> <img alt=\"Figure 2\" class=\"graphic zoom-in\" height=\"619\" loading=\"lazy\" src=\"https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae96/11178430/d2e0386fa3ba/EMS195999-f002.jpg\" width=\"800\"/> </a> </p> <div class=\"p text-right font-secondary\"> <a class=\"usa-link\" href=\"figure/F2/\" rel=\"noopener noreferrer\" target=\"_blank\"> Open in a new tab </a> </div> <figcaption> <p> <strong> A </strong> DNA methylation was assessed using reduced-representation bisulfite sequencing (RRBS) and DNA methylation was averaged per sample and subtype over 100kbp bins and the rolling average over 500 bins (= 50mbp) is highlighted in the c1 tumor samples. <strong> B-G </strong> Analysis of gene expression per SCLC subtype for DNA-methyltransferase 1 (DNMT1; <strong> B </strong> ), DNA-methyltransferase 3A (DNMT3A; <strong> C </strong> ) and 3B (DNMT3B; <strong> D </strong> ), methionine adenosyltransferase 2A (MAT2A; <strong> E </strong> ) and histone lysine methyltransferase (SUV39H1; <strong> F </strong> ). <strong> G </strong> Overview of mechanism that links SUV39H1 expression with histone methylation. <strong> H </strong> Scheme highlighting the analysis and selection of DNA methylation sites associated with each of the SCLC subtypes using 100bp bins. By calculating the area under the curve by receiver operator characteristics (AUROC) we defined genomic region with high (AUC &gt; 0.8) association with one the four respective subtypes. DNA methylation bins are shown related to their position within the genome for each chromosome for SCLC-A ( <strong> I </strong> ), SCLC-N ( <strong> J </strong> ), SCLC-P ( <strong> K </strong> ) and SCLC-I ( <strong> L </strong> ) and number of regions is stated for each subtype. Boxplot shows the median as thick line, the box highlighting the first and third quartile with the whiskers highlighting 1.5x the interquartile range. Wilcoxon test was used to compute p-values between groups. </p> <p> See also <a class=\"usa-link\" href=\"#SD1\"> Figures S2-5 </a> and <a class=\"usa-link\" href=\"#SD3\"> Table S2 </a> . </p> </figcaption> </figure> <p id=\"P11\"> To further explore these subtype-specific differences in global methylation, we analyzed expression of 73 genes responsible for reading, writing, or erasing DNA and histone methylation and found 47 (64%) of them to be significantly differentially regulated across subtypes ( <a class=\"usa-link\" href=\"#SD3\"> Table S2 </a> ; <a class=\"usa-link\" href=\"#SD1\"> Figure S3 </a> ). In addition to the major DNA methyltransferases, <em> DNMT1 </em> ( <a class=\"usa-link\" href=\"#F2\"> Figure 2B </a> ), <em> DNMT3A </em> ( <a class=\"usa-link\" href=\"#F2\"> Figure 2C </a> ) and <em> DNMT3B </em> ( <a class=\"usa-link\" href=\"#F2\"> Figure 2D </a> ) and the S-Adenosylmethionine synthetase ( <em> MAT2A </em> ; <a class=\"usa-link\" href=\"#F2\"> Figure 2E </a> ) which creates S-adenosylmethionine (SAM) which is critical for methylation processes, we also found <em> SUV39H1 </em> ( <a class=\"usa-link\" href=\"#F2\"> Figure 2F </a> ) to be differentially expressed between the four SCLC subtypes, especially between neuroendocrine and non-neuroendocrine subtypes. <em> SUV39H1 </em> is a methyltransferase that trimethylates histone H3 lysine 9 (H3K9) residues. Functionally, H3K9me3 recruits <em> HP1 </em> and <em> DNMT3A </em> / <em> B </em> for stable methylation of DNA ( <a class=\"usa-link\" href=\"#F2\"> Figure 2G </a> ) <sup> <a aria-describedby=\"R31\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R31\"> 31 </a> , <a aria-describedby=\"R32\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R32\"> 32 </a> </sup> , thereby linking histone methylation with induction of DNA methylation ( <a class=\"usa-link\" href=\"#F2\"> Figures 2C, D, F, G </a> ). These data suggest that <em> SUV39H1 </em> - <em> DNMT3A </em> / <em> B </em> axis is a candidate pathway contributing to differences in global methylation patterns across SCLC subtypes and highlighting further differences in epigenetic regulation of SCLC subtypes. Interestingly, the expression patterns of methylation effectors were distinct in SCLC cell line models, which might contribute to the discordance of global methylation patterns in cell lines compared to that in primary tumor samples ( <a class=\"usa-link\" href=\"#SD1\"> Figure S4 </a> ; <a class=\"usa-link\" href=\"#SD3\"> Table S2 </a> ). </p> <p id=\"P12\"> In order to further understand the genomic regions differing between SCLC subtypes, we analyzed the average methylation using bins of 100bp across the genome ( <a class=\"usa-link\" href=\"#F2\"> Figure 2H </a> ). We utilized the training set of our combined RRBS data (see Materials and Methods) and used receiver-operator characteristics (ROC) to analyze the association of each 100bp bin with each of the four respective subtypes by computing the area under the curve (AUC) and filtered for highly associated sites with AUC &gt; 0.8. We then highlight these highly associated sites according to their genomic location, for SCLC-A ( <a class=\"usa-link\" href=\"#F2\"> Figure 2I </a> ), SCLC-N ( <a class=\"usa-link\" href=\"#F2\"> Figure 2J </a> ), SCLC-P ( <a class=\"usa-link\" href=\"#F2\"> Figure 2K </a> ) and SCLC-I ( <a class=\"usa-link\" href=\"#F2\"> Figure 2L </a> ) as well as for each sample individually ( <a class=\"usa-link\" href=\"#SD1\"> Figure S5 </a> ). Importantly, bins were spread across the different chromosomes confirming the genome-wide methylation differences. </p> </section> <section id=\"S7\"> <h3 class=\"pmc_sec_title\"> 5. DNA Methylation allows classification of SCLC specimens </h3> <p id=\"P13\"> Our findings suggested that differences in DNA methylation could be exploited for the generation of biomarkers that are able to differentiate SCLC subtypes. Therefore, we combined the DNA methylation data from both cohorts and randomly split the combined dataset in a training and an independent testing set (70% and 30% of samples, respectively). The training set was used for both marker selection and model training to ensure that the testing set could be used for independent validation. DNA methylation sites for training have been associated with each of the four subtypes in the training set using ROC ( <a class=\"usa-link\" href=\"#F3\"> Figure 3A </a> ; <a class=\"usa-link\" href=\"#SD4\"> Table S3 </a> ). Despite marketed differences in DNA methylation compared to cell lines, we furthermore filtered for DNA regions which have also been associated with the four subtypes in cell lines (AUC &gt; 0.7) to enable the model to train on tumor-intrinsic signals and avoid overfitting the model based on tumor-stroma derived methylation data, which we expect to be a larger contribution in the SCLC-P and SCLC-I subtype. We then selected the top DNA methylation sites for each of the four subtypes by differences in DNA methylation level and AUC, and created models that were trained by randomly selecting 10, 50, or 100 methylation sites per subtype, since this has been shown to provide sufficient information ( <a class=\"usa-link\" href=\"#SD1\"> Figure S6A </a> ). Furthermore, methylation sites selected are specific to SCLC compared to data obtained from lung adenocarcinoma and pre-neoplasia as well as non-cancer controls ( <a class=\"usa-link\" href=\"#SD1\"> Figure S6B </a> ) <sup> <a aria-describedby=\"R33\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R33\"> 33 </a> </sup> . Similar to our approach on RNA-seq data ( <a class=\"usa-link\" href=\"#F1\"> Figure 1B </a> ), we used a threshold of <span class=\"text-underline\"> &gt; </span> 50% consensus across the models to call a subtype. We ultimately selected 50 methylation sites/subtype for our final predictive model, as this provided classification with high accuracy ( <a class=\"usa-link\" href=\"#SD1\"> Figure S7A </a> ). Accuracy for our DNA methylation classifier (SCLC-DMC) in the independent testing set was 95.8% (95% CI: 78.9% - 99.9%; Kappa = 0.9286). Importantly, the SCLC-DMC approach allowed the subtyping of 30 additional samples for which no RNA-seq data was available and thus RNA-based classification was impossible ( <a class=\"usa-link\" href=\"#F3\"> Figure 3B </a> ; <a class=\"usa-link\" href=\"#SD4\"> Table S3 </a> ). Interestingly, heterogeneity from the consensus approach was reduced in the DMC approach, compared to our GRC approach ( <a class=\"usa-link\" href=\"#SD1\"> Figure S7B </a> ; <a class=\"usa-link\" href=\"#F1\"> Figure 1D </a> ). In order to validate the performance of the assay and to ensure that tumor-intrinsic features have been used for the training, we used the DMC approach to also predict subtypes in a set of cell lines that had been classified previously ( <a class=\"usa-link\" href=\"#SD3\"> Figure S7C </a> ). <sup> <a aria-describedby=\"R10\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R10\"> 10 </a> </sup> Our SCLC-DMC approach was also capable of classifying SCLC cell lines across all four subtypes with an accuracy of 96.6% (95% CI: 88.1 \u2013 99.6). </p> <figure class=\"fig xbox font-sm\" id=\"F3\"> <h4 class=\"obj_head\"> Figure 3. DNA methylation-based subtyping in SCLC. </h4> <p class=\"img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center\"> <a class=\"tileshop\" href=\"https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=11178430_EMS195999-f003.jpg\" target=\"_blank\"> <img alt=\"Figure 3\" class=\"graphic zoom-in\" height=\"726\" loading=\"lazy\" src=\"https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae96/11178430/b7401c03ca4d/EMS195999-f003.jpg\" width=\"800\"/> </a> </p> <div class=\"p text-right font-secondary\"> <a class=\"usa-link\" href=\"figure/F3/\" rel=\"noopener noreferrer\" target=\"_blank\"> Open in a new tab </a> </div> <figcaption> <p> <strong> A </strong> Scheme describing the process to develop the SCLC DNA methylation classifier (SCLC-DMC). Both cohorts were combined and the dataset was split in a training and a testing set and highly predictive DNA methylation sites were selected using area under the receiver operator characteristics curve (AUROC) to create predictive models using extreme gradient boosting with Dropouts multiple Additive Regression Trees (xGB-DART) with leave one out cross validation (LOOCV). For each subtype, 500 models were individually trained. Performance was assessed on the testing set. A cfDNA adjusted consensus classification approach (SCLC-cfDMC) was created using the same DNA methylation sites as used for the SCLC-DMC to predict subtypes in liquid biopsies. <strong> B </strong> Classification of SCLC tissue specimen using the SCLC-DMC approach. Prediction of subtype is shown in the training set, the independent testing set as well as in samples were classification by RNA (GRC) was not possible due to the absence of RNA-seq data (untested). The consensus in percentage of agreement between the models is shown. <strong> C </strong> Correlation of computed circulating tumor DNA (ctDNA) fraction by ultra-low pass whole genome sequencing (ULP-WGS) and a classifier based on seven methylation sites (Calculated Fraction [%]). <strong> D </strong> Differences in ctDNA fraction per DNA methylation were compared between samples analyzed at baseline prior to treatment and samples at tumor progression. <strong> E </strong> Differences in genome-wide DNA methylation between tumor tissue samples and matched baseline plasma samples were compared. DNA methylation was averaged per sample and subtype over 100kbp bins and changes between tumor DNA methylation and plasma DNA methylation were analyzed for each 100kb bin for each patient represented by a row in the heatmap across each chromosome as highlighted above. Furthermore, mean methylation per bin across the samples is highlighted in grey color above the heatmap together with the rolling average depicted by a black line. A histogram to the right highlights the distribution of differences for each bin across all samples. <strong> F </strong> The classification of SCLC subtypes using the SCLC-cfDMA approach is shown in plasma sample taken at baseline prior to treatment. Additionally, to the consensus, the classification based on the gene-ratio approach (GRC) as well as based on the tissue DMC approach is shown. Samples with GRC classification were included in the training cohort and inclusion for each sample is shown. <strong> G </strong> Classification of SCLC-subtypes using the SCLC-cfDMC approach is shown for samples with matched baseline plasma and plasma at progression. Boxplot shows the median as thick line, the box highlighting the first and third quartile with the whiskers highlighting 1.5x the interquartile range. Wilcoxon test was used to compute p-values between groups. </p> <p> See also <a class=\"usa-link\" href=\"#SD1\"> Figures S6-9 </a> and <a class=\"usa-link\" href=\"#SD4\"> Table S3 </a> . </p> </figcaption> </figure> </section> <section id=\"S8\"> <h3 class=\"pmc_sec_title\"> 6. DNA Methylation is preserved in ctDNA and can be used for classification of SCLC subtypes </h3> <p id=\"P14\"> Since DNA methylation is highly conserved in plasma, we hypothesized that DNA methylation can also serve as biomarker in SCLC liquid biopsies. First, we established a DNA methylation-based assessment of ctDNA to calculate the ctDNA burden. While the highly sensitive method for SCLC detection ( <a class=\"usa-link\" href=\"#F1\"> Figure 1A </a> ) only allows the assessment of SCLC presence/absence, an additional method that allows the quantification of ctDNA fraction could potentially enable more insights on data derived from tumor and thus quality of classification. Indeed, we found multiple DNA methylation sites that correlate with ctDNA fraction based on ultra-low pass whole genome sequencing (ULP-WGS) and we selected seven methylation sites which are highly and linearly correlated to ctDNA fraction ( <a class=\"usa-link\" href=\"#SD1\"> Figure S8A </a> ). By calculating the mean for the seven selected sites, we established a convenient and easy method to assess ctDNA in SCLC with high correlation to ULP-WGS ( <em> R </em> = 0.89; p &lt; 0.0001; <a class=\"usa-link\" href=\"#F3\"> Figure 3C </a> ). We further analyzed how the ctDNA fraction differed between samples at baseline and progression, and observed no significant differences ( <a class=\"usa-link\" href=\"#F3\"> Figure 3D </a> ). Consequently, samples selected at tumor progression yielded results comparable to samples at baseline, underscoring the applicability of our SCLC subtyping approach. </p> <p id=\"P15\"> Based on the robust results from our tissue SCLC-DMC, we hypothesized that our approach could also be applied to SCLC plasma samples. Using a subset of five matched samples, we analyzed the differences between tumor DNA methylation and plasma DNA methylation and observed that SCLC DNA methylation patterns are indeed conserved in plasma ( <a class=\"usa-link\" href=\"#F3\"> Figure 3E </a> ), enabling a liquid biopsy approach. We therefore utilized the same DNA methylation sites as selected for our SCLC-DMC for tissue samples, filtered for sites detected in plasma and refitted a model using only samples with GRC classification ( <em> N </em> = 43/54 80%; SCLC-cfDMC; <a class=\"usa-link\" href=\"#F3\"> Figure 3A </a> ). Indeed, this allowed us to classify SCLC plasma samples with an accuracy of 100% (43/43) compared to the RNA-based SCLC-GRC and 93.3% (28/30) compared to the SCLC-DMC ( <a class=\"usa-link\" href=\"#F3\"> Figure 3F </a> ; <a class=\"usa-link\" href=\"#SD4\"> Table S3 </a> ). Moreover, we observed excellent concordance with samples profiled only by our tissue-based SCLC-DMC to robustly detect all four SCLC subtypes from clinical plasma samples. Of note, all samples used for the classification were from untreated patients to allow correlation of subtypes with the associated tumor tissue. We also compared the DNA methylation levels selected for the training with DNA methylation data obtained from healthy donors <sup> <a aria-describedby=\"R34\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R34\"> 34 </a> </sup> , and could demonstrate that baseline cfDNA samples from SCLC patients cluster generally distinctly to DNA methylation profiles from the healthy comparison ( <a class=\"usa-link\" href=\"#SD1\"> Figure S8B </a> ). Correlating global DNA methylation between healthy cfDNA and baseline samples, we observed a statistically significant drop in correlation for samples with higher ctDNA fraction (third and fourth quartile) compared to samples with lower ctDNA fraction (first and second quartile; <a class=\"usa-link\" href=\"#SD1\"> Figure S8C </a> ). </p> <p id=\"P16\"> Prior studies using single cell profiling from our group and others suggest that SCLC tumors can become more heterogenous, and shift their subtype, after progression on therapy. <sup> <a aria-describedby=\"R20\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R20\"> 20 </a> , <a aria-describedby=\"R35\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R35\"> 35 </a> , <a aria-describedby=\"R36\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R36\"> 36 </a> </sup> To assess this, we analyzed a subset of patients, in which baseline samples as well as plasma sample at clinical progression were available. Our analysis of these samples demonstrated a strong heterogeneity in the sample subtype at progression as compared to their baseline classification ( <a class=\"usa-link\" href=\"#F3\"> Figure 3G </a> ; <a class=\"usa-link\" href=\"#SD1\"> Figure S9A </a> ). For example, in a large subset of patients, the SCLC subtype of their respective tumor switched from SCLC-A to SCLC-I at progression. Therefore, we further analyzed the promoter methylation levels in the cfDNA of patients with a baseline SCLC-A subtype whose did or did not demonstrate a subtype switch to SCLC-I. Indeed, in samples with subtype switching we saw marked differences in the promoter methylation of immune-related genes, such as <em> CXCL12 (T cell recruitment), CIITA (antigen presentation machinery transcription), STAT1 (inflammatory gene transcription) </em> as well as the interferon alpha and gamma receptors ( <em> IFNRA1, IFNRA2, IFNGR1 </em> ) highlighting profound changes in the tumor:immune phenotypes ( <a class=\"usa-link\" href=\"#SD1\"> Figure S9B </a> ). Even though all those changes were not limited to the subtype switching samples this further highlights that analysis of promoter methylation from liquid biopsy samples can also provide information on tumor evolution under therapeutic pressure. Despite the switch to a more inflammatory phenotype, we did not detect any differences in PFS (HR = 0.49; 95% CI: 0.11 \u2013 2.24) or OS (HR = 1.02; 95% CI: 0.27 \u2013 3.9) for patients whose tumors switched to SCLC-I versus those that maintained SCLC-A subtype ( <a class=\"usa-link\" href=\"#SD1\"> Figure S9C </a> ). Treating SCLC cell lines with 2\u00b5M cisplatin for 9 days, did not alter DNA methylation in the respective genes, suggesting that the contribution of the tumor microenvironment might be required for subtype plasticity ( <a class=\"usa-link\" href=\"#SD1\"> Figure S9D </a> ). </p> </section> <section id=\"S9\"> <h3 class=\"pmc_sec_title\"> 7. DNA Methylation predicts drug response and clinical outcome similar to gene expression </h3> <p id=\"P17\"> Previously, we demonstrated that, <em> in vitro </em> , cell lines assigned to SCLC-A and SCLC-N by gene expression possessed unique therapeutic vulnerabilities <sup> <a aria-describedby=\"R10\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R10\"> 10 </a> </sup> .To validate that these same vulnerabilities are preserved using the methylation classifier, we compared IC50 values for over 400 drugs <sup> <a aria-describedby=\"R37\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R37\"> 37 </a> </sup> between methylation-assigned SCLC-A and SCLC-N subtypes and identified numerous distinct vulnerabilities between the groups. For example, as demonstrated with the gene expression classifier, SCLC-N cell lines were more sensitive to the CDK inhibitor (BCL2i) R-547 ( <a class=\"usa-link\" href=\"#F4\"> Figure 4A </a> ), as well as to Aurora kinase inhibitor (AURKi). CYC-116 ( <a class=\"usa-link\" href=\"#F4\"> Figure 4B </a> ). Collectively, these data provide evidence that DNA methylation is able to predict drug response <em> in </em> vitro similar to RNA-based classification. </p> <figure class=\"fig xbox font-sm\" id=\"F4\"> <h4 class=\"obj_head\"> Figure 4. Influence of SCLC subtyping methods on in vitro drug screening and clinical outcome. </h4> <p class=\"img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center\"> <a class=\"tileshop\" href=\"https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=11178430_EMS195999-f004.jpg\" target=\"_blank\"> <img alt=\"Figure 4\" class=\"graphic zoom-in\" height=\"1137\" loading=\"lazy\" src=\"https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae96/11178430/edeab393fb31/EMS195999-f004.jpg\" width=\"800\"/> </a> </p> <div class=\"p text-right font-secondary\"> <a class=\"usa-link\" href=\"figure/F4/\" rel=\"noopener noreferrer\" target=\"_blank\"> Open in a new tab </a> </div> <figcaption> <p> Comparison of IC50 values for the <strong> A </strong> CDKi R-547 and the <strong> B </strong> AURKi CYC-116 between cell lines assigned to SCLC-A and SCLC-N using SCLC-DMC. <strong> C-D </strong> Clinical outcome depending on classification method used. Overall survival of SCLC patients stratified by classification using the SCLC-GRC (RNA-seq) and SCLC-DMC (DNA Methylation) method for <strong> C </strong> SCLC-A and <strong> D </strong> SCLC-N. Statistical significance is calculated using log-rank test. Cox-proportional hazard ratio is calculated and shown with 95% confidence interval. Boxplot shows the median as thick line, the box highlighting the first and third quartile with the whiskers highlighting 1.5x the interquartile range. Wilcoxon test was used to compute p-values between groups. </p> </figcaption> </figure> <p id=\"P18\"> Finally, to determine whether methylation- and RNA-based subtyping approaches yielded comparable clinical outcomes among SCLC patients, we used our SCLC-GRC or our SCLC-DMC for patients with known clinical outcomes. While many samples had both RNA and methylation data present, several of the patients were only subtyped by one of the two methods. To ensure adequate statistical power for the analysis, we focused on the two most prevalent subtypes, SCLC-A and SCLC-N, respectively. Importantly, when comparing the two approaches, overall survival was comparable for patients identified as SCLC-A (HR (95% CI) = 1.01 (0.61 \u2013 1.66); <a class=\"usa-link\" href=\"#F4\"> Figure 4C </a> ) as well as for patients identified as SCLC-N (HR = 1.02 (0.48 \u2212 2.18); <a class=\"usa-link\" href=\"#F4\"> Figure 4D </a> ) when using SCLC-GRC (RNA-seq) or SCLC-DMC (DNA methylation), demonstrating that DNA methylation and RNA-seq can be assessed and provide concordant results in the clinical setting. </p> </section> </section> <section id=\"S10\"> <h2 class=\"pmc_sec_title\"> <a class=\"usa-anchor\" id=\"S10-anchor\"> </a> Discussion </h2> <p id=\"P19\"> Lung cancer histological subtypes are increasingly defined by transcriptomic features rather than solely by mutational signatures <sup> <a aria-describedby=\"R38\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R38\"> 38 </a> </sup> . This is especially true in small-cell lung cancer with its four distinct subtypes that are defined by specific gene expression rather than by targetable, or even distinct, genomic alterations. Indeed, advancement of personalized therapies in such a setting requires more complex clinical classification strategies. Consequently, we developed robust classifiers using gene expression data (SCLC-GRC) as well as DNA methylation (SCLC-DMC) to accurately and reliably predict SCLC subtypes in clinical specimens. Importantly, classification using SCLC-DMC was also established in plasma specimen addressing a critical need in SCLC, where tumor specimens are scarce and accurate liquid biopsy-based approaches are urgently needed. Both methods allow the precise classification of a transcriptionally defined tumor phenotype while the DNA methylation-based method allowed to further subtyping using liquid biopsy specimen. Consequently, DNA methylation-only strategies can be employed in settings where molecular analysis is performed primarily with DNA specimen, while the use of transcriptionally methods might enable the integration with additional signatures, for example for better description of the tumor microenvironment or assessment of marker genes <sup> <a aria-describedby=\"R39\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R39\"> 39 </a> </sup> . </p> <p id=\"P20\"> To date, SCLC subtypes have been associated with the predominant expression of a transcription factor (ASCL-1, NEUROD1, or POU2F3) although it is worth noting that the SCLC-A, -N, -P, and -I subtypes were defined by clusters that arose from NMF clustering and not by the individual factors themselves. Initial subtyping approaches have explored the use of immunohistochemistry (IHC) for these factors <sup> <a aria-describedby=\"R9\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R9\"> 9 </a> , <a aria-describedby=\"R10\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R10\"> 10 </a> , <a aria-describedby=\"R40\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R40\"> 40 </a> </sup> , although this approach is limited by the tissue requirements, challenges in quantitation, heterogeneity in staining, and the observation that no single marker specifically can unequivocally define each subgroup <sup> <a aria-describedby=\"R9\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R9\"> 9 </a> , <a aria-describedby=\"R40\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R40\"> 40 </a> </sup> . Additionally, YAP1 was initially proposed to define a distinct subtype itself <sup> <a aria-describedby=\"R8\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R8\"> 8 </a> </sup> but on further analysis was found to be absent or expressed only at low levels in tumors (typically in the stroma or in the NSCLC component of mixed tumors), although a subpopulation of YAP1 positive cells may emerge in the setting of resistance <sup> <a aria-describedby=\"R9\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R9\"> 9 </a> , <a aria-describedby=\"R10\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R10\"> 10 </a> , <a aria-describedby=\"R20\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R20\"> 20 </a> , <a aria-describedby=\"R41\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R41\"> 41 </a> </sup> . Intriguing results from the SWOG1929 trial, a phase II trial assessing the addition of the PARP inhibitor talazoparib to atezolizumab maintenance in ES-SCLC highlighted that biomarker-driven trials in SCLC are possible, even with stratification based on limited tissue, as this trial required SLFN11 positive IHC for enrollment <sup> <a aria-describedby=\"R42\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R42\"> 42 </a> </sup> . Therefore, IHC remains to be an important method for biomarker assessment in SCLC but also for understanding of heterogeneity. Consequently, tissue-based biomarker assessment can guide clinical treatment decisions and the use of an mRNA-based approach can be implemented for SCLC subtyping. However, technical challenges and tissue limitations persist, and thus classification is not possible for all samples as is the analysis of longitudinal samples. </p> <p id=\"P21\"> Consequently, we and others hypothesized that DNA methylation might overcome these limitations by providing a more robust classification method as well as enabling a liquid biopsy option. Indeed, DNA methylation has been reported to distinguish ASCL1 and NEUROD1 driven tumors as well as subtypes independent of those transcription factors <sup> <a aria-describedby=\"R21\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R21\"> 21 </a> , <a aria-describedby=\"R43\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R43\"> 43 </a> </sup> and to be associated with drug response <sup> <a aria-describedby=\"R44\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R44\"> 44 </a> </sup> . In addition, DNA methylation has also been implicated in phenotypic regulations like EMT <sup> <a aria-describedby=\"R45\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R45\"> 45 </a> , <a aria-describedby=\"R46\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R46\"> 46 </a> </sup> . DNA methylation is highly dysregulated in cancer with transcription factors being particularly regulated by DNA methylation <sup> <a aria-describedby=\"R47\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R47\"> 47 </a> </sup> , making it highly relevant in transcriptionally-defined cancer subtypes like in SCLC. </p> <p id=\"P22\"> Hence, using a large cohort of clinical SCLC specimen with genome-wide DNA methylation data, we were able to establish a robust classifier to define SCLC subtypes with comparable clinical outcomes to our RNA-based classification. Importantly, the SCLC-DMC was able to classify tumor samples that failed classification using RNA suggesting potential advantages of DNA methylation over gene expression signatures. Even more, the preservation of DNA methylation patterns in cfDNA is of particular interest as it allows the classification from liquid biopsies. Indeed, our data show limited differences between cfDNA methylation and DNA methylation in the primary tumor. This is critical in SCLC where tumor tissue is limited but high amounts of cfDNA can be isolated <sup> <a aria-describedby=\"R48\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R48\"> 48 </a> </sup> . Thus, the use of cfDNA to identify disease subtypes could rapidly facilitate clinical implementation. DNA methylation has previously been used for detection of SCLC, as well as for its differentiation to other cancers from liquid biopsies <sup> <a aria-describedby=\"R49\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R49\"> 49 </a> </sup> , findings we replicated here by utilizing a commercial DNA methylation assay that incorporates limited DNA methylation sites <sup> <a aria-describedby=\"R24\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R24\"> 24 </a> </sup> .Future assays might be able to combine both, the detection of SCLC for initial diagnosis with the subtyping, to enable a liquid-first rapid therapy initiation, which is especially important in rapidly progressing SCLC <sup> <a aria-describedby=\"R50\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R50\"> 50 </a> </sup> . Additionally, DNA methylation is increasingly used to detect tumor DNA in plasma which could serve as predictor of response to therapy. Consequently, longitudinal plasma samples are critical to track tumor evolution during treatment and serve as early markers of treatment response and relapse <sup> <a aria-describedby=\"R18\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R18\"> 18 </a> , <a aria-describedby=\"R51\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R51\"> 51 </a> </sup> . </p> <p id=\"P23\"> Furthermore, our study provides new insights into the epigenetic regulation of SCLC subtypes. Interestingly, SCLC-P was consistently hypomethylated in our both primary tissue cohorts, while the other subtypes demonstrated more variability between the two clinical cohorts that will require further investigation. However, our analysis only allowed to investigate DNA methylation and gene expression differences while many epigenetic processes contribute to different SCLC phenotypes <sup> <a aria-describedby=\"R52\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R52\"> 52 </a> </sup> . Importantly, we highlighted strong differences between primary tumor samples and cell lines as well as differences in expression of epigenetic enzymes that might contribute to those differences. Strikingly, SCLC-P cell line models exhibited hypermethylated phenotypes compared to primary tumors. Intriguingly, in this shift in global methylation was coincident with significantly increased expression of the SUV39H1-HP1-DNMT3A/B axis, along with several other methyltransferases, not seen in SCLC-P tissue samples. It is possible that tumor extrinsic factors, such as the tumor microenvironment, play key roles in shaping global methylation patterns in SCLC as has been reported in other cancers <sup> <a aria-describedby=\"R53\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R53\"> 53 </a> </sup> . Thus, in cell only systems, such as in vitro cell culture, absence of these factors produces global shifts in tumor methylation patterns. Changes in gene expression and global DNA methylation have also been reported during tumor sphere formation <em> in vitro </em> as well as compared to primary tumor, suggesting that cell line cultivation in SCLC might impact gene expression and epigenetic regulation <sup> <a aria-describedby=\"R54\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R54\"> 54 </a> \u2013 <a aria-describedby=\"R56\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R56\"> 56 </a> </sup> . Considering that cell lines are often used as model for further investigation, it will be important to clarify how representative cell lines are in SCLC to allow robust <em> in vitro </em> studies. </p> <p id=\"P24\"> Previous work based on mouse models already demonstrated that SCLC subtypes may shift, and that tumors may evolve towards greater heterogeneity, under the selection pressure of different treatments. <sup> <a aria-describedby=\"R20\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R20\"> 20 </a> </sup> In this study, we confirm the heterogeneity of SCLC subtypes during treatment, as we observed a switch to an inflamed subtype in a large proportion of ASCL1 <sup> + </sup> samples at progression. This finding was supported by the notion that the switch to a more inflammatory phenotype was accompanied by profound changes in the promoter methylation of genes controlling immune cell recruitment, interferon responsiveness and production, as well as inflammatory gene transcription. These findings support the ability of frontline etoposide, platinum, and immunotherapy (EP+IO) therapies to \u201creawaken\u201d tumor-immune crosstalk in a subset of tumors, including those not initially \u201cinflamed\u201d or SCLC-I. In line with this, we also observed that some samples with SCLC-A or SCLC-N have inflammatory features suggesting that inflammatory states also exist in those samples, in line with recently presented data <sup> <a aria-describedby=\"R57\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R57\"> 57 </a> </sup> . Understanding how some tumors evolve to a more \u201cinflamed\u201d state but still progress clinically will be essential for identifying treatment regimens that can successfully harness the immune system for increased tumor control. Additionally, it is critical to further establish longitudinal collection of SCLC specimens to enable better understanding of evolution and gain deeper insights into SCLC subtype plasticity. </p> <p id=\"P25\"> The capability of our system to identify those changes further highlights the power of for liquid-biopsy guided surveillance during cancer treatment in SCLC. Furthermore, it is likely that a cfDNA-specific classifier could be further refined to take into account cfDNA-specific attributes (e.g. background cfDNA methylation) which could further enhance its accuracy. <sup> <a aria-describedby=\"R58\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R58\"> 58 </a> </sup> Likewise, confirmation of our findings in additional independent clinical cohorts is critical for clinical implementation, and will also further clarify reliability in the rare SCLC-P and SCLC-I subtypes. Additional analysis will also need to take into account limitations in ctDNA fraction and will need to establish clear analytical parameters to allow a precise classification of SCLC subtypes in a clinical setting. Likewise, the analysis of gene expression changes from liquid biopsy specimen have not been limited to DNA methylation analysis but also other approaches, assessing the distribution of cfDNA fragments across the genome, like the DELFI <sup> <a aria-describedby=\"R59\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R59\"> 59 </a> </sup> or the EPICseq method <sup> <a aria-describedby=\"R23\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R23\"> 23 </a> </sup> to enable fragmentomics-based analysis of SCLC. In addition, the development of highly sensitive nucleosome-capture methods <sup> <a aria-describedby=\"R22\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R22\"> 22 </a> </sup> have also demonstrated high performance for SCLC subtyping and detection. Future assays might consequently deviate from DNA methylation approaches or might incorporate a combination of different approaches for improved performance <sup> <a aria-describedby=\"R60\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R60\"> 60 </a> </sup> . </p> <p id=\"P26\"> Taken together, our approaches using gene expression data as well as DNA methylation in SCLC highlight that reliable subtyping in transcriptionally-defined cancer is feasible from tumor specimen as well as by using a methylation-based liquid biopsy assay. Our findings indicate that DNA methylation-based biomarkers using tumor or blood samples can be implemented for the identification of clinically relevant SCLC subtypes, a critical step towards bringing precision, biomarker-directed therapy into the clinic for SCLC and potentially other tumor types. </p> <section id=\"S11\"> <h3 class=\"pmc_sec_title\"> Limitations of the study </h3> <p id=\"P27\"> In this study we do not assess parameters critical for routine implementation of the developed methods such as RNA/DNA quality, minimal tumor content for tissue-based assays as well as the influence of ctDNA content on subtyping performance and minimal ctDNA content for subtyping. Additionally, while we report on LOD and LOB for the epicheck assay designed to detect SCLC from previously undiagnosed individuals, we do not assess LOD and LOB for our 7-methylation site assay designed to assess ctDNA fraction. Consequently, additional studies are required to translate this method into a validated assay with strict analysis criteria. Furthermore, the limited amount of SCLC plasma samples with matched tissue required to assess performance required us to rely on cross-validation instead of validating the results in independent cohorts. Gathering additional cohorts from various resources and regions is critical to assess the robustness of the methods (for both tissue and plasma) and will be subject of future studies. Lastly, while we observed differences in drug response in cell line models according to SCLC subtypes, final validation of clinical validity of SCLC subtyping is pending prospective clinical trials. </p> <p id=\"P28\"> [The Key Resources Table could be either included here OR uploaded as a separate file] Key Resources Table </p> </section> <section id=\"S12\"> <h3 class=\"pmc_sec_title\"> Key Resources Table </h3> <section class=\"tw xbox font-sm\" id=\"T2\"> <div class=\"tbl-box p\" tabindex=\"0\"> <table class=\"content\" frame=\"box\" rules=\"groups\"> <thead> <tr> <th align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> REAGENT or RESOURCE </th> <th align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> SOURCE </th> <th align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> IDENTIFIER </th> </tr> </thead> <tbody> <tr> <td align=\"left\" colspan=\"3\" rowspan=\"1\" valign=\"top\"> Biological samples </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Human FFPE specimen </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> This paper </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> N/A </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Human blood plasma specimen </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> This paper </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> N/A </td> </tr> <tr> <td align=\"left\" colspan=\"3\" rowspan=\"1\" valign=\"top\"> Critical commercial assays </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> SMARTer Seq V3 </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Takara </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> #634487 </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> RNA TruSeq RNA Exome </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Illumina </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> 20020189 </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Ovation RRBS Methyl-Seq </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Tecan </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> 0553-32 </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> MagMAX\u2122 FFPE DNA/RNA Ultra Kit </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Applied Biosystems </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> A31881 </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Apostle MiniMax High Efficiency Cell-Free DNA Isolation Kit </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Apostle Bio </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> A17622-250 </td> </tr> <tr> <td align=\"left\" colspan=\"3\" rowspan=\"1\" valign=\"top\"> Chemicals, peptides, and recombinant proteins </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Cisplatin </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> MD Anderson Pharmacy </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> N/A </td> </tr> <tr> <td align=\"left\" colspan=\"3\" rowspan=\"1\" valign=\"top\"> Software and algorithms </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> R v4.2.1 </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> R foundation for statistical computing </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> <a class=\"usa-link usa-link--external\" href=\"https://www.r-project.org/\" rel=\"noopener noreferrer\" target=\"_blank\"> https://www.r-project.org/ </a> </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Caret </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Max Kuhn </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> <a class=\"usa-link usa-link--external\" href=\"https://topepo.github.io/caret/\" rel=\"noopener noreferrer\" target=\"_blank\"> https://topepo.github.io/caret/ </a> </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> xGBoost </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Chen et al. <sup> <a aria-describedby=\"R61\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R61\"> 61 </a> </sup> </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> <a class=\"usa-link usa-link--external\" href=\"https://github.com/dmlc/xgboost/tree/36ad160501251336bfe69b602acc37ab3ec32d69\" rel=\"noopener noreferrer\" target=\"_blank\"> https://github.com/dmlc/xgboost/tree/36ad160501251336bfe69b602acc37ab3ec32d69 </a> </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Trimmomatic </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Bolger et al. <sup> <a aria-describedby=\"R62\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R62\"> 62 </a> </sup> </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> <a class=\"usa-link usa-link--external\" href=\"https://github.com/usadellab/Trimmomatic\" rel=\"noopener noreferrer\" target=\"_blank\"> https://github.com/usadellab/Trimmomatic </a> </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Bismark </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Felix Krueger </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> <a class=\"usa-link usa-link--external\" href=\"https://github.com/FelixKrueger/Bismark\" rel=\"noopener noreferrer\" target=\"_blank\"> https://github.com/FelixKrueger/Bismark </a> </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Salmon </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Patro et al. <sup> <a aria-describedby=\"R63\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R63\"> 63 </a> </sup> </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> <a class=\"usa-link usa-link--external\" href=\"https://github.com/COMBINE-lab/salmon\" rel=\"noopener noreferrer\" target=\"_blank\"> https://github.com/COMBINE-lab/salmon </a> </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> CAMDAC </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Cadieux et al. <sup> <a aria-describedby=\"R28\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R28\"> 28 </a> </sup> </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> <a class=\"usa-link usa-link--external\" href=\"https://github.com/VanLoo-lab/CAMDAC\" rel=\"noopener noreferrer\" target=\"_blank\"> https://github.com/VanLoo-lab/CAMDAC </a> </td> </tr> <tr> <td align=\"left\" colspan=\"3\" rowspan=\"1\" valign=\"top\"> Deposited data </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> RNA-seq of SCLC specimen </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> This paper </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> phs003416.v1.p1 </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> RRBS of SCLC specimen </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> This paper </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> phs003416.v1.p1 </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> ULP-WGS of SCLC plasma specimen </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> This paper </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> phs003416.v1.p1 </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> RRBS of plasma specimen </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> This paper </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> phs003416.v1.p1 </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> RRBS of cell line specimen </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> This paper </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> <a class=\"usa-link\" href=\"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE241673\" rel=\"noopener noreferrer\" target=\"_blank\"> GSE241673 </a> </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> RNA-seq of SCLC Specimen </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> George et al. <sup> <a aria-describedby=\"R25\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R25\"> 25 </a> </sup> </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> EGAS00001000925 </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> RNA-seq of SCLC Specimen </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> IMPower133 <sup> <a aria-describedby=\"R10\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R10\"> 10 </a> </sup> </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> EGAS00001004888 </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> RNA-seq of cell lines </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> NCI Cell Miner <sup> <a aria-describedby=\"R29\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R29\"> 29 </a> </sup> </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> <a class=\"usa-link\" href=\"https://discover.nci.nih.gov/rsconnect/SclcCellMinerCDB/\" rel=\"noopener noreferrer\" target=\"_blank\"> https://discover.nci.nih.gov/rsconnect/SclcCellMinerCDB/ </a> </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> RNA-seq of cell lines </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> GDSC <sup> <a aria-describedby=\"R30\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R30\"> 30 </a> </sup> </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> <a class=\"usa-link usa-link--external\" href=\"https://www.cancerrxgene.org/downloads/bulk_download\" rel=\"noopener noreferrer\" target=\"_blank\"> https://www.cancerrxgene.org/downloads/bulk_download </a> </td> </tr> <tr> <td align=\"left\" colspan=\"3\" rowspan=\"1\" valign=\"top\"> Experimental models: Cell lines </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Human cell line: H1694 </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> ATCC </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Cat # CRL-5888 </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Human cell line: H446 </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> ATCC </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Cat # HTB-171 </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Human cell line: H2171 </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> ATCC </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Cat # CRL-5929 </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Human cell line: H847 </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> ATCC </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Cat # CRL-5846 </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Human cell line: H82 </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> ATCC </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Cat # HTB-175 </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Human cell line: NJH29 </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Kindly provided by Dr. Julien Sage (Stanford University, Stanford, CA) </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> N/A </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Human cell line: H524 </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> ATCC </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Cat # CRL-5831 </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Human cell line: DMS273 </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Sigma Aldrich </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Cat # 95062830-1VL </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Human cell line: SHP-77 </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> ATCC </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Cat # CRL-2195 </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Human cell line: H865 </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> ATCC </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Cat # CRL-5849 </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Human cell line: H2330 </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> ATCC </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Cat # CRL-5940 </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Human cell line: H1522 </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> ATCC </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Cat # CRL-5874_FL </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Human cell line: H2196 </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> ATCC </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Cat # CRL-5932 </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Human cell line: DMS53 </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> ATCC </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Cat # CRL-2062 </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Human cell line: H146 </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> ATCC </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Cat # HTB-173 </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Human cell line: DMS79 </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> ATCC </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Cat # CRL-2049 </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Human cell line: H1876 </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> ATCC </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Cat # CRL-5902 </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Human cell line: H209 </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> ATCC </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Cat # HTB-172 </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Human cell line: H2108 </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> ATCC </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Cat # CRL-5984_FL </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Human cell line: H378 </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> ATCC </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Cat # CRL-5808 </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Human cell line: H1688 </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> ATCC </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Cat # CCL-257 </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Human cell line: H2195 </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> ATCC </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Cat # CRL-5931 </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Human cell line: H1436 </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> ATCC </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Cat # CRL-5871 </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Human cell line: H345 </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> ATCC </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Cat # CRL-5846 </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Human cell line: H2198 </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> ATCC </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Cat # HTB-180 </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Human cell line: H735 </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> ATCC </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Cat # CRL-5978 </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Human cell line: H69 </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> ATCC </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Cat # HTB-119 </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Human cell line: H250 </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> ATCC </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Cat # CRL-5828 </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Human cell line: H1963 </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> ATCC </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Cat # CRL-5982 </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Human cell line: H187 </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> ATCC </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Cat # CRL-5804 </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Human cell line: H1105 </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> ATCC </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Cat # CRL-5856 </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Human cell line: H128 </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> ATCC </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Cat # HTB-120 </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Human cell line: H510A </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> ATCC </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Cat # HTB-184 </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Human cell line: H1672 </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> ATCC </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Cat # CRL-5886 </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Human cell line: DMS153 </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> ATCC </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Cat # CRL-2064 </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Human cell line: H1417 </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> ATCC </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Cat # CRL-5869 </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Human cell line: H748 </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> ATCC </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Cat # CRL-5841 </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Human cell line: H2029 </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> ATCC </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Cat # CRL-5913 </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Human cell line: H1238 </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> ATCC </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Cat # CRL-5859 </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Human cell line: H740 </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> ATCC </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Cat # CRL-5840 </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Human cell line: H774 </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> ATCC </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Cat # CRL-5842 </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Human cell line: H2081 </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> ATCC </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Cat # CRL-5920 </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Human cell line: H2141 </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> ATCC </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Cat # CRL-5927 </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Human cell line: H2107 </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> ATCC </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Cat # CRL-5983_FL </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Human cell line: CORL88 </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Sigma Aldrich </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Cat # 92031917-1VL </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Human cell line: H889 </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> ATCC </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Cat # CRL-5817 </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Human cell line: H1092 </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> ATCC </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Cat # CRL-5855 </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Human cell line: H719 </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> ATCC </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Cat # CRL-5837 </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Human cell line: H1836 </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> ATCC </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Cat # CRL-5898 </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Human cell line: H1618 </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> ATCC </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Cat # CRL-5879 </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Human cell line: H526 </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> ATCC </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Cat # CRL-5811 </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Human cell line: H211 </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> ATCC </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Cat # CRL-5824 </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Human cell line: H196 </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> ATCC </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Cat # CRL-5823 </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Human cell line: H841 </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> ATCC </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Cat # CRL-5845 </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Human cell line: DMS114 </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> ATCC </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Cat # CRL-2066 </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Human cell line: H1930 </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> ATCC </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Cat # CRL-5906 </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Human cell line: H1048 </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> ATCC </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Cat # CRL-5853 </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Human cell line: H1341 </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> ATCC </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Cat # CRL-5864 </td> </tr> <tr> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Human cell line: H2227 </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> ATCC </td> <td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\"> Cat # CRL-5934 </td> </tr> </tbody> </table> </div> <div class=\"p text-right font-secondary\"> <a class=\"usa-link\" href=\"table/T2/\" rel=\"noopener noreferrer\" target=\"_blank\"> Open in a new tab </a> </div> </section> </section> </section> <section id=\"S13\"> <h2 class=\"pmc_sec_title\"> <a class=\"usa-anchor\" id=\"S13-anchor\"> </a> STAR Methods </h2> <section id=\"S14\"> <h3 class=\"pmc_sec_title\"> Resource Availability </h3> <section id=\"S15\"> <h4 class=\"pmc_sec_title\"> Lead Contact </h4> <p id=\"P29\"> Further information and requests for resources and reagents should be directed to and will be fulfilled by the lead contact, John V. Heymach ( <span> jheymach@mdanderson.org </span> ). </p> </section> <section id=\"S16\"> <h4 class=\"pmc_sec_title\"> Materials Availability </h4> <p id=\"P30\"> This study did not generate new unique reagents. Cell lines used in this manuscript have been retrieved and are available from ATCC. </p> </section> </section> <section id=\"S17\"> <h3 class=\"pmc_sec_title\"> Experimental Model and Study Participant Details </h3> <section id=\"S18\"> <h4 class=\"pmc_sec_title\"> Patient Selection </h4> <p id=\"P31\"> Patients in this study were included in two cohorts. In cohort 1, 105 patients have been selected after pathological examination of the tissue quality. All patients in this cohort were consented to the GEMINI protocol at the UT MD Anderson Cancer Center (UT MDACC). In cohort 2, 74 patients were included from the UT MD Anderson Cancer Center, the Hospital del Mar, Barcelona, Spain, Vanderbilt Medical Center, Nashville, TN USA, and LPCE Biobank Cote d\u2019Azur (BB-0033-00025), Nice, France. For 15/74 patients in cohort 2, plasma and previously extracted RNA was included. For those patients, only RNA-seq and plasma DNA methylation was performed but no tissue DNA methylation due to the absence of tissue for DNA extraction. All patients provided written informed consent. Each sample was required to have &gt; 100 tumor cell in each specimen, and at least 2 slides of tissue sections was required for inclusion in the study. All patients provided written informed consent prior to study enrollment and the study complied with the declaration of Helsinki. </p> <section id=\"S19\"> <h5 class=\"pmc_sec_title\"> Patient samples </h5> <p id=\"P32\"> Formalin-fixed and paraffin embedded (FFPE) specimen were used from all patients. At least two sections of 5-8\u00b5m were used. Each slide were analyzed by a board certified pathologist to contain at least 100 tumor cells. Blood was obtained by phlebotomy and plasma was processed within 6h of blood draw. 1-2ml of plasma were used for each patient. </p> </section> </section> <section id=\"S20\"> <h4 class=\"pmc_sec_title\"> Clinical Data </h4> <p id=\"P33\"> Clinical data was retrieved from the GEMINI database which includes clinical data obtained during treatment at the UT MDACC and consent was provided for accessing the clinical data. Additional data was retrieved manually and reviewed by three board-certified oncologists. For the analysis of survival, overall survival was calculated by time from date of diagnosis to death and patients with lost follow-up were censored at the date where the last information was obtained. Survival analysis was performed using Kaplan-Meier analysis and cox-proportional hazard ratio estimation using the survminer package <sup> <a aria-describedby=\"R64\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R64\"> 64 </a> </sup> in R <sup> <a aria-describedby=\"R65\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R65\"> 65 </a> </sup> . </p> </section> <section id=\"S21\"> <h4 class=\"pmc_sec_title\"> Cell line Samples </h4> <p id=\"P34\"> The human SCLC cell lines H1694, H446, H2171, H847, H82, NJH29, H524, DMS273, SHP-77, H865, H2330, H1522, H2196, DMS53, H146, DMS79, H1876, H209, H2108, H378, H1688, H2195, H1436, H345, H2198, H735, H69, H250, H1963, H187, H1105, H128, H510A, H1672, DMS153, H1417, H748, H2029, H1238, H740, H774, H2081, H2141, H2107, CORL88, H889, H1092, H719, H1836, H1618, H526, H211, H196, H841, DMS114, H1930, H1048, H1341, H2227 were obtained from ATCC (Manassas, VA) or Sigma Aldrich (St. Louis, MO). The patient-derived xenograft cell line NJH29 was kindly provided by Dr. Julien Sage (Stanford University, Stanford, CA). Cells were grown in suggested media supplemented with 5% fetal bovine serum and 1% penicillin/streptomycin and maintained in a 37\u00b0C humidified chamber with 5% CO2. Cells were passaged less than six months from the time they were received, regularly tested for Mycoplasma contamination and routinely subjected to DNA fingerprinting. </p> <p id=\"P35\"> For the treatment with chemotherapy, H1876 and H2195 cells were cultivated in HITES with 5% fetal bovine serum and 1% penicillin/streptomycin. They were treated with 2\u00b5M cisplatin for 0, 2, 5, 9 days, respectively. </p> </section> </section> <section id=\"S22\"> <h3 class=\"pmc_sec_title\"> Method Details </h3> <section id=\"S23\"> <h4 class=\"pmc_sec_title\"> SCLC detection using cfDNA </h4> <p id=\"P36\"> Detection of SCLC has been performed using a commercial PCR based assay. Initial validation has been performed previously <sup> <a aria-describedby=\"R24\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R24\"> 24 </a> </sup> . Sample inclusion, assay execution and data analysis has been performed as highlighted previously. However, 288 additional specimens have been included in this analysis. Furthermore, new cut-offs specifically for the detection of SCLC have been selected in this study. Level of detection (LOD) and level of blank (LOB) was determined by 22 replicates of an unmethylated plasmid DNA that contain the cloned markers spiked into healthy human cfDNA in order to establish the limit of blank (LOB) for each marker separately (the average LOB across the markers was 1:249,281). Totally 35ng of DNA was used for the spike-in experiment of which 3.5ng of DNA was used per qPCR reaction for each of the six markers. For the assessment of LOD, we spiked the unmethylated DNA together with DNA that is methylated in these 6 markers from a human lung cancer cell line into 35ng of the healthy human plasma cfDNA at a dilution of 1:10,000 (methylated:unmethylated). All 22 replicates detected DNA methylation in the six markers demonstrating a LOD of at least 1:10,000. </p> </section> <section id=\"S24\"> <h4 class=\"pmc_sec_title\"> Nucleic Acid Extraction </h4> <p id=\"P37\"> For the nucleic acid extraction, at least two slides of FFPE tissue samples were cut at 5-8\u00b5m each. For each sample, tumor area was highlighted by a board-certified Pathologist and macrodissection was used prior to extraction in cohort 1 but not cohort 2, if necessary. For combined RNA and DNA extraction, the MagMAX FFPE DNA/RNA Ultra Kit (Thermo Fisher Scientific, A31881) was used following the manufacturer\u2019s protocol. DNA concentration was assessed using the Qubit 1X dsDNA HS Assay Kit and a Qubit 2.0 fluorimeter. For RNA, concentration was measured using the Qubit RNA high sensitivity (HS) assay kit. RNA quality was analyzed using the Agilent RNA 6000 Pico kit on a 2100 Bioanalyzer. </p> <p id=\"P38\"> For cfDNA extraction, 1-3 ml Plasma obtained in Streck Cell-Free DNA BCT tubes was used for each sample. Plasma was obtained within 6h of phlebotomy by spinning the blood for 10 minutes at 1800xg followed by a second centrifugation step of the isolated plasma for 10 minutes at 2000xg. Both centrifugation steps were performed in swing-bucket rotors. cfDNA was extracted using the Apostle MiniMax High Efficiency Cell-Free DNA Isolation Kit (Apostle Inc). cfDNA concentration was assessed using the Qubit 1X dsDNA HS Assay Kit and a Qubit 2.0 fluorimeter. </p> </section> <section id=\"S25\"> <h4 class=\"pmc_sec_title\"> RNA-seq </h4> <p id=\"P39\"> For cohort 1, 85 samples have been selected for RNA sequencing. All samples were treated with DNase treatment using DNase I (ThermoFisher, Massachusetts, USA) prior to RNA-seq to reduce DNA contamination that might interfere with downstream results. Library generation using the SMARTer Stranded Total RNA-seq Kit V3 (Takara Bio USA Inc., California, USA) was performed following the manufacturer\u2019s instructions. Final library quantity was measured by KAPA SYBR FAST qPCR and library quality was evaluated using a TapeStation D1000 ScreenTape (Agilent Technologies, CA, USA). Libraries were sequenced on an Illumina NovaSeq instrument (Illumina, California, USA) with a read length configuration of 150 PE for 80M PE reads per sample (40M clusters). Fastq files were quality trimmed using trimmomatic and aligned to the GRCh38 transcriptome using salmon v1.6.0. </p> <p id=\"P40\"> For cohort 2, 57 samples have been submitted for RNA-seq using the Illumina RNA Access hybrid capture-based protocol. All samples were treated with DNAse I prior to library generation according to manufacturer\u2019s protocol. Sequencing was performed on an Illumina NovaSeq instrument with 100M PE configuration. 40M reads were used for each sample. Fastq files were quality trimmed using trimmomatic and aligned to the GRCh38 transcriptome using salmon v1.6.0. </p> </section> <section id=\"S26\"> <h4 class=\"pmc_sec_title\"> RRBS </h4> <p id=\"P41\"> To analyze DNA Methylation across the genome, RRBS (Reduced Representation Bisulfite Sequencing) <sup> <a aria-describedby=\"R66\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R66\"> 66 </a> , <a aria-describedby=\"R67\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R67\"> 67 </a> </sup> was utilized using the Ovation RRBS Methyl-Seq kit (Tecan Group Ltd., Zurich, Switzerland). To account for the highly degraded DNA from FFPE and plasma samples, the material was first treated with one unit of Shrimp Alkaline Phosphatase (New England Biolabs, Ipswich, MA) to remove phosphorylated DNA which might interfere with downstream analysis <sup> <a aria-describedby=\"R34\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R34\"> 34 </a> </sup> . Briefly, 0.1 \u2013 100ng of genomic DNA was digested using MspI, and Illumina-compatible cytosine-methylated adaptor were ligated to the enzyme-digested DNA. For lower concentrations of DNA, adapters were diluted 1:40 to 1:120, in order to decrease the representation of randomly fragmented DNA and adapter-dimers in the final library. RRBS libraries were then visualized using Bioanalyzer High Sensitivity DNA chips (Agilent, Santa Clara, CA), and those passing QC were subsequently sequenced as 100bp paired-end reads on an Illumina NovaSeq instrument with a target sequencing depth of 300M PE reads (150M clusters). After sequencing, Fastq files were obtained and adapters were trimmed using trimmomatic. Alignment and retrieval of DNA Methylation (in percent of total methylated Cytosines) was performed using Bismark v 0.22 <sup> <a aria-describedby=\"R68\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R68\"> 68 </a> </sup> against the GRCh38 human genome. Samples with &lt; 50% mapping rate and, &lt; 60M aligned reads were excluded from further analysis. Finally, cytosines with coverage &lt; 10 were filtered out to assure high confidence DNA Methylation analysis. </p> <p id=\"P42\"> For cell lines, 100ng of RNA was used using the Ovation RRBS Methyl-Seq kit (Tecan Group Ltd., Zurich, Switzerland) as for the clinical samples but without the initial phosphatase step. Sequencing was performed in a single Read 57 bp configuration on a Illumina HiSeq 3000 sequencer. Data processing was performed likewise using Bismark v 0.22. Annotations of methylated regions was performed using the annotatr <sup> <a aria-describedby=\"R69\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R69\"> 69 </a> </sup> package and the Hg38 database. </p> <p id=\"P43\"> Deconvolution of tumor intrinsic signals in cohort 2 was performed using the Copy number-aware deconvolution of tumor-normal DNA methylation (CAMDAC) algorithm as published previously <sup> <a aria-describedby=\"R28\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R28\"> 28 </a> </sup> . </p> </section> <section id=\"S27\"> <h4 class=\"pmc_sec_title\"> ULP-WGS </h4> <p id=\"P44\"> Library preparation was performed using the KAPA HyperPrep Kit with Library Amplification product KK8504) and IDT\u2019s duplex UMI adapters (KAPA Biosciences). Sequencing is performed on a NovaSeq 6000 with 2x 150bp configuration and a target sequencing depth of ~ 0.3x. </p> <p id=\"P45\"> In order to define DNA methylation sites that are associated with general ctDNA content, we correlated DNA methylation sites against their reported cDNA content using ULP-WGS. Only sites with R <sup> 2 </sup> &gt; 0.65, slope between 0.9 and 1.1 and intercept between -10 and 10 were selected. After manual analysis, seven sites have been selected: \u201cchr12:27974490\u201d, \u201cchr1:7236563\u201d, \u201cchr17:29139387\u201d, \u201cchr19:128737209\u201d, \u201cchr2:10401557\u201d, \u201cchr21:34669078\u201d, \u201cchr21:45590104\u201d. ctDNA content was calculated by averaging the methylation level across all seven sites for each sample. </p> </section> <section id=\"S28\"> <h4 class=\"pmc_sec_title\"> Generation of Predictive Models for Classification using RNA-seq </h4> <p id=\"P46\"> We hypothesized that using gene ratios of one gene over another gene might be more robust to classify SCLC across different datasets than using the single expression value. For this purpose, we combined the data retrieved from George et al. comprising of surgical SCLC specimen and the data from the IMPower133 clinical trial as published in Gay CM et al <sup> <a aria-describedby=\"R10\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R10\"> 10 </a> </sup> . While for the latter only limited genes were published, we filtered for genes that were present in both datasets that served as training set. We used ROC analysis to define the genes which were mostly associated with one of the four subtypes by analysing the association of each respective gene with each of the four subtypes. For each of the four subtypes, the Top 50 genes with the highest area under the curve in ROC analysis have been selected for model generation. Due to some overlaps across the genes selected, finally 181 genes were used ( <a class=\"usa-link\" href=\"#SD2\"> Table S1 </a> ). We then created all different gene ratios of those genes. To select highly relevant gene ratios, we created predictive models, incorporating randomly selected 20 gene ratios per model with 500 distinct models for each of the four subtypes (totally 2000 models created). For the training, the caret package <sup> <a aria-describedby=\"R70\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R70\"> 70 </a> </sup> in R was used, and extreme gradient boosting with DART (Dropout Additive Regression Trees) <sup> <a aria-describedby=\"R71\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R71\"> 71 </a> </sup> was utilized with repeated cross validation with a 5-fold split and 20 repeats during training. Those models were then used to define the subtypes in our clinical dataset. In order to obtain the most generalized subtype classification, we used all models for the prediction and if <span class=\"text-underline\"> &gt; </span> 50% of the models agreed on the subtype, the subtype was called based on this consensus classification. Samples with less than 50% agreement are called \u201cequivocal\u201d as a clear classification could not be obtained with our current methodology. Consensus as well as subtyping for each sample is provided in <a class=\"usa-link\" href=\"#SD2\"> Table S1 </a> . </p> </section> <section id=\"S29\"> <h4 class=\"pmc_sec_title\"> Generation of Predictive Models for Classification using DNA Methylation Data </h4> <p id=\"P47\"> To generate models with broader applicability, we combined data from the cell lines and our clinical GEMINI cohort in order to tune models to work across different sample types. The selected DNA Methylation sites were filtered to be present in both datasets. Furthermore, only methylation sites with &lt;= 10% missing data were used. Following, we performed ROC analysis on the combined set to select the methylation sites that had the highest association with one of the four subtypes by analysing the association of each DNA methylation site with each of the four subtypes. We selected based on the following criteria; For SCLC-A: AUC &gt;= 0.7 &amp; difference to other subtypes &gt;= abs(25%) (N = 199), for SCLC-N: AUC &gt;= 0.7 &amp; diff &gt;= abs(30) (N = 127), for SCLC-P: AUC &gt;= 0.8 &amp; diff &gt;= abs(35) (N = 194), for SCLC-I: AUC &gt;= 0.7 &amp; diff &gt;= abs(30) (N = 293; <a class=\"usa-link\" href=\"#SD4\"> Table S3 </a> ). Initially, we analyzed the influence of number of methylation sites and performance by selecting, 1, 2, 3, 4, 5, 10, 20, 30, 40, 50, 100 methylation sites randomly training 100 models for each of the combinations. We analyzed the accuracy for each of those models on the training and the testing set ( <a class=\"usa-link\" href=\"#SD1\"> Figure S6A </a> ). Based on this analysis, for each of the four subtypes we created models by randomly selecting 10, 50, or 100 methylation sites per subtype per model for our final classifier. For each number of methylation sites, 500 models were created using xgboost with DART leave-one-out cross validation (LOOCV) using the training set. Similar to the RNA-seq approach, a subtype was called when <span class=\"text-underline\"> &gt; </span> 50% agreed on the subtype. If &lt; 50% agreement was achieved, the subtype was classified as \u201cequivocal\u201d due to the lack of consensus. The classification for each sample is provided in <a class=\"usa-link\" href=\"#SD4\"> Table S3 </a> . </p> <p id=\"P48\"> For models predicting subtypes using cfDNA, the same methylation sites were used but filtered for presence in the cfDNA dataset. Similarily to tissue models, we used xgBOOST with DART and LOOCV and trained 500 models per subtype. The consensus approach was applied. The classification for each sample is provided in <a class=\"usa-link\" href=\"#SD4\"> Table S3 </a> . </p> </section> </section> <section id=\"S30\"> <h3 class=\"pmc_sec_title\"> Quantification and Statistical Analyses </h3> <p id=\"P49\"> All analysis have been performed in R v4.1.1 <sup> <a aria-describedby=\"R65\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R65\"> 65 </a> </sup> . Binning of the genome was performed based on the BSgenome.Hsapiens.NCBI.GRCh38 database <sup> <a aria-describedby=\"R72\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R72\"> 72 </a> </sup> using a tile width of 100bp or 100,000 bp cutting the last tile of each chromosome. DNA methylation across each tile was averaged excluding missing data. To analyse the genome-wide methylation per subtype, the mean methylation per tile per sample was further averaged per subtype. The rolling average of 500 bins (= 50Mbp) was calculated using the \u2018rollmean\u2019 function in the R zoo package <sup> <a aria-describedby=\"R73\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R73\"> 73 </a> </sup> . </p> <p id=\"P50\"> In order to annotate the methylation sites to regions in the genome associated with genes, the annotatr package has been used <sup> <a aria-describedby=\"R69\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R69\"> 69 </a> </sup> . The following regions have been annotated based on the GRCh38 genome: \u201chg38_genes_promoters\u201d, \u201chg38_genes_exons\u201d, \u201chg38_genes_introns\u201d, \u201chg38_genes_1to5kb\u201d, \u201chg38_genes_5UTRs\u201d, \u201chg38_genes_intergenic\u201d, \u201chg38_genes_3UTRs\u201d, \u201chg38_genes_firstexons\u201d, \u201chg38_genes_intronexonboundaries\u201d, \u201chg38_genes_exonintronboundaries\u201d. </p> <p id=\"P51\"> Association of DNA methylation sites or regions has been performed using pROC <sup> <a aria-describedby=\"R74\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R74\"> 74 </a> </sup> . Cut-offs were calculated using Youden\u2019s J and sensitivity and specificity has been calculated based on the pre-calculated cut-off. For the calculations of differences, unless otherwise highlighted, Wilcoxon test has been used with FDR correction for multiple testing using rstatix <sup> <a aria-describedby=\"R75\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R75\"> 75 </a> </sup> . </p> <p id=\"P52\"> Figures were created using ggplot2 <sup> <a aria-describedby=\"R76\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R76\"> 76 </a> </sup> or ComplexHeatmap <sup> <a aria-describedby=\"R77\" aria-expanded=\"false\" class=\"usa-link\" href=\"#R77\"> 77 </a> </sup> . The graphical abstract was created using <a class=\"usa-link usa-link--external\" href=\"http://Biorender.com\" rel=\"noopener noreferrer\" target=\"_blank\"> Biorender.com </a> . </p> </section> </section> <section id=\"SM\"> <h2 class=\"pmc_sec_title\"> <a class=\"usa-anchor\" id=\"SM-anchor\"> </a> Supplementary Material </h2> <section class=\"sm xbox font-sm\" id=\"SD1\"> <div class=\"caption p\"> <span> Data S1. RNA-seq data of cohort 1, related to Figure 1. </span> </div> <div class=\"media p\" id=\"d67e2004\"> <div class=\"caption\"> <a class=\"usa-link\" href=\"/articles/instance/11178430/bin/EMS195999-supplement-Data_S1.csv\"> EMS195999-supplement-Data_S1.csv </a> <sup> (34.9MB, csv) </sup> </div> </div> </section> <section class=\"sm xbox font-sm\" id=\"SD2\"> <div class=\"caption p\"> <span> Data S2. RNA-seq data of cohort 2, related to Figure 2. </span> </div> <div class=\"media p\" id=\"d67e2009\"> <div class=\"caption\"> <a class=\"usa-link\" href=\"/articles/instance/11178430/bin/EMS195999-supplement-Data_S2.csv\"> EMS195999-supplement-Data_S2.csv </a> <sup> (14.5MB, csv) </sup> </div> </div> </section> <section class=\"sm xbox font-sm\" id=\"SD3\"> <div class=\"caption p\"> <span> Figure S1 </span> </div> <div class=\"media p\" id=\"d67e2012\"> <div class=\"caption\"> <a class=\"usa-link\" href=\"/articles/instance/11178430/bin/EMS195999-supplement-Figure_S1.pdf\"> EMS195999-supplement-Figure_S1.pdf </a> <sup> (10.4MB, pdf) </sup> </div> </div> </section> <section class=\"sm xbox font-sm\" id=\"SD4\"> <div class=\"caption p\"> <span> Table S1 </span> </div> <div class=\"media p\" id=\"d67e2015\"> <div class=\"caption\"> <a class=\"usa-link\" href=\"/articles/instance/11178430/bin/EMS195999-supplement-Table_S1.xlsx\"> EMS195999-supplement-Table_S1.xlsx </a> <sup> (28.7KB, xlsx) </sup> </div> </div> </section> <section class=\"sm xbox font-sm\" id=\"SD5\"> <div class=\"caption p\"> <span> Table S2 </span> </div> <div class=\"media p\" id=\"d67e2018\"> <div class=\"caption\"> <a class=\"usa-link\" href=\"/articles/instance/11178430/bin/EMS195999-supplement-Table_S2.xlsx\"> EMS195999-supplement-Table_S2.xlsx </a> <sup> (18.2KB, xlsx) </sup> </div> </div> </section> <section class=\"sm xbox font-sm\" id=\"SD6\"> <div class=\"caption p\"> <span> Table S3 </span> </div> <div class=\"media p\" id=\"d67e2021\"> <div class=\"caption\"> <a class=\"usa-link\" href=\"/articles/instance/11178430/bin/EMS195999-supplement-Table_S3.xlsx\"> EMS195999-supplement-Table_S3.xlsx </a> <sup> (221.4KB, xlsx) </sup> </div> </div> </section> </section> <section class=\"ack\" id=\"S31\"> <h2 class=\"pmc_sec_title\"> <a class=\"usa-anchor\" id=\"S31-anchor\"> </a> Acknowledgements </h2> <p> Funding has been provided by the NIH; NIH/NCI Core grant CA016672(ATGC), NIH/NCI U24CA213274, NIH/NCI SCLC U01CA213273, NIH/NCI SCLC U01CA256780, NCI/NIH R01CA207295, NIH/NCI P50CA070907, NIH/NCI R50CA243698, NIH/NCI P30CA016672; 1R50CA265307 and NIH Cancer Center Support Grand (CCSG)- Bioinformatics Shared Resources (BISR); the CPRIT Core Facility Support Grants (#RP120348 &amp; #RP170002), CPRIT Early Clinical Investigator Award (RP210159), LUNGevity Career Development Award, the Horizon 2020 research and innovation program (#829218); the AnnaRose King Cancer Research Fund, and the Camp fund, the Bruton endowment, John and Debbie Lyon Small Cell Lung Cancer Research fund and Rexanna\u2019s Foundation for Fighting Lung Cancer. This work was supported through generous philanthropic contributions to The University of Texas MD Anderson Cancer Center Lung Cancer Moonshot Program. BBM is a TRIUMPH Fellow in the CPRIT Research Training Program (RP210028). C.M.L was supported by National Institutes of Health grant numbers CA217450, CA224276, and CA233259. PR was partially funded by ESMO, SEOM and AECC. PVL was supported by the Francis Crick Institute which receives its core funding from Cancer Research UK (CC2008), the UK Medical Research Council (CC2008), and the Wellcome Trust (CC2008). For the purpose of Open Access, the author has applied a CC BY public copyright license to any Author Accepted Manuscript version arising from this submission. P.V.L. is a Winton Group Leader in recognition of the Winton Charitable Foundation\u2019s support towards the establishment of The Francis Crick Institute. P.V.L. is a CPRIT Scholar in Cancer Research and acknowledges CPRIT grant support (RR210006). The authors would like to thank the MDACC ATGC core facility as well as the MDACC Epigenetics core for supporting this project. Furthermore, the authors would like to thank Dr. Revital Knirsh and Orna Savin for their support in the laboratory. </p> </section> <section class=\"fn-group\" id=\"fn-group1\"> <h2 class=\"pmc_sec_title\"> <a class=\"usa-anchor\" id=\"fn-group1-anchor\"> </a> Footnotes </h2> <div class=\"fn-group p font-secondary-light font-sm\"> <div class=\"fn p\" id=\"FN2\"> <p id=\"P53\"> <strong> Author Contributions </strong> </p> <p id=\"P54\"> S.H., CM.G., LA.B. and JV.H developed the concept and design of the study. S.H. and MR.E. developed protocols. S.H., C.M.G., H.T., BB.M., B.Z., X.T., G.R., P.R., S.L., E.A., P.H., V.H., P.K., CM.L., K.C., LG.S., WE.L., K.K., X.H., A.T., NI.V., MB.N., A.S., M.J., I.H., M.G., V.P., Y.R., D.F., A.W., A.S., CA.S., J.Z., II.W., LA.B., JV.H. provided data and supported analysis. S.H., MR.E., H.T., BB.M., B.Z., S.L., K.C. D.F., A.W., A.S., CA.S., Y.X., L.D., Q.W., J.W., P.VL performed data analysis. S.H. and JV.H. wrote the manuscript. All authors contributed to the critical revision of the manuscript and approved the final version. </p> </div> <div class=\"fn p\" id=\"FN3\"> <p id=\"P55\"> <strong> Disclosures </strong> </p> <p id=\"P56\"> SH, CMG, LAB, JVH own intellectual property on the classification of SCLC from DNA methylation and Gene expression. DF, AW, AS, CAS are full time employees of Nucleix and own stocks and stock options of Nucleix. Furthermore, SH reports consulting fees from Guardant Health, AstraZeneca, Boehringer Ingelheim and Qiagen. CMG is a member of the advisory board at Jazz Pharmaceuticals, AstraZeneca, Bristol Myers Squibb and served as speaker for AstraZeneca and BeiGene. PR received travel support from AstraZeneca, BMS and MSD. EA reports consulting fees from Eli Lilly, AstraZeneca, BMS, Boehringer Ingelheim, Takeda, Roche and MSD, speaker\u2019s fees from AstraZeneca, BMS, Boehringer Ingelheim, Roche and MSD, research funding from Roche and AstraZeneca and travel support from AstraZeneca and Takeda. PH reports research grants from Thermo Fisher Scientific and Biocartis, and speakers\u2019 fees from AstraZeneca, Roche, Novartis, Bristol-Myers Squibb, Pfizer, Bayer, Illumina, Biocartis, Thermo Fisher Scientific, AbbVie, Amgen, Janssen, Eli Lilly, Daiichi Sankyo, Pierre Fabre, and Guardant. VH reports speakers\u2019 fees from BMS. CM.L. reports personal fees from Amgen, Arrivent, AstraZeneca, Blueprints Medicine, Cepheid, D2G Oncology, Daiichi Sankyo, Eli Lilly, EMD Serono, Foundation Medicine, Genentech, Janssen, Medscape, Novartis, Pfizer, Puma, Syros, and Takeda. N.V. receives consulting fees from Sanofi, Regeneron, Oncocyte, and Eli Lilly, and research funding from Mirati. MBN receives royalties and licensing fees from Spectrum Pharmaceuticals. IH received personal as well as institutional funding from Nucleix. JZ served on advisory board for AstraZeneca and Geneplus and received speaker\u2019s fees from BMS, Geneplus, OrigMed, Innovent, grants from Merck, Johnson and Johnson. LAB received consulting fees and research funding from AstraZeneca, GenMab, Sierra Oncology, research funding from ToleroPharmaceuticals and served as advisor or consultant for PharmaMar, AbbVie, Bristol-Myers Squibb, Alethia, Merck, Pfizer, Jazz Pharmaceuticals, Genentech, Debiopharm Group. JVH served as advisor for AstraZeneca, EMD Serono, Boehringer-Ingelheim, Catalyst, Genentech, GlaxoSmithKline, Guardant Health, Foundation medicine, Hengrui Therapeutics, Eli Lilly, Novartis, Spectrum, Sanofi, Takeda, Mirati Therapeutics, BMS, BrightPath Biotherapeutics, Janssen Global Services, Nexus Health Systems, Pneuma Respiratory, Kairos Venture Investments, Roche, Leads Biolabs, RefleXion, Chugai Pharmaceuticals, received research support from AstraZeneca, GlaxoSmithKline, Spectrum as well as royalties and licensing fees from Spectrum. All other authors have no conflict of interest to declare. </p> </div> </div> </section> <section id=\"S32\"> <h2 class=\"pmc_sec_title\"> <a class=\"usa-anchor\" id=\"S32-anchor\"> </a> Data and code availability </h2> <p> Code generated in this manuscript can be found at: <a class=\"usa-link usa-link--external\" href=\"https://github.com/MD-Anderson-Bioinformatics/SCLC_Subtyping\" rel=\"noopener noreferrer\" target=\"_blank\"> https://github.com/MD-Anderson-Bioinformatics/SCLC_Subtyping </a> </p> <p> Raw sequencing data generated as part of this manuscript are deposited in dbGap ( <a class=\"usa-link\" href=\"https://www.ncbi.nlm.nih.gov/gap/\" rel=\"noopener noreferrer\" target=\"_blank\"> https://www.ncbi.nlm.nih.gov/gap/ </a> ) under accession number phs003416.v1.p1. Sequencing data from cell lines are deposited in GEO ( <a class=\"usa-link\" href=\"https://www.ncbi.nlm.nih.gov/geo/\" rel=\"noopener noreferrer\" target=\"_blank\"> https://www.ncbi.nlm.nih.gov/geo/ </a> ) with accession number <a class=\"usa-link\" href=\"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE241673\" rel=\"noopener noreferrer\" target=\"_blank\"> GSE241673 </a> . Processed RNA-seq data for cohort 1 and cohort are additionally directly provided in this manuscript as <a class=\"usa-link\" href=\"#SD1\"> data S1 </a> and <a class=\"usa-link\" href=\"#SD2\"> data S2 </a> , respectively. </p> <p> Any additional information required to reanalyze the data reported in this paper is available from the lead contact upon request. </p> </section> <section class=\"ref-list\" id=\"ref-list1\"> <h2 class=\"pmc_sec_title\"> <a class=\"usa-anchor\" id=\"ref-list1-anchor\"> </a> References </h2> <section id=\"ref-list1_sec2\"> <ul class=\"ref-list font-sm\"> <li id=\"R1\"> <span class=\"label\"> 1. </span> <cite> Horn L, Mansfield AS, Szczesna A, Havel L, Krzakowski M, Hochmair MJ, Huemer F, Losonczy G, Johnson ML, Nishio M, et al. First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer. N Engl J Med. 2018;379:2220\u20132229. doi: 10.1056/NEJMoa1809064. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1056/NEJMoa1809064\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/30280641/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&amp;title=First-Line%20Atezolizumab%20plus%20Chemotherapy%20in%20Extensive-Stage%20Small-Cell%20Lung%20Cancer&amp;author=L%20Horn&amp;author=AS%20Mansfield&amp;author=A%20Szczesna&amp;author=L%20Havel&amp;author=M%20Krzakowski&amp;volume=379&amp;publication_year=2018&amp;pages=2220-2229&amp;pmid=30280641&amp;doi=10.1056/NEJMoa1809064&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"R2\"> <span class=\"label\"> 2. </span> <cite> Paz-Ares L, Dvorkin M, Chen Y, Reinmuth N, Hotta K, Trukhin D, Statsenko G, Hochmair MJ, Ozguroglu M, Ji JH, et al. Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial. Lancet. 2019;394:1929\u20131939. doi: 10.1016/S0140-6736(19)32222-6. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1016/S0140-6736(19)32222-6\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/31590988/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Durvalumab%20plus%20platinum-etoposide%20versus%20platinum-etoposide%20in%20first-line%20treatment%20of%20extensive-stage%20small-cell%20lung%20cancer%20(CASPIAN):%20a%20randomised,%20controlled,%20open-label,%20phase%203%20trial&amp;author=L%20Paz-Ares&amp;author=M%20Dvorkin&amp;author=Y%20Chen&amp;author=N%20Reinmuth&amp;author=K%20Hotta&amp;volume=394&amp;publication_year=2019&amp;pages=1929-1939&amp;pmid=31590988&amp;doi=10.1016/S0140-6736(19)32222-6&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"R3\"> <span class=\"label\"> 3. </span> <cite> Byers LA, Chiappori A, Smit M-AD. Phase 1 study of AMG 119, a chimeric antigen receptor (CAR) T cell therapy targeting DLL3, in patients with relapsed/refractory small cell lung cancer (SCLC) J Clin Oncol. 2019;37:1\u2013TPS8576. doi: 10.1200/JCO.2019.37.15_suppl.TPS8576. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1200/JCO.2019.37.15_suppl.TPS8576\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Oncol&amp;title=Phase%201%20study%20of%20AMG%20119,%20a%20chimeric%20antigen%20receptor%20(CAR)%20T%20cell%20therapy%20targeting%20DLL3,%20in%20patients%20with%20relapsed/refractory%20small%20cell%20lung%20cancer%20(SCLC)&amp;author=LA%20Byers&amp;author=A%20Chiappori&amp;author=M-AD%20Smit&amp;volume=37&amp;publication_year=2019&amp;pages=1%E2%80%93TPS8576&amp;doi=10.1200/JCO.2019.37.15_suppl.TPS8576&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"R4\"> <span class=\"label\"> 4. </span> <cite> Hipp S, Voynov V, Drobits-Handl B, Giragossian C, Trapani F, Nixon AE, Scheer JM, Adam PJ. A Bispecific DLL3/CD3 IgG-Like T-Cell Engaging Antibody Induces Antitumor Responses in Small Cell Lung Cancer. Clin Cancer Res. 2020;26:5258\u20135268. doi: 10.1158/1078-0432.CCR-20-0926. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1158/1078-0432.CCR-20-0926\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/32554516/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Clin%20Cancer%20Res&amp;title=A%20Bispecific%20DLL3/CD3%20IgG-Like%20T-Cell%20Engaging%20Antibody%20Induces%20Antitumor%20Responses%20in%20Small%20Cell%20Lung%20Cancer&amp;author=S%20Hipp&amp;author=V%20Voynov&amp;author=B%20Drobits-Handl&amp;author=C%20Giragossian&amp;author=F%20Trapani&amp;volume=26&amp;publication_year=2020&amp;pages=5258-5268&amp;pmid=32554516&amp;doi=10.1158/1078-0432.CCR-20-0926&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"R5\"> <span class=\"label\"> 5. </span> <cite> Paz-Ares L, Champiat S, Lai WV, Izumi H, Govindan R, Boyer M, Hummel HD, Borghaei H, Johnson ML, Steeghs N, et al. Tarlatamab, a First-In-Class DLL3-Targeted Bispecific T-Cell Engager, in Recurrent Small Cell Lung Cancer: An Open-Label, Phase I Study. J Clin Oncol. 2023:JCO2202823. doi: 10.1200/JCO.22.02823. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1200/JCO.22.02823\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC10414718/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/36689692/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Oncol&amp;title=Tarlatamab,%20a%20First-In-Class%20DLL3-Targeted%20Bispecific%20T-Cell%20Engager,%20in%20Recurrent%20Small%20Cell%20Lung%20Cancer:%20An%20Open-Label,%20Phase%20I%20Study&amp;author=L%20Paz-Ares&amp;author=S%20Champiat&amp;author=WV%20Lai&amp;author=H%20Izumi&amp;author=R%20Govindan&amp;publication_year=2023&amp;pages=JCO2202823&amp;pmid=36689692&amp;doi=10.1200/JCO.22.02823&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"R6\"> <span class=\"label\"> 6. </span> <cite> Pietanza MC, Waqar SN, Krug LM, Dowlati A, Hann CL, Chiappori A, Owonikoko TK, Woo KM, Cardnell RJ, Fujimoto J, et al. Randomized, Double-Blind, Phase II Study of Temozolomide in Combination With Either Veliparib or Placebo in Patients With Relapsed-Sensitive or Refractory Small-Cell Lung Cancer. J Clin Oncol. 2018;36:2386\u20132394. doi: 10.1200/JCO.2018.77.7672. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1200/JCO.2018.77.7672\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC6085179/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/29906251/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Oncol&amp;title=Randomized,%20Double-Blind,%20Phase%20II%20Study%20of%20Temozolomide%20in%20Combination%20With%20Either%20Veliparib%20or%20Placebo%20in%20Patients%20With%20Relapsed-Sensitive%20or%20Refractory%20Small-Cell%20Lung%20Cancer&amp;author=MC%20Pietanza&amp;author=SN%20Waqar&amp;author=LM%20Krug&amp;author=A%20Dowlati&amp;author=CL%20Hann&amp;volume=36&amp;publication_year=2018&amp;pages=2386-2394&amp;pmid=29906251&amp;doi=10.1200/JCO.2018.77.7672&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"R7\"> <span class=\"label\"> 7. </span> <cite> Howlader N, Forjaz G, Mooradian MJ, Meza R, Kong CY, Cronin KA, Mariotto AB, Lowy DR, Feuer EJ. The Effect of Advances in Lung-Cancer Treatment on Population Mortality. N Engl J Med. 2020;383:640\u2013649. doi: 10.1056/NEJMoa1916623. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1056/NEJMoa1916623\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC8577315/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/32786189/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&amp;title=The%20Effect%20of%20Advances%20in%20Lung-Cancer%20Treatment%20on%20Population%20Mortality&amp;author=N%20Howlader&amp;author=G%20Forjaz&amp;author=MJ%20Mooradian&amp;author=R%20Meza&amp;author=CY%20Kong&amp;volume=383&amp;publication_year=2020&amp;pages=640-649&amp;pmid=32786189&amp;doi=10.1056/NEJMoa1916623&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"R8\"> <span class=\"label\"> 8. </span> <cite> Rudin CM, Poirier JT, Byers LA, Dive C, Dowlati A, George J, Heymach JV, Johnson JE, Lehman JM, MacPherson D, et al. Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data. Nat Rev Cancer. 2019;19:289\u2013297. doi: 10.1038/s41568-019-0133-9. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1038/s41568-019-0133-9\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC6538259/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/30926931/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Nat%20Rev%20Cancer&amp;title=Molecular%20subtypes%20of%20small%20cell%20lung%20cancer:%20a%20synthesis%20of%20human%20and%20mouse%20model%20data&amp;author=CM%20Rudin&amp;author=JT%20Poirier&amp;author=LA%20Byers&amp;author=C%20Dive&amp;author=A%20Dowlati&amp;volume=19&amp;publication_year=2019&amp;pages=289-297&amp;pmid=30926931&amp;doi=10.1038/s41568-019-0133-9&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"R9\"> <span class=\"label\"> 9. </span> <cite> Baine MK, Hsieh MS, Lai WV, Egger JV, Jungbluth AA, Daneshbod Y, Beras A, Spencer R, Lopardo J, Bodd F, et al. SCLC Subtypes Defined by ASCL1, NEUROD1, POU2F3, and YAP1: A Comprehensive Immunohistochemical and Histopathologic Characterization. J Thorac Oncol. 2020;15:1823\u20131835. doi: 10.1016/j.jtho.2020.09.009. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1016/j.jtho.2020.09.009\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC8362797/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/33011388/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=J%20Thorac%20Oncol&amp;title=SCLC%20Subtypes%20Defined%20by%20ASCL1,%20NEUROD1,%20POU2F3,%20and%20YAP1:%20A%20Comprehensive%20Immunohistochemical%20and%20Histopathologic%20Characterization&amp;author=MK%20Baine&amp;author=MS%20Hsieh&amp;author=WV%20Lai&amp;author=JV%20Egger&amp;author=AA%20Jungbluth&amp;volume=15&amp;publication_year=2020&amp;pages=1823-1835&amp;pmid=33011388&amp;doi=10.1016/j.jtho.2020.09.009&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"R10\"> <span class=\"label\"> 10. </span> <cite> Gay CM, Stewart CA, Park EM, Diao L, Groves SM, Heeke S, Nabet BY, Fujimoto J, Solis LM, Lu W, et al. Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities. Cancer Cell. 2021;39:346\u2013360.:e347. doi: 10.1016/j.ccell.2020.12.014. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1016/j.ccell.2020.12.014\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC8143037/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/33482121/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Cancer%20Cell&amp;title=Patterns%20of%20transcription%20factor%20programs%20and%20immune%20pathway%20activation%20define%20four%20major%20subtypes%20of%20SCLC%20with%20distinct%20therapeutic%20vulnerabilities&amp;author=CM%20Gay&amp;author=CA%20Stewart&amp;author=EM%20Park&amp;author=L%20Diao&amp;author=SM%20Groves&amp;volume=39&amp;publication_year=2021&amp;pages=346-360&amp;pmid=33482121&amp;doi=10.1016/j.ccell.2020.12.014&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"R11\"> <span class=\"label\"> 11. </span> <cite> Wagner AH, Devarakonda S, Skidmore ZL, Krysiak K, Ramu A, Trani L, Kunisaki J, Masood A, Waqar SN, Spies NC, et al. Recurrent WNT pathway alterations are frequent in relapsed small cell lung cancer. Nat Commun. 2018;9:3787. doi: 10.1038/s41467-018-06162-9. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1038/s41467-018-06162-9\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC6141466/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/30224629/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Nat%20Commun&amp;title=Recurrent%20WNT%20pathway%20alterations%20are%20frequent%20in%20relapsed%20small%20cell%20lung%20cancer&amp;author=AH%20Wagner&amp;author=S%20Devarakonda&amp;author=ZL%20Skidmore&amp;author=K%20Krysiak&amp;author=A%20Ramu&amp;volume=9&amp;publication_year=2018&amp;pages=3787&amp;pmid=30224629&amp;doi=10.1038/s41467-018-06162-9&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"R12\"> <span class=\"label\"> 12. </span> <cite> Xie M, Chugh P, Broadhurst H, Lai Z, Whitston D, Paz-Ares L, Gay C, Byers L, Rudin CM, Stewart R, et al. Abstract CT024: Durvalumab (D) + platinum-etoposide (EP) in 1L extensive-stage small-cell lung cancer (ES-SCLC): Exploratory analysis of SCLC molecular subtypes in CASPIAN. Cancer Research. 2022;82:CT024. doi: 10.1158/1538-7445.Am2022-ct024. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1158/1538-7445.Am2022-ct024\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Cancer%20Research&amp;title=Abstract%20CT024:%20Durvalumab%20(D)%20+%20platinum-etoposide%20(EP)%20in%201L%20extensive-stage%20small-cell%20lung%20cancer%20(ES-SCLC):%20Exploratory%20analysis%20of%20SCLC%20molecular%20subtypes%20in%20CASPIAN&amp;author=M%20Xie&amp;author=P%20Chugh&amp;author=H%20Broadhurst&amp;author=Z%20Lai&amp;author=D%20Whitston&amp;volume=82&amp;publication_year=2022&amp;pages=CT024&amp;doi=10.1158/1538-7445.Am2022-ct024&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"R13\"> <span class=\"label\"> 13. </span> <cite> Schwendenwein A, Megyesfalvi Z, Barany N, Valko Z, Bugyik E, Lang C, Ferencz B, Paku S, Lantos A, Fillinger J, et al. Molecular profiles of small cell lung cancer subtypes: therapeutic implications. Mol Ther Oncolytics. 2021;20:470\u2013483. doi: 10.1016/j.omto.2021.02.004. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1016/j.omto.2021.02.004\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC7917449/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/33718595/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Mol%20Ther%20Oncolytics&amp;title=Molecular%20profiles%20of%20small%20cell%20lung%20cancer%20subtypes:%20therapeutic%20implications&amp;author=A%20Schwendenwein&amp;author=Z%20Megyesfalvi&amp;author=N%20Barany&amp;author=Z%20Valko&amp;author=E%20Bugyik&amp;volume=20&amp;publication_year=2021&amp;pages=470-483&amp;pmid=33718595&amp;doi=10.1016/j.omto.2021.02.004&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"R14\"> <span class=\"label\"> 14. </span> <cite> Chen H, Gesumaria L, Park Y-K, Oliver TG, Singer DS, Ge K, Schrump DS. BET Inhibitors Target the SCLC-N Subtype of Small-Cell Lung Cancer by Blocking NEUROD1 Transactivation. Molecular Cancer Research. 2023;21:91\u2013101. doi: 10.1158/1541-7786.Mcr-22-0594. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1158/1541-7786.Mcr-22-0594\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC9898120/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/36378541/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Molecular%20Cancer%20Research&amp;title=BET%20Inhibitors%20Target%20the%20SCLC-N%20Subtype%20of%20Small-Cell%20Lung%20Cancer%20by%20Blocking%20NEUROD1%20Transactivation&amp;author=H%20Chen&amp;author=L%20Gesumaria&amp;author=Y-K%20Park&amp;author=TG%20Oliver&amp;author=DS%20Singer&amp;volume=21&amp;publication_year=2023&amp;pages=91-101&amp;pmid=36378541&amp;doi=10.1158/1541-7786.Mcr-22-0594&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"R15\"> <span class=\"label\"> 15. </span> <cite> National Comprehensive Cancer Network. Small Cell Lung Cancer (2022) 2021. <a class=\"usa-link usa-link--external\" href=\"https://www.nccn.org/professionals/physician_gls/pdf/sclc.pdf\" rel=\"noopener noreferrer\" target=\"_blank\"> https://www.nccn.org/professionals/physician_gls/pdf/sclc.pdf </a> . </cite> </li> <li id=\"R16\"> <span class=\"label\"> 16. </span> <cite> Blackhall F, Frese KK, Simpson K, Kilgour E, Brady G, Dive C. Will liquid biopsies improve outcomes for patients with small-cell lung cancer? The Lancet Oncology. 2018;19:e470\u2013e481. doi: 10.1016/s1470-2045(18)30455-8. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1016/s1470-2045(18)30455-8\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/30191851/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=The%20Lancet%20Oncology&amp;title=Will%20liquid%20biopsies%20improve%20outcomes%20for%20patients%20with%20small-cell%20lung%20cancer?&amp;author=F%20Blackhall&amp;author=KK%20Frese&amp;author=K%20Simpson&amp;author=E%20Kilgour&amp;author=G%20Brady&amp;volume=19&amp;publication_year=2018&amp;pages=e470-e481&amp;pmid=30191851&amp;doi=10.1016/s1470-2045(18)30455-8&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"R17\"> <span class=\"label\"> 17. </span> <cite> Church M, Carter L, Blackhall F. Liquid Biopsy in Small Cell Lung Cancer\u2014A Route to Improved Clinical Care? Cells. 2020;9 doi: 10.3390/cells9122586. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.3390/cells9122586\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC7761700/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/33287165/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Cells&amp;title=Liquid%20Biopsy%20in%20Small%20Cell%20Lung%20Cancer%E2%80%94A%20Route%20to%20Improved%20Clinical%20Care?&amp;author=M%20Church&amp;author=L%20Carter&amp;author=F%20Blackhall&amp;volume=9&amp;publication_year=2020&amp;pmid=33287165&amp;doi=10.3390/cells9122586&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"R18\"> <span class=\"label\"> 18. </span> <cite> Sivapalan L, Iams WT, Belcaid Z, Scott SC, Niknafs N, Balan A, White JR, Kopparapu P, Cann C, Landon BV, et al. Dynamics of Sequence and Structural Cell-Free DNA Landscapes in Small-Cell Lung Cancer. Clin Cancer Res. 2023;29:2310\u20132323. doi: 10.1158/1078-0432.CCR-22-2242. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1158/1078-0432.CCR-22-2242\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC10261918/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/37071497/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Clin%20Cancer%20Res&amp;title=Dynamics%20of%20Sequence%20and%20Structural%20Cell-Free%20DNA%20Landscapes%20in%20Small-Cell%20Lung%20Cancer&amp;author=L%20Sivapalan&amp;author=WT%20Iams&amp;author=Z%20Belcaid&amp;author=SC%20Scott&amp;author=N%20Niknafs&amp;volume=29&amp;publication_year=2023&amp;pages=2310-2323&amp;pmid=37071497&amp;doi=10.1158/1078-0432.CCR-22-2242&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"R19\"> <span class=\"label\"> 19. </span> <cite> Drapkin BJ, George J, Christensen CL, Mino-Kenudson M, Dries R, Sundaresan T, Phat S, Myers DT, Zhong J, Igo P, et al. Genomic and Functional Fidelity of Small Cell Lung Cancer Patient-Derived Xenografts. Cancer Discovery. 2018;8:600\u2013615. doi: 10.1158/2159-8290.Cd-17-0935. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1158/2159-8290.Cd-17-0935\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC6369413/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/29483136/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Cancer%20Discovery&amp;title=Genomic%20and%20Functional%20Fidelity%20of%20Small%20Cell%20Lung%20Cancer%20Patient-Derived%20Xenografts&amp;author=BJ%20Drapkin&amp;author=J%20George&amp;author=CL%20Christensen&amp;author=M%20Mino-Kenudson&amp;author=R%20Dries&amp;volume=8&amp;publication_year=2018&amp;pages=600-615&amp;pmid=29483136&amp;doi=10.1158/2159-8290.Cd-17-0935&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"R20\"> <span class=\"label\"> 20. </span> <cite> Stewart CA, Gay CM, Xi Y, Sivajothi S, Sivakamasundari V, Fujimoto J, Bolisetty M, Hartsfield PM, Balasubramaniyan V, Chalishazar MD, et al. Single-cell analyses reveal increased intratumoral heterogeneity after the onset of therapy resistance in small-cell lung cancer. Nat Cancer. 2020;1:423\u2013436. doi: 10.1038/s43018-019-0020-z. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1038/s43018-019-0020-z\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC7842382/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/33521652/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Nat%20Cancer&amp;title=Single-cell%20analyses%20reveal%20increased%20intratumoral%20heterogeneity%20after%20the%20onset%20of%20therapy%20resistance%20in%20small-cell%20lung%20cancer&amp;author=CA%20Stewart&amp;author=CM%20Gay&amp;author=Y%20Xi&amp;author=S%20Sivajothi&amp;author=V%20Sivakamasundari&amp;volume=1&amp;publication_year=2020&amp;pages=423-436&amp;pmid=33521652&amp;doi=10.1038/s43018-019-0020-z&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"R21\"> <span class=\"label\"> 21. </span> <cite> Chemi F, Pearce SP, Clipson A, Hill SM, Conway A-M, Richardson SA, Kamieniecka K, Caeser R, White DJ, Mohan S, et al. cfDNA methylome profiling for detection and subtyping of small cell lung cancers. Nature Cancer. 2022;3:1260\u20131270. doi: 10.1038/s43018-022-00415-9. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1038/s43018-022-00415-9\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC9586870/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/35941262/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Nature%20Cancer&amp;title=cfDNA%20methylome%20profiling%20for%20detection%20and%20subtyping%20of%20small%20cell%20lung%20cancers&amp;author=F%20Chemi&amp;author=SP%20Pearce&amp;author=A%20Clipson&amp;author=SM%20Hill&amp;author=A-M%20Conway&amp;volume=3&amp;publication_year=2022&amp;pages=1260-1270&amp;pmid=35941262&amp;doi=10.1038/s43018-022-00415-9&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"R22\"> <span class=\"label\"> 22. </span> <cite> Fialkoff G, Takahashi N, Sharkia I, Gutin J, Pongor L, Rajan A, Nichols S, Sciuto L, Vilimas R, Graham C, et al. Subtyping of Small Cell Lung Cancer using plasma cell-free nucleosomes. bioRxiv. 2022 doi: 10.1101/2022.06.24.497386. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1101/2022.06.24.497386\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=bioRxiv&amp;title=Subtyping%20of%20Small%20Cell%20Lung%20Cancer%20using%20plasma%20cell-free%20nucleosomes&amp;author=G%20Fialkoff&amp;author=N%20Takahashi&amp;author=I%20Sharkia&amp;author=J%20Gutin&amp;author=L%20Pongor&amp;publication_year=2022&amp;doi=10.1101/2022.06.24.497386&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"R23\"> <span class=\"label\"> 23. </span> <cite> Esfahani MS, Hamilton EG, Mehrmohamadi M, Nabet BY, Alig SK, King DA, Steen CB, Macaulay CW, Schultz A, Nesselbush MC, et al. Inferring gene expression from cell-free DNA fragmentation profiles. Nature Biotechnology. 2022;40:585\u2013597. doi: 10.1038/s41587-022-01222-4. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1038/s41587-022-01222-4\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC9337986/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/35361996/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Nature%20Biotechnology&amp;title=Inferring%20gene%20expression%20from%20cell-free%20DNA%20fragmentation%20profiles&amp;author=MS%20Esfahani&amp;author=EG%20Hamilton&amp;author=M%20Mehrmohamadi&amp;author=BY%20Nabet&amp;author=SK%20Alig&amp;volume=40&amp;publication_year=2022&amp;pages=585-597&amp;pmid=35361996&amp;doi=10.1038/s41587-022-01222-4&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"R24\"> <span class=\"label\"> 24. </span> <cite> Gaga M, Chorostowska-Wynimko J, Horvath I, Tammemagi MC, Shitrit D, Eisenberg VH, Liang H, Stav D, Levy Faber D, Jansen M, et al. Validation of Lung EpiCheck, a novel methylation-based blood assay, for the detection of lung cancer in European and Chinese high-risk individuals. Eur Respir J. 2021;57 doi: 10.1183/13993003.02682-2020. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1183/13993003.02682-2020\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC7806969/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/33122336/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Eur%20Respir%20J&amp;title=Validation%20of%20Lung%20EpiCheck,%20a%20novel%20methylation-based%20blood%20assay,%20for%20the%20detection%20of%20lung%20cancer%20in%20European%20and%20Chinese%20high-risk%20individuals&amp;author=M%20Gaga&amp;author=J%20Chorostowska-Wynimko&amp;author=I%20Horvath&amp;author=MC%20Tammemagi&amp;author=D%20Shitrit&amp;volume=57&amp;publication_year=2021&amp;pmid=33122336&amp;doi=10.1183/13993003.02682-2020&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"R25\"> <span class=\"label\"> 25. </span> <cite> George J, Lim JS, Jang SJ, Cun Y, Ozretic L, Kong G, Leenders F, Lu X, Fernandez-Cuesta L, Bosco G, et al. Comprehensive genomic profiles of small cell lung cancer. Nature. 2015;524:47\u201353. doi: 10.1038/nature14664. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1038/nature14664\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC4861069/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/26168399/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Comprehensive%20genomic%20profiles%20of%20small%20cell%20lung%20cancer&amp;author=J%20George&amp;author=JS%20Lim&amp;author=SJ%20Jang&amp;author=Y%20Cun&amp;author=L%20Ozretic&amp;volume=524&amp;publication_year=2015&amp;pages=47-53&amp;pmid=26168399&amp;doi=10.1038/nature14664&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"R26\"> <span class=\"label\"> 26. </span> <cite> Yoshihara K, Shahmoradgoli M, Mart\u00ednez E, Vegesna R, Kim H, Torres-Garcia W, Trevi\u00f1o V, Shen H, Laird PW, Levine DA, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nature Communications. 2013;4 doi: 10.1038/ncomms3612. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1038/ncomms3612\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC3826632/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/24113773/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Nature%20Communications&amp;title=Inferring%20tumour%20purity%20and%20stromal%20and%20immune%20cell%20admixture%20from%20expression%20data&amp;author=K%20Yoshihara&amp;author=M%20Shahmoradgoli&amp;author=E%20Mart%C3%ADnez&amp;author=R%20Vegesna&amp;author=H%20Kim&amp;volume=4&amp;publication_year=2013&amp;pmid=24113773&amp;doi=10.1038/ncomms3612&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"R27\"> <span class=\"label\"> 27. </span> <cite> Chen B, Khodadoust MS, Liu CL, Newman AM, Alizadeh AA. Profiling Tumor Infiltrating Immune Cells with CIBERSORT. Cancer Systems Biology. 2018:243\u2013259. doi: 10.1007/978-1-4939-7493-1_12. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1007/978-1-4939-7493-1_12\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC5895181/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/29344893/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Cancer%20Systems%20Biology&amp;title=Profiling%20Tumor%20Infiltrating%20Immune%20Cells%20with%20CIBERSORT&amp;author=B%20Chen&amp;author=MS%20Khodadoust&amp;author=CL%20Liu&amp;author=AM%20Newman&amp;author=AA%20Alizadeh&amp;publication_year=2018&amp;pages=243-259&amp;pmid=29344893&amp;doi=10.1007/978-1-4939-7493-1_12&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"R28\"> <span class=\"label\"> 28. </span> <cite> Cadieux EL, Mensah NE, Castignani C, Tani\u0107 M, Wilson GA, Dietzen M, Dhami P, Vaikkinen H, Verfaillie A, Martin CC, et al. Copy number-aware deconvolution of tumor-normal DNA methylation profiles. BioRxiv. 2022 doi: 10.1101/2020.11.03.366252. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1101/2020.11.03.366252\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=BioRxiv&amp;title=Copy%20number-aware%20deconvolution%20of%20tumor-normal%20DNA%20methylation%20profiles&amp;author=EL%20Cadieux&amp;author=NE%20Mensah&amp;author=C%20Castignani&amp;author=M%20Tani%C4%87&amp;author=GA%20Wilson&amp;publication_year=2022&amp;doi=10.1101/2020.11.03.366252&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"R29\"> <span class=\"label\"> 29. </span> <cite> Tlemsani C, Pongor L, Elloumi F, Girard L, Huffman KE, Roper N, Varma S, Luna A, Rajapakse VN, Sebastian R, et al. SCLC-CellMiner: A Resource for Small Cell Lung Cancer Cell Line Genomics and Pharmacology Based on Genomic Signatures. Cell Rep. 2020;33:108296. doi: 10.1016/j.celrep.2020.108296. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1016/j.celrep.2020.108296\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC7643325/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/33086069/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Cell%20Rep&amp;title=SCLC-CellMiner:%20A%20Resource%20for%20Small%20Cell%20Lung%20Cancer%20Cell%20Line%20Genomics%20and%20Pharmacology%20Based%20on%20Genomic%20Signatures&amp;author=C%20Tlemsani&amp;author=L%20Pongor&amp;author=F%20Elloumi&amp;author=L%20Girard&amp;author=KE%20Huffman&amp;volume=33&amp;publication_year=2020&amp;pages=108296&amp;pmid=33086069&amp;doi=10.1016/j.celrep.2020.108296&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"R30\"> <span class=\"label\"> 30. </span> <cite> Iorio F, Knijnenburg TA, Vis DJ, Bignell GR, Menden MP, Schubert M, Aben N, Goncalves E, Barthorpe S, Lightfoot H, et al. A Landscape of Pharmacogenomic Interactions in Cancer. Cell. 2016;166:740\u2013754. doi: 10.1016/j.cell.2016.06.017. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1016/j.cell.2016.06.017\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC4967469/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/27397505/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=A%20Landscape%20of%20Pharmacogenomic%20Interactions%20in%20Cancer&amp;author=F%20Iorio&amp;author=TA%20Knijnenburg&amp;author=DJ%20Vis&amp;author=GR%20Bignell&amp;author=MP%20Menden&amp;volume=166&amp;publication_year=2016&amp;pages=740-754&amp;pmid=27397505&amp;doi=10.1016/j.cell.2016.06.017&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"R31\"> <span class=\"label\"> 31. </span> <cite> Weirich S, Khella MS, Jeltsch A. Structure, Activity and Function of the Suv39h1 and Suv39h2 Protein Lysine Methyltransferases. Life. 2021;11 doi: 10.3390/life11070703. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.3390/life11070703\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC8303541/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/34357075/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Life&amp;title=Structure,%20Activity%20and%20Function%20of%20the%20Suv39h1%20and%20Suv39h2%20Protein%20Lysine%20Methyltransferases&amp;author=S%20Weirich&amp;author=MS%20Khella&amp;author=A%20Jeltsch&amp;volume=11&amp;publication_year=2021&amp;pmid=34357075&amp;doi=10.3390/life11070703&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"R32\"> <span class=\"label\"> 32. </span> <cite> Fuks F. The DNA methyltransferases associate with HP1 and the SUV39H1 histone methyltransferase. Nucleic Acids Research. 2003;31:2305\u20132312. doi: 10.1093/nar/gkg332. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1093/nar/gkg332\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC154218/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/12711675/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Nucleic%20Acids%20Research&amp;title=The%20DNA%20methyltransferases%20associate%20with%20HP1%20and%20the%20SUV39H1%20histone%20methyltransferase&amp;author=F%20Fuks&amp;volume=31&amp;publication_year=2003&amp;pages=2305-2312&amp;pmid=12711675&amp;doi=10.1093/nar/gkg332&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"R33\"> <span class=\"label\"> 33. </span> <cite> Hu X, Estecio MR, Chen R, Reuben A, Wang L, Fujimoto J, Carrot-Zhang J, McGranahan N, Ying L, Fukuoka J, et al. Evolution of DNA methylome from precancerous lesions to invasive lung adenocarcinomas. Nature Communications. 2021;12:687. doi: 10.1038/s41467-021-20907-z. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1038/s41467-021-20907-z\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC7846738/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/33514726/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Nature%20Communications&amp;title=Evolution%20of%20DNA%20methylome%20from%20precancerous%20lesions%20to%20invasive%20lung%20adenocarcinomas&amp;author=X%20Hu&amp;author=MR%20Estecio&amp;author=R%20Chen&amp;author=A%20Reuben&amp;author=L%20Wang&amp;volume=12&amp;publication_year=2021&amp;pages=687&amp;pmid=33514726&amp;doi=10.1038/s41467-021-20907-z&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"R34\"> <span class=\"label\"> 34. </span> <cite> Van Paemel R, De Koker A, Caggiano C, Morlion A, Mestdagh P, De Wilde B, Vandesompele J, De Preter K. Genome-wide study of the effect of blood collection tubes on the cell-free DNA methylome. Epigenetics. 2021;16:797\u2013807. doi: 10.1080/15592294.2020.1827714. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1080/15592294.2020.1827714\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC8216177/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/33074045/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Epigenetics&amp;title=Genome-wide%20study%20of%20the%20effect%20of%20blood%20collection%20tubes%20on%20the%20cell-free%20DNA%20methylome&amp;author=R%20Van%20Paemel&amp;author=A%20De%20Koker&amp;author=C%20Caggiano&amp;author=A%20Morlion&amp;author=P%20Mestdagh&amp;volume=16&amp;publication_year=2021&amp;pages=797-807&amp;pmid=33074045&amp;doi=10.1080/15592294.2020.1827714&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"R35\"> <span class=\"label\"> 35. </span> <cite> Tian Y, Li Q, Yang Z, Zhang S, Xu J, Wang Z, Bai H, Duan J, Zheng B, Li W, et al. Single-cell transcriptomic profiling reveals the tumor heterogeneity of small-cell lung cancer. Signal Transduction and Targeted Therapy. 2022;7 doi: 10.1038/s41392-022-01150-4. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1038/s41392-022-01150-4\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC9532437/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/36195615/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Signal%20Transduction%20and%20Targeted%20Therapy&amp;title=Single-cell%20transcriptomic%20profiling%20reveals%20the%20tumor%20heterogeneity%20of%20small-cell%20lung%20cancer&amp;author=Y%20Tian&amp;author=Q%20Li&amp;author=Z%20Yang&amp;author=S%20Zhang&amp;author=J%20Xu&amp;volume=7&amp;publication_year=2022&amp;pmid=36195615&amp;doi=10.1038/s41392-022-01150-4&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"R36\"> <span class=\"label\"> 36. </span> <cite> Borromeo Mark D, Savage Trisha K, Kollipara Rahul K, He M, Augustyn A, Osborne Jihan K, Girard L, Minna John D, Gazdar Adi F, Cobb Melanie H, Johnson Jane E. ASCL1 and NEUROD1 Reveal Heterogeneity in Pulmonary Neuroendocrine Tumors and Regulate Distinct Genetic Programs. Cell Reports. 2016;16:1259\u20131272. doi: 10.1016/j.celrep.2016.06.081. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1016/j.celrep.2016.06.081\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC4972690/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/27452466/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Cell%20Reports&amp;title=ASCL1%20and%20NEUROD1%20Reveal%20Heterogeneity%20in%20Pulmonary%20Neuroendocrine%20Tumors%20and%20Regulate%20Distinct%20Genetic%20Programs&amp;author=Mark%20D%20Borromeo&amp;author=Trisha%20K%20Savage&amp;author=Rahul%20K%20Kollipara&amp;author=M%20He&amp;author=A%20Augustyn&amp;volume=16&amp;publication_year=2016&amp;pages=1259-1272&amp;pmid=27452466&amp;doi=10.1016/j.celrep.2016.06.081&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"R37\"> <span class=\"label\"> 37. </span> <cite> Polley E, Kunkel M, Evans D, Silvers T, Delosh R, Laudeman J, Ogle C, Reinhart R, Selby M, Connelly J, et al. Small Cell Lung Cancer Screen of Oncology Drugs, Investigational Agents, and Gene and microRNA Expression. J Natl Cancer Inst. 2016;108 doi: 10.1093/jnci/djw122. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1093/jnci/djw122\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC6279282/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/27247353/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=J%20Natl%20Cancer%20Inst&amp;title=Small%20Cell%20Lung%20Cancer%20Screen%20of%20Oncology%20Drugs,%20Investigational%20Agents,%20and%20Gene%20and%20microRNA%20Expression&amp;author=E%20Polley&amp;author=M%20Kunkel&amp;author=D%20Evans&amp;author=T%20Silvers&amp;author=R%20Delosh&amp;volume=108&amp;publication_year=2016&amp;pmid=27247353&amp;doi=10.1093/jnci/djw122&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"R38\"> <span class=\"label\"> 38. </span> <cite> Tang M, Abbas HA, Negrao MV, Ramineni M, Hu X, Hubert SM, Fujimoto J, Reuben A, Varghese S, Zhang J, et al. The histologic phenotype of lung cancers is associated with transcriptomic features rather than genomic characteristics. Nat Commun. 2021;12:7081. doi: 10.1038/s41467-021-27341-1. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1038/s41467-021-27341-1\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC8648877/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/34873156/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Nat%20Commun&amp;title=The%20histologic%20phenotype%20of%20lung%20cancers%20is%20associated%20with%20transcriptomic%20features%20rather%20than%20genomic%20characteristics&amp;author=M%20Tang&amp;author=HA%20Abbas&amp;author=MV%20Negrao&amp;author=M%20Ramineni&amp;author=X%20Hu&amp;volume=12&amp;publication_year=2021&amp;pages=7081&amp;pmid=34873156&amp;doi=10.1038/s41467-021-27341-1&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"R39\"> <span class=\"label\"> 39. </span> <cite> Zaitsev A, Chelushkin M, Dyikanov D, Cheremushkin I, Shpak B, Nomie K, Zyrin V, Nuzhdina E, Lozinsky Y, Zotova A, et al. Precise reconstruction of the TME using bulk RNA-seq and a machine learning algorithm trained on artificial transcriptomes. Cancer Cell. 2022;40:879\u2013894.:e816. doi: 10.1016/j.ccell.2022.07.006. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1016/j.ccell.2022.07.006\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/35944503/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Cancer%20Cell&amp;title=Precise%20reconstruction%20of%20the%20TME%20using%20bulk%20RNA-seq%20and%20a%20machine%20learning%20algorithm%20trained%20on%20artificial%20transcriptomes&amp;author=A%20Zaitsev&amp;author=M%20Chelushkin&amp;author=D%20Dyikanov&amp;author=I%20Cheremushkin&amp;author=B%20Shpak&amp;volume=40&amp;publication_year=2022&amp;pages=879-894&amp;pmid=35944503&amp;doi=10.1016/j.ccell.2022.07.006&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"R40\"> <span class=\"label\"> 40. </span> <cite> Sato Y, Okamoto I, Kameyama H, Kudoh S, Saito H, Sanada M, Kudo N, Wakimoto J, Fujino K, Ikematsu Y, et al. Integrated Immunohistochemical Study on Small-Cell Carcinoma of the Lung Focusing on Transcription and Co-Transcription Factors. Diagnostics (Basel) 2020;10 doi: 10.3390/diagnostics10110949. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.3390/diagnostics10110949\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC7697657/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/33202998/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Diagnostics%20(Basel)&amp;title=Integrated%20Immunohistochemical%20Study%20on%20Small-Cell%20Carcinoma%20of%20the%20Lung%20Focusing%20on%20Transcription%20and%20Co-Transcription%20Factors&amp;author=Y%20Sato&amp;author=I%20Okamoto&amp;author=H%20Kameyama&amp;author=S%20Kudoh&amp;author=H%20Saito&amp;volume=10&amp;publication_year=2020&amp;pmid=33202998&amp;doi=10.3390/diagnostics10110949&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"R41\"> <span class=\"label\"> 41. </span> <cite> Wu Q, Guo J, Liu Y, Zheng Q, Li X, Wu C, Fang D, Chen X, Ma L, Xu P, et al. YAP drives fate conversion and chemoresistance of small cell lung cancer. Science Advances. 2021;7 doi: 10.1126/sciadv.abg1850. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1126/sciadv.abg1850\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC10938532/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/34597132/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Science%20Advances&amp;title=YAP%20drives%20fate%20conversion%20and%20chemoresistance%20of%20small%20cell%20lung%20cancer&amp;author=Q%20Wu&amp;author=J%20Guo&amp;author=Y%20Liu&amp;author=Q%20Zheng&amp;author=X%20Li&amp;volume=7&amp;publication_year=2021&amp;pmid=34597132&amp;doi=10.1126/sciadv.abg1850&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"R42\"> <span class=\"label\"> 42. </span> <cite> Karim NFA, Miao J, Reckamp KL, Gay CM, Byers LA, Zhao Y, Redman MW, Carrizosa DR, Wang W-L, Petty WJ, et al. SWOG S1929: Phase II randomized study of maintenance atezolizumab (A) versus atezolizumab + talazoparib (AT) in patients with SLFN11 positive extensive stage small cell lung cancer (ES-SCLC) Journal of Clinical Oncology. 2023;41:8504. doi: 10.1200/JCO.2023.41.16_suppl.8504. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1200/JCO.2023.41.16_suppl.8504\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Clinical%20Oncology&amp;title=SWOG%20S1929:%20Phase%20II%20randomized%20study%20of%20maintenance%20atezolizumab%20(A)%20versus%20atezolizumab%20+%20talazoparib%20(AT)%20in%20patients%20with%20SLFN11%20positive%20extensive%20stage%20small%20cell%20lung%20cancer%20(ES-SCLC)&amp;author=NFA%20Karim&amp;author=J%20Miao&amp;author=KL%20Reckamp&amp;author=CM%20Gay&amp;author=LA%20Byers&amp;volume=41&amp;publication_year=2023&amp;pages=8504&amp;doi=10.1200/JCO.2023.41.16_suppl.8504&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"R43\"> <span class=\"label\"> 43. </span> <cite> Poirier JT, Gardner EE, Connis N, Moreira AL, de Stanchina E, Hann CL, Rudin CM. DNA methylation in small cell lung cancer defines distinct disease subtypes and correlates with high expression of EZH2. Oncogene. 2015;34:5869\u20135878. doi: 10.1038/onc.2015.38. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1038/onc.2015.38\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC4564363/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/25746006/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Oncogene&amp;title=DNA%20methylation%20in%20small%20cell%20lung%20cancer%20defines%20distinct%20disease%20subtypes%20and%20correlates%20with%20high%20expression%20of%20EZH2&amp;author=JT%20Poirier&amp;author=EE%20Gardner&amp;author=N%20Connis&amp;author=AL%20Moreira&amp;author=E%20de%20Stanchina&amp;volume=34&amp;publication_year=2015&amp;pages=5869-5878&amp;pmid=25746006&amp;doi=10.1038/onc.2015.38&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"R44\"> <span class=\"label\"> 44. </span> <cite> Krushkal J, Silvers T, Reinhold WC, Sonkin D, Vural S, Connelly J, Varma S, Meltzer PS, Kunkel M, Rapisarda A, et al. Epigenome-wide DNA methylation analysis of small cell lung cancer cell lines suggests potential chemotherapy targets. Clin Epigenetics. 2020;12:93. doi: 10.1186/s13148-020-00876-8. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1186/s13148-020-00876-8\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC7318526/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/32586373/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Clin%20Epigenetics&amp;title=Epigenome-wide%20DNA%20methylation%20analysis%20of%20small%20cell%20lung%20cancer%20cell%20lines%20suggests%20potential%20chemotherapy%20targets&amp;author=J%20Krushkal&amp;author=T%20Silvers&amp;author=WC%20Reinhold&amp;author=D%20Sonkin&amp;author=S%20Vural&amp;volume=12&amp;publication_year=2020&amp;pages=93&amp;pmid=32586373&amp;doi=10.1186/s13148-020-00876-8&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"R45\"> <span class=\"label\"> 45. </span> <cite> Lin SH, Wang J, Saintigny P, Wu CC, Giri U, Zhang J, Menju T, Diao L, Byers L, Weinstein JN, et al. Genes suppressed by DNA methylation in non-small cell lung cancer reveal the epigenetics of epithelial-mesenchymal transition. BMC Genomics. 2014;15:1079. doi: 10.1186/1471-2164-15-1079. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1186/1471-2164-15-1079\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC4298954/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/25486910/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=BMC%20Genomics&amp;title=Genes%20suppressed%20by%20DNA%20methylation%20in%20non-small%20cell%20lung%20cancer%20reveal%20the%20epigenetics%20of%20epithelial-mesenchymal%20transition&amp;author=SH%20Lin&amp;author=J%20Wang&amp;author=P%20Saintigny&amp;author=CC%20Wu&amp;author=U%20Giri&amp;volume=15&amp;publication_year=2014&amp;pages=1079&amp;pmid=25486910&amp;doi=10.1186/1471-2164-15-1079&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"R46\"> <span class=\"label\"> 46. </span> <cite> Krohn A, Ahrens T, Yalcin A, Pl\u00f6nes T, Wehrle J, Taromi S, Wollner S, Follo M, Brabletz T, Mani SA, et al. Tumor Cell Heterogeneity in Small Cell Lung Cancer (SCLC): Phenotypical and Functional Differences Associated with Epithelial-Mesenchymal Transition (EMT) and DNA Methylation Changes. PLOS ONE. 2014;9:e100249. doi: 10.1371/journal.pone.0100249. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1371/journal.pone.0100249\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC4069054/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/24959847/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=PLOS%20ONE&amp;title=Tumor%20Cell%20Heterogeneity%20in%20Small%20Cell%20Lung%20Cancer%20(SCLC):%20Phenotypical%20and%20Functional%20Differences%20Associated%20with%20Epithelial-Mesenchymal%20Transition%20(EMT)%20and%20DNA%20Methylation%20Changes&amp;author=A%20Krohn&amp;author=T%20Ahrens&amp;author=A%20Yalcin&amp;author=T%20Pl%C3%B6nes&amp;author=J%20Wehrle&amp;volume=9&amp;publication_year=2014&amp;pages=e100249&amp;pmid=24959847&amp;doi=10.1371/journal.pone.0100249&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"R47\"> <span class=\"label\"> 47. </span> <cite> Wang Z, Yin J, Zhou W, Bai J, Xie Y, Xu K, Zheng X, Xiao J, Zhou L, Qi X, et al. Complex impact of DNA methylation on transcriptional dysregulation across 22 human cancer types. Nucleic Acids Res. 2020;48:2287\u20132302. doi: 10.1093/nar/gkaa041. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1093/nar/gkaa041\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC7049702/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/32002550/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Nucleic%20Acids%20Res&amp;title=Complex%20impact%20of%20DNA%20methylation%20on%20transcriptional%20dysregulation%20across%2022%20human%20cancer%20types&amp;author=Z%20Wang&amp;author=J%20Yin&amp;author=W%20Zhou&amp;author=J%20Bai&amp;author=Y%20Xie&amp;volume=48&amp;publication_year=2020&amp;pages=2287-2302&amp;pmid=32002550&amp;doi=10.1093/nar/gkaa041&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"R48\"> <span class=\"label\"> 48. </span> <cite> Zhang Y, Yao Y, Xu Y, Li L, Gong Y, Zhang K, Zhang M, Guan Y, Chang L, Xia X, et al. Pan-cancer circulating tumor DNA detection in over 10,000 Chinese patients. Nat Commun. 2021;12:11. doi: 10.1038/s41467-020-20162-8. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1038/s41467-020-20162-8\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC7782482/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/33397889/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Nat%20Commun&amp;title=Pan-cancer%20circulating%20tumor%20DNA%20detection%20in%20over%2010,000%20Chinese%20patients&amp;author=Y%20Zhang&amp;author=Y%20Yao&amp;author=Y%20Xu&amp;author=L%20Li&amp;author=Y%20Gong&amp;volume=12&amp;publication_year=2021&amp;pages=11&amp;pmid=33397889&amp;doi=10.1038/s41467-020-20162-8&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"R49\"> <span class=\"label\"> 49. </span> <cite> Liu MC, Oxnard GR, Klein EA, Swanton C, Seiden MV, Consortium, C Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA. Ann Oncol. 2020;31:745\u2013759. doi: 10.1016/j.annonc.2020.02.011. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1016/j.annonc.2020.02.011\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC8274402/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/33506766/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Ann%20Oncol&amp;title=Sensitive%20and%20specific%20multi-cancer%20detection%20and%20localization%20using%20methylation%20signatures%20in%20cell-free%20DNA&amp;author=MC%20Liu&amp;author=GR%20Oxnard&amp;author=EA%20Klein&amp;author=C%20Swanton&amp;author=MV%20Seiden&amp;volume=31&amp;publication_year=2020&amp;pages=745-759&amp;pmid=33506766&amp;doi=10.1016/j.annonc.2020.02.011&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"R50\"> <span class=\"label\"> 50. </span> <cite> Megyesfalvi Z, Gay CM, Popper H, Pirker R, Ostoros G, Heeke S, Lang C, Hoetzenecker K, Schwendenwein A, Boettiger K, et al. Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions. CA Cancer J Clin. 2023 doi: 10.3322/caac.21785. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.3322/caac.21785\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/37329269/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=CA%20Cancer%20J%20Clin&amp;title=Clinical%20insights%20into%20small%20cell%20lung%20cancer:%20Tumor%20heterogeneity,%20diagnosis,%20therapy,%20and%20future%20directions&amp;author=Z%20Megyesfalvi&amp;author=CM%20Gay&amp;author=H%20Popper&amp;author=R%20Pirker&amp;author=G%20Ostoros&amp;publication_year=2023&amp;pmid=37329269&amp;doi=10.3322/caac.21785&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"R51\"> <span class=\"label\"> 51. </span> <cite> Kilgour E, Rothwell DG, Brady G, Dive C. Liquid Biopsy-Based Biomarkers of Treatment Response and Resistance. Cancer Cell. 2020;37:485\u2013495. doi: 10.1016/j.ccell.2020.03.012. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1016/j.ccell.2020.03.012\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/32289272/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Cancer%20Cell&amp;title=Liquid%20Biopsy-Based%20Biomarkers%20of%20Treatment%20Response%20and%20Resistance&amp;author=E%20Kilgour&amp;author=DG%20Rothwell&amp;author=G%20Brady&amp;author=C%20Dive&amp;volume=37&amp;publication_year=2020&amp;pages=485-495&amp;pmid=32289272&amp;doi=10.1016/j.ccell.2020.03.012&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"R52\"> <span class=\"label\"> 52. </span> <cite> Pongor LS, Tlemsani C, Elloumi F, Arakawa Y, Jo U, Gross JM, Mosavarpour S, Varma S, Kollipara RK, Roper N, et al. Integrative epigenomic analyses of small cell lung cancer cells demonstrates the clinical translational relevance of gene body methylation. iScience. 2022;25:105338. doi: 10.1016/j.isci.2022.105338. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1016/j.isci.2022.105338\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC9619308/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/36325065/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=iScience&amp;title=Integrative%20epigenomic%20analyses%20of%20small%20cell%20lung%20cancer%20cells%20demonstrates%20the%20clinical%20translational%20relevance%20of%20gene%20body%20methylation&amp;author=LS%20Pongor&amp;author=C%20Tlemsani&amp;author=F%20Elloumi&amp;author=Y%20Arakawa&amp;author=U%20Jo&amp;volume=25&amp;publication_year=2022&amp;pages=105338&amp;pmid=36325065&amp;doi=10.1016/j.isci.2022.105338&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"R53\"> <span class=\"label\"> 53. </span> <cite> Pidsley R, Lawrence MG, Zotenko E, Niranjan B, Statham A, Song J, Chabanon RM, Qu W, Wang H, Richards M, et al. Enduring epigenetic landmarks define the cancer microenvironment. Genome Res. 2018;28:625\u2013638. doi: 10.1101/gr.229070.117. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1101/gr.229070.117\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC5932604/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/29650553/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Genome%20Res&amp;title=Enduring%20epigenetic%20landmarks%20define%20the%20cancer%20microenvironment&amp;author=R%20Pidsley&amp;author=MG%20Lawrence&amp;author=E%20Zotenko&amp;author=B%20Niranjan&amp;author=A%20Statham&amp;volume=28&amp;publication_year=2018&amp;pages=625-638&amp;pmid=29650553&amp;doi=10.1101/gr.229070.117&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"R54\"> <span class=\"label\"> 54. </span> <cite> Stickler S, Rath B, Hochmair M, Lang C, Weigl L, Hamilton G. Changes of protein expression during tumorosphere formation of small cell lung cancer circulating tumor cells. Oncol Res. 2023;31:13\u201322. doi: 10.32604/or.2022.027281. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.32604/or.2022.027281\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC10207976/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/37303738/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Oncol%20Res&amp;title=Changes%20of%20protein%20expression%20during%20tumorosphere%20formation%20of%20small%20cell%20lung%20cancer%20circulating%20tumor%20cells&amp;author=S%20Stickler&amp;author=B%20Rath&amp;author=M%20Hochmair&amp;author=C%20Lang&amp;author=L%20Weigl&amp;volume=31&amp;publication_year=2023&amp;pages=13-22&amp;pmid=37303738&amp;doi=10.32604/or.2022.027281&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"R55\"> <span class=\"label\"> 55. </span> <cite> Cai L, Sondhi V, Zhu M, Akbay E, DeBerardinis RJ, Xie Y, Minna JD, Xiao G, Gazdar A. The small cell lung cancer neuroendocrine transdifferentiation explorer. bioRxiv. 2022:2022.2008.2001.502252. doi: 10.1101/2022.08.01.502252. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1101/2022.08.01.502252\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=bioRxiv&amp;title=The%20small%20cell%20lung%20cancer%20neuroendocrine%20transdifferentiation%20explorer&amp;author=L%20Cai&amp;author=V%20Sondhi&amp;author=M%20Zhu&amp;author=E%20Akbay&amp;author=RJ%20DeBerardinis&amp;publication_year=2022&amp;pages=2022.2008.2001.502252&amp;doi=10.1101/2022.08.01.502252&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"R56\"> <span class=\"label\"> 56. </span> <cite> Heredia-Mendez AJ, Sanchez-Sanchez G, Lopez-Camarillo C. Reprogramming of the Genome-Wide DNA Methylation Landscape in Three-Dimensional Cancer Cell Cultures. Cancers (Basel) 2023;15 doi: 10.3390/cancers15071991. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.3390/cancers15071991\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC10093594/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/37046652/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Cancers%20(Basel)&amp;title=Reprogramming%20of%20the%20Genome-Wide%20DNA%20Methylation%20Landscape%20in%20Three-Dimensional%20Cancer%20Cell%20Cultures&amp;author=AJ%20Heredia-Mendez&amp;author=G%20Sanchez-Sanchez&amp;author=C%20Lopez-Camarillo&amp;volume=15&amp;publication_year=2023&amp;pmid=37046652&amp;doi=10.3390/cancers15071991&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"R57\"> <span class=\"label\"> 57. </span> <cite> Park S, Hong TH, Hwang S, Jung H-A, Sun J-M, Ahn JS, Ahn M-J, Cho JH, Choi YS, Kim J, et al. Abstract 4546: Comprehensive analysis using transcriptional factor based molecular subtypes and correlation to clinical outcomes in small-cell lung cancer. Cancer Research. 2023;83:4546. doi: 10.1158/1538-7445.AM2023-4546. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1158/1538-7445.AM2023-4546\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC10959651/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/38492534/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Cancer%20Research&amp;title=Abstract%204546:%20Comprehensive%20analysis%20using%20transcriptional%20factor%20based%20molecular%20subtypes%20and%20correlation%20to%20clinical%20outcomes%20in%20small-cell%20lung%20cancer&amp;author=S%20Park&amp;author=TH%20Hong&amp;author=S%20Hwang&amp;author=H-A%20Jung&amp;author=J-M%20Sun&amp;volume=83&amp;publication_year=2023&amp;pages=4546&amp;pmid=38492534&amp;doi=10.1158/1538-7445.AM2023-4546&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"R58\"> <span class=\"label\"> 58. </span> <cite> Ul Haq S, Schmid S, Aparnathi MK, Hueniken K, Zhan LJ, Sacdalan D, Li JJN, Meti N, Patel D, Cheng D, et al. Cell-free DNA methylation-defined prognostic subgroups in small-cell lung cancer identified by leukocyte methylation subtraction. iScience. 2022;25 doi: 10.1016/j.isci.2022.105487. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1016/j.isci.2022.105487\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC9678731/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/36425756/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=iScience&amp;title=Cell-free%20DNA%20methylation-defined%20prognostic%20subgroups%20in%20small-cell%20lung%20cancer%20identified%20by%20leukocyte%20methylation%20subtraction&amp;author=S%20Ul%20Haq&amp;author=S%20Schmid&amp;author=MK%20Aparnathi&amp;author=K%20Hueniken&amp;author=LJ%20Zhan&amp;volume=25&amp;publication_year=2022&amp;pmid=36425756&amp;doi=10.1016/j.isci.2022.105487&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"R59\"> <span class=\"label\"> 59. </span> <cite> Cristiano S, Leal A, Phallen J, Fiksel J, Adleff V, Bruhm DC, Jensen S\u00d8, Medina JE, Hruban C, White JR, et al. Genome-wide cell-free DNA fragmentation in patients with cancer. Nature. 2019;570:385\u2013389. doi: 10.1038/s41586-019-1272-6. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1038/s41586-019-1272-6\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC6774252/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/31142840/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Genome-wide%20cell-free%20DNA%20fragmentation%20in%20patients%20with%20cancer&amp;author=S%20Cristiano&amp;author=A%20Leal&amp;author=J%20Phallen&amp;author=J%20Fiksel&amp;author=V%20Adleff&amp;volume=570&amp;publication_year=2019&amp;pages=385-389&amp;pmid=31142840&amp;doi=10.1038/s41586-019-1272-6&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"R60\"> <span class=\"label\"> 60. </span> <cite> Lo YMD, Han DSC, Jiang P, Chiu RWK. Epigenetics, fragmentomics, and topology of cell-free DNA in liquid biopsies. Science. 2021;372 doi: 10.1126/science.aaw3616. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1126/science.aaw3616\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/33833097/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Epigenetics,%20fragmentomics,%20and%20topology%20of%20cell-free%20DNA%20in%20liquid%20biopsies&amp;author=YMD%20Lo&amp;author=DSC%20Han&amp;author=P%20Jiang&amp;author=RWK%20Chiu&amp;volume=372&amp;publication_year=2021&amp;pmid=33833097&amp;doi=10.1126/science.aaw3616&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"R61\"> <span class=\"label\"> 61. </span> <cite> Chen T, Guestrin C. XGBoost: A Scalable Tree Boosting System. arXiv. 2016 doi: 10.1145/2939672.2939785. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1145/2939672.2939785\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=arXiv&amp;title=XGBoost:%20A%20Scalable%20Tree%20Boosting%20System&amp;author=T%20Chen&amp;author=C%20Guestrin&amp;publication_year=2016&amp;doi=10.1145/2939672.2939785&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"R62\"> <span class=\"label\"> 62. </span> <cite> Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics. 2014;30:2114\u20132120. doi: 10.1093/bioinformatics/btu170. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1093/bioinformatics/btu170\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC4103590/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/24695404/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Bioinformatics&amp;title=Trimmomatic:%20a%20flexible%20trimmer%20for%20Illumina%20sequence%20data&amp;author=AM%20Bolger&amp;author=M%20Lohse&amp;author=B%20Usadel&amp;volume=30&amp;publication_year=2014&amp;pages=2114-2120&amp;pmid=24695404&amp;doi=10.1093/bioinformatics/btu170&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"R63\"> <span class=\"label\"> 63. </span> <cite> Patro R, Duggal G, Love MI, Irizarry RA, Kingsford C. Salmon provides fast and bias-aware quantification of transcript expression. Nat Methods. 2017;14:417\u2013419. doi: 10.1038/nmeth.4197. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1038/nmeth.4197\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC5600148/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/28263959/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Nat%20Methods&amp;title=Salmon%20provides%20fast%20and%20bias-aware%20quantification%20of%20transcript%20expression&amp;author=R%20Patro&amp;author=G%20Duggal&amp;author=MI%20Love&amp;author=RA%20Irizarry&amp;author=C%20Kingsford&amp;volume=14&amp;publication_year=2017&amp;pages=417-419&amp;pmid=28263959&amp;doi=10.1038/nmeth.4197&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"R64\"> <span class=\"label\"> 64. </span> <cite> Alboukadel K, Marcin K, Przemyslaw B. survminer: Drawing Survival Curves using \u2018ggplot2\u2019. 2021. </cite> </li> <li id=\"R65\"> <span class=\"label\"> 65. </span> <cite> R: A Language and Environment for Statistical Computing. 2021. </cite> </li> <li id=\"R66\"> <span class=\"label\"> 66. </span> <cite> Meissner A, Mikkelsen TS, Gu H, Wernig M, Hanna J, Sivachenko A, Zhang X, Bernstein BE, Nusbaum C, Jaffe DB, et al. Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature. 2008;454:766\u2013770. doi: 10.1038/nature07107. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1038/nature07107\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC2896277/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/18600261/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Genome-scale%20DNA%20methylation%20maps%20of%20pluripotent%20and%20differentiated%20cells&amp;author=A%20Meissner&amp;author=TS%20Mikkelsen&amp;author=H%20Gu&amp;author=M%20Wernig&amp;author=J%20Hanna&amp;volume=454&amp;publication_year=2008&amp;pages=766-770&amp;pmid=18600261&amp;doi=10.1038/nature07107&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"R67\"> <span class=\"label\"> 67. </span> <cite> Gu H, Smith ZD, Bock C, Boyle P, Gnirke A, Meissner A. Preparation of reduced representation bisulfite sequencing libraries for genome-scale DNA methylation profiling. Nat Protoc. 2011;6:468\u2013481. doi: 10.1038/nprot.2010.190. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1038/nprot.2010.190\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/21412275/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Nat%20Protoc&amp;title=Preparation%20of%20reduced%20representation%20bisulfite%20sequencing%20libraries%20for%20genome-scale%20DNA%20methylation%20profiling&amp;author=H%20Gu&amp;author=ZD%20Smith&amp;author=C%20Bock&amp;author=P%20Boyle&amp;author=A%20Gnirke&amp;volume=6&amp;publication_year=2011&amp;pages=468-481&amp;pmid=21412275&amp;doi=10.1038/nprot.2010.190&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"R68\"> <span class=\"label\"> 68. </span> <cite> Krueger F, Andrews SR. Bismark: a flexible aligner and methylation caller for Bisulfite-Seq applications. Bioinformatics. 2011;27:1571\u20131572. doi: 10.1093/bioinformatics/btr167. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1093/bioinformatics/btr167\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC3102221/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/21493656/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Bioinformatics&amp;title=Bismark:%20a%20flexible%20aligner%20and%20methylation%20caller%20for%20Bisulfite-Seq%20applications&amp;author=F%20Krueger&amp;author=SR%20Andrews&amp;volume=27&amp;publication_year=2011&amp;pages=1571-1572&amp;pmid=21493656&amp;doi=10.1093/bioinformatics/btr167&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"R69\"> <span class=\"label\"> 69. </span> <cite> Raymond GC, Maureen AS. annotatr: genomic regions in context. Bioinformatics. 2017 doi: 10.1093/bioinformatics/btx183. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1093/bioinformatics/btx183\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC5860117/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/28369316/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Bioinformatics&amp;title=annotatr:%20genomic%20regions%20in%20context&amp;author=GC%20Raymond&amp;author=AS%20Maureen&amp;publication_year=2017&amp;pmid=28369316&amp;doi=10.1093/bioinformatics/btx183&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"R70\"> <span class=\"label\"> 70. </span> <cite> Max K. caret: Classification and Regression Training. 2021. </cite> </li> <li id=\"R71\"> <span class=\"label\"> 71. </span> <cite> Tianqi C, Tong H, Michael B, Vadim K, Yuan T, Hyunsu C, Kailong C, Rory M, Ignacio C, Tianyi Z, et al. xgboost: Extreme Gradient Boosting. 2021. </cite> </li> <li id=\"R72\"> <span class=\"label\"> 72. </span> <cite> The Bioconductor Dev, T. BSgenome Hsapiens NCBI GRCh38: Full genome sequences for Homo sapiens (GRCh38) 2014. </cite> </li> <li id=\"R73\"> <span class=\"label\"> 73. </span> <cite> Achim Z, Gabor G. zoo: S3 Infrastructure for Regular and Irregular Time Series. Journal of Statistical Software. 2005;14:1\u201327. doi: 10.18637/jss.v014.i06. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.18637/jss.v014.i06\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Statistical%20Software&amp;title=zoo:%20S3%20Infrastructure%20for%20Regular%20and%20Irregular%20Time%20Series&amp;author=Z%20Achim&amp;author=G%20Gabor&amp;volume=14&amp;publication_year=2005&amp;pages=1-27&amp;doi=10.18637/jss.v014.i06&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"R74\"> <span class=\"label\"> 74. </span> <cite> Xavier R, Natacha T, Alexandre H, Natalia T, Fr\u00e9d\u00e9rique L, Jean-Charles S, Markus M. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics. 2011;12:77. doi: 10.1186/1471-2105-12-77. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1186/1471-2105-12-77\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC3068975/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/21414208/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=BMC%20Bioinformatics&amp;title=pROC:%20an%20open-source%20package%20for%20R%20and%20S+%20to%20analyze%20and%20compare%20ROC%20curves&amp;author=R%20Xavier&amp;author=T%20Natacha&amp;author=H%20Alexandre&amp;author=T%20Natalia&amp;author=L%20Fr%C3%A9d%C3%A9rique&amp;volume=12&amp;publication_year=2011&amp;pages=77&amp;pmid=21414208&amp;doi=10.1186/1471-2105-12-77&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"R75\"> <span class=\"label\"> 75. </span> <cite> Alboukadel K. rstatix: Pipe-Friendly Framework for Basic Statistical Tests. 2021. </cite> </li> <li id=\"R76\"> <span class=\"label\"> 76. </span> <cite> Hadley W. ggplot2: Elegant Graphics for Data Analysis. 2016. </cite> </li> <li id=\"R77\"> <span class=\"label\"> 77. </span> <cite> Zuguang G, Roland E, Matthias S. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics. 2016 doi: 10.1093/bioinformatics/btw313. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1093/bioinformatics/btw313\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/27207943/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Bioinformatics&amp;title=Complex%20heatmaps%20reveal%20patterns%20and%20correlations%20in%20multidimensional%20genomic%20data&amp;author=G%20Zuguang&amp;author=E%20Roland&amp;author=S%20Matthias&amp;publication_year=2016&amp;pmid=27207943&amp;doi=10.1093/bioinformatics/btw313&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> </ul> </section> </section> <section class=\"associated-data\" id=\"_ad93_\" lang=\"en\"> <h2 class=\"pmc_sec_title\"> <a class=\"usa-anchor\" id=\"_ad93_-anchor\"> </a> Associated Data </h2> <p class=\"font-secondary\"> <em> This section collects any data citations, data availability statements, or supplementary materials included in this article. </em> </p> <section class=\"supplementary-materials\" id=\"_adsm93_\" lang=\"en\"> <h3 class=\"pmc_sec_title\"> Supplementary Materials </h3> <section class=\"sm xbox font-sm\" id=\"db_ds_supplementary-material1_reqid_\"> <div class=\"caption p\"> <span> Data S1. RNA-seq data of cohort 1, related to Figure 1. </span> </div> <div class=\"media p\"> <div class=\"caption\"> <a class=\"usa-link\" href=\"/articles/instance/11178430/bin/EMS195999-supplement-Data_S1.csv\"> EMS195999-supplement-Data_S1.csv </a> <sup> (34.9MB, csv) </sup> </div> </div> </section> <section class=\"sm xbox font-sm\" id=\"db_ds_supplementary-material2_reqid_\"> <div class=\"caption p\"> <span> Data S2. RNA-seq data of cohort 2, related to Figure 2. </span> </div> <div class=\"media p\"> <div class=\"caption\"> <a class=\"usa-link\" href=\"/articles/instance/11178430/bin/EMS195999-supplement-Data_S2.csv\"> EMS195999-supplement-Data_S2.csv </a> <sup> (14.5MB, csv) </sup> </div> </div> </section> <section class=\"sm xbox font-sm\" id=\"db_ds_supplementary-material3_reqid_\"> <div class=\"caption p\"> <span> Figure S1 </span> </div> <div class=\"media p\"> <div class=\"caption\"> <a class=\"usa-link\" href=\"/articles/instance/11178430/bin/EMS195999-supplement-Figure_S1.pdf\"> EMS195999-supplement-Figure_S1.pdf </a> <sup> (10.4MB, pdf) </sup> </div> </div> </section> <section class=\"sm xbox font-sm\" id=\"db_ds_supplementary-material4_reqid_\"> <div class=\"caption p\"> <span> Table S1 </span> </div> <div class=\"media p\"> <div class=\"caption\"> <a class=\"usa-link\" href=\"/articles/instance/11178430/bin/EMS195999-supplement-Table_S1.xlsx\"> EMS195999-supplement-Table_S1.xlsx </a> <sup> (28.7KB, xlsx) </sup> </div> </div> </section> <section class=\"sm xbox font-sm\" id=\"db_ds_supplementary-material5_reqid_\"> <div class=\"caption p\"> <span> Table S2 </span> </div> <div class=\"media p\"> <div class=\"caption\"> <a class=\"usa-link\" href=\"/articles/instance/11178430/bin/EMS195999-supplement-Table_S2.xlsx\"> EMS195999-supplement-Table_S2.xlsx </a> <sup> (18.2KB, xlsx) </sup> </div> </div> </section> <section class=\"sm xbox font-sm\" id=\"db_ds_supplementary-material6_reqid_\"> <div class=\"caption p\"> <span> Table S3 </span> </div> <div class=\"media p\"> <div class=\"caption\"> <a class=\"usa-link\" href=\"/articles/instance/11178430/bin/EMS195999-supplement-Table_S3.xlsx\"> EMS195999-supplement-Table_S3.xlsx </a> <sup> (221.4KB, xlsx) </sup> </div> </div> </section> </section> <section class=\"data-availability-statement\" id=\"_adda93_\" lang=\"en\"> <h3 class=\"pmc_sec_title\"> Data Availability Statement </h3> <p> Code generated in this manuscript can be found at: <a class=\"usa-link usa-link--external\" href=\"https://github.com/MD-Anderson-Bioinformatics/SCLC_Subtyping\" rel=\"noopener noreferrer\" target=\"_blank\"> https://github.com/MD-Anderson-Bioinformatics/SCLC_Subtyping </a> </p> <p> Raw sequencing data generated as part of this manuscript are deposited in dbGap ( <a class=\"usa-link\" href=\"https://www.ncbi.nlm.nih.gov/gap/\" rel=\"noopener noreferrer\" target=\"_blank\"> https://www.ncbi.nlm.nih.gov/gap/ </a> ) under accession number phs003416.v1.p1. Sequencing data from cell lines are deposited in GEO ( <a class=\"usa-link\" href=\"https://www.ncbi.nlm.nih.gov/geo/\" rel=\"noopener noreferrer\" target=\"_blank\"> https://www.ncbi.nlm.nih.gov/geo/ </a> ) with accession number <a class=\"usa-link\" href=\"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE241673\" rel=\"noopener noreferrer\" target=\"_blank\"> GSE241673 </a> . Processed RNA-seq data for cohort 1 and cohort are additionally directly provided in this manuscript as <a class=\"usa-link\" href=\"#SD1\"> data S1 </a> and <a class=\"usa-link\" href=\"#SD2\"> data S2 </a> , respectively. </p> <p> Any additional information required to reanalyze the data reported in this paper is available from the lead contact upon request. </p> </section> </section> </section> </section> </article> </main> </div> </div> </div> <div class=\"pmc-sidenav desktop:grid-col-4 display-flex\"> <section aria-label=\"Article resources and navigation\" class=\"pmc-sidenav__container\"> <button class=\"usa-button pmc-sidenav__container__close usa-button--unstyled\" type=\"button\"> <img alt=\"Close\" role=\"img\" src=\"/static/img/usa-icons/close.svg\"/> </button> <div class=\"display-none desktop:display-block\"> <section class=\"margin-top-4 desktop:margin-top-0\"> <h2 class=\"margin-top-0\"> ACTIONS </h2> <ul class=\"usa-list usa-list--unstyled usa-list--actions\"> <li> <a class=\"usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1\" href=\"https://doi.org/10.1016/j.ccell.2024.01.001\" rel=\"noreferrer noopener\" target=\"_blank\"> <svg aria-hidden=\"true\" class=\"usa-icon width-3 height-3\" focusable=\"false\" hidden=\"\" role=\"img\"> <use xlink:href=\"/static/img/sprite.svg#launch\"> </use> </svg> <span class=\"display-inline-flex flex-justify-center flex-1 padding-right-2\"> View on publisher site </span> </a> </li> <li> <a class=\"usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1\" href=\"pdf/EMS195999.pdf\"> <svg aria-hidden=\"true\" class=\"usa-icon width-3 height-3\" focusable=\"false\" hidden=\"\" role=\"img\"> <use xlink:href=\"/static/img/sprite.svg#file_download\"> </use> </svg> <span class=\"display-inline-flex flex-justify-center flex-1\"> PDF (2.2 MB) </span> </a> </li> <li> <button aria-label=\"Open dialog with citation text in different styles\" class=\"usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1\" role=\"button\"> <svg aria-hidden=\"true\" class=\"usa-icon width-3 height-3\" focusable=\"false\" hidden=\"\" role=\"img\"> <use xlink:href=\"/static/img/sprite.svg#format_quote\"> </use> </svg> <span class=\"display-inline-flex flex-justify-center flex-1 button-label\"> Cite </span> </button> </li> <li> <button aria-label=\"Save article in MyNCBI collections.\" class=\"usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty\"> <svg aria-hidden=\"true\" class=\"usa-icon width-3 height-3 usa-icon--bookmark-full\" focusable=\"false\" hidden=\"\" role=\"img\"> <use xlink:href=\"/static/img/action-bookmark-full.svg#icon\"> </use> </svg> <svg aria-hidden=\"true\" class=\"usa-icon width-3 height-3 usa-icon--bookmark-empty\" focusable=\"false\" hidden=\"\" role=\"img\"> <use xlink:href=\"/static/img/action-bookmark-empty.svg#icon\"> </use> </svg> <span class=\"display-inline-flex flex-justify-center flex-1\"> Collections </span> </button> </li> <li class=\"pmc-permalink\"> <button aria-expanded=\"false\" aria-haspopup=\"true\" aria-label=\"Show article permalink\" class=\"usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none\" type=\"button\"> <svg aria-hidden=\"true\" class=\"usa-icon width-3 height-3\" focusable=\"false\" hidden=\"\" role=\"img\"> <use xlink:href=\"/static/img/sprite.svg#share\"> </use> </svg> <span class=\"display-inline-flex flex-justify-center flex-1 button-label\"> Permalink </span> </button> <div class=\"pmc-permalink__dropdown\" hidden=\"\"> <div class=\"pmc-permalink__dropdown__container\"> <h2 class=\"usa-modal__heading margin-top-0 margin-bottom-2\"> PERMALINK </h2> <div class=\"pmc-permalink__dropdown__content\"> <input aria-label=\"Article permalink\" class=\"usa-input\" type=\"text\" value=\"https://pmc.ncbi.nlm.nih.gov/articles/PMC10982990/\"/> <button aria-expanded=\"false\" class=\"usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0\" title=\"Copy article permalink\"> <svg aria-hidden=\"true\" class=\"usa-icon\" focusable=\"false\" role=\"img\"> <use xlink:href=\"/static/img/sprite.svg#content_copy\"> </use> </svg> <span class=\"margin-left-1\"> Copy </span> </button> </div> </div> </div> </li> </ul> </section> </div> <section class=\"pmc-resources margin-top-6 desktop:margin-top-4\"> <h2 class=\"margin-top-0\"> RESOURCES </h2> <div class=\"usa-accordion usa-accordion--multiselectable\"> <h3 class=\"usa-accordion__heading\"> <button aria-controls=\"resources-similar-articles\" aria-expanded=\"false\" class=\"usa-accordion__button\" type=\"button\"> Similar articles </button> </h3> <div class=\"usa-accordion__content usa-prose\" hidden=\"\" id=\"resources-similar-articles\"> </div> <h3 class=\"usa-accordion__heading\"> <button aria-controls=\"resources-cited-by-other-articles\" aria-expanded=\"false\" class=\"usa-accordion__button\" type=\"button\"> Cited by other articles </button> </h3> <div class=\"usa-accordion__content usa-prose\" hidden=\"\" id=\"resources-cited-by-other-articles\"> </div> <h3 class=\"usa-accordion__heading\"> <button aria-controls=\"resources-links-to-ncbi-databases\" aria-expanded=\"false\" class=\"usa-accordion__button\" type=\"button\"> Links to NCBI Databases </button> </h3> <div class=\"usa-accordion__content usa-prose\" hidden=\"\" id=\"resources-links-to-ncbi-databases\"> </div> </div> </section> <section class=\"usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4\"> <nav aria-label=\"On this page\" class=\"usa-in-page-nav__nav\"> <h2 class=\"usa-in-page-nav__heading\" tabindex=\"0\"> On this page </h2> <ul class=\"usa-in-page-nav__list\"> <li class=\"usa-in-page-nav__item\"> <a class=\"usa-in-page-nav__link\" href=\"#abstract1\"> Summary </a> </li> <li class=\"usa-in-page-nav__item\"> <a class=\"usa-in-page-nav__link\" href=\"#S1\"> Introduction </a> </li> <li class=\"usa-in-page-nav__item\"> <a class=\"usa-in-page-nav__link\" href=\"#S2\"> Results </a> </li> <li class=\"usa-in-page-nav__item\"> <a class=\"usa-in-page-nav__link\" href=\"#S10\"> Discussion </a> </li> <li class=\"usa-in-page-nav__item\"> <a class=\"usa-in-page-nav__link\" href=\"#S13\"> STAR Methods </a> </li> <li class=\"usa-in-page-nav__item\"> <a class=\"usa-in-page-nav__link\" href=\"#SM\"> Supplementary Material </a> </li> <li class=\"usa-in-page-nav__item\"> <a class=\"usa-in-page-nav__link\" href=\"#S31\"> Acknowledgements </a> </li> <li class=\"usa-in-page-nav__item\"> <a class=\"usa-in-page-nav__link\" href=\"#fn-group1\"> Footnotes </a> </li> <li class=\"usa-in-page-nav__item\"> <a class=\"usa-in-page-nav__link\" href=\"#S32\"> Data and code availability </a> </li> <li class=\"usa-in-page-nav__item\"> <a class=\"usa-in-page-nav__link\" href=\"#ref-list1\"> References </a> </li> <li class=\"usa-in-page-nav__item\"> <a class=\"usa-in-page-nav__link\" href=\"#_ad93_\"> Associated Data </a> </li> </ul> </nav> </section> </section> </div> <div aria-label=\"Citation Dialog\" class=\"overlay citation-dialog-overlay\" role=\"dialog\"> <div aria-hidden=\"true\" class=\"dialog citation-dialog\" role=\"document\"> <div class=\"display-inline-flex flex-align-center flex-justify width-full margin-bottom-2\"> <h2 class=\"usa-modal__heading margin-0\"> Cite </h2> <button class=\"usa-button usa-button--unstyled close-overlay text-black width-auto\" tabindex=\"1\" type=\"button\"> <svg aria-hidden=\"true\" class=\"usa-icon width-3 height-3\" focusable=\"false\" role=\"img\"> <use xlink:href=\"/static/img/sprite.svg#close\"> </use> </svg> </button> </div> <div class=\"citation-text-block\"> <div class=\"citation-text margin-bottom-2\"> </div> <ul class=\"usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center\"> <li> <button class=\"usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus\" tabindex=\"2\"> <svg aria-hidden=\"true\" class=\"usa-icon width-3 height-3\" focusable=\"false\" role=\"img\"> <use xlink:href=\"/static/img/sprite.svg#content_copy\"> </use> </svg> <span> Copy </span> </button> </li> <li> <a class=\"usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button\" href=\"#\" role=\"button\" tabindex=\"3\" title=\"Download a file for external citation management software\"> <svg aria-hidden=\"true\" class=\"usa-icon width-3 height-3\" focusable=\"false\" role=\"img\"> <use xlink:href=\"/static/img/sprite.svg#file_download\"> </use> </svg> <span class=\"display-none mobile-lg:display-inline\"> Download .nbib </span> <span class=\"display-inline mobile-lg:display-none\"> .nbib </span> </a> </li> <li> <div class=\"display-inline-flex flex-align-center\"> <label class=\"usa-label margin-top-0\"> Format: </label> <select aria-label=\"Format\" class=\"usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4\" tabindex=\"4\"> <option value=\"AMA\"> AMA </option> <option value=\"APA\"> APA </option> <option value=\"MLA\"> MLA </option> <option selected=\"selected\" value=\"NLM\"> NLM </option> </select> </div> </li> </ul> <div class=\"dots-loading-indicator citation-loading-indicator\"> <div class=\"dot dot-1\"> </div> <div class=\"dot dot-2\"> </div> <div class=\"dot dot-3\"> </div> </div> </div> </div> </div> <div class=\"overlay collections-dialog-overlay\" role=\"dialog\"> <div aria-hidden=\"true\" class=\"dialog collections-dialog\" id=\"collections-action-dialog\" role=\"document\"> <div class=\"display-inline-flex flex-align-center flex-justify width-full margin-bottom-2\"> <h2 class=\"usa-modal__heading margin-0\"> Add to Collections </h2> </div> <div class=\"collections-action-panel action-panel\"> <form class=\"usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors\" id=\"collections-action-dialog-form\"> <fieldset class=\"usa-fieldset margin-bottom-2\"> <div class=\"usa-radio\"> <input class=\"usa-radio__input usa-radio__input--tile collections-new margin-top-0\" id=\"collections-action-dialog-new\" name=\"collections\" type=\"radio\" value=\"new\"/> <label class=\"usa-radio__label\" for=\"collections-action-dialog-new\"> Create a new collection </label> </div> <div class=\"usa-radio\"> <input checked=\"true\" class=\"usa-radio__input usa-radio__input--tile collections-existing\" id=\"collections-action-dialog-existing\" name=\"collections\" type=\"radio\" value=\"existing\"/> <label class=\"usa-radio__label\" for=\"collections-action-dialog-existing\"> Add to an existing collection </label> </div> </fieldset> <fieldset class=\"usa-fieldset margin-bottom-2\"> <div class=\"action-panel-control-wrap new-collections-controls\"> <label class=\"usa-label margin-top-0\" for=\"collections-action-dialog-add-to-new\"> Name your collection <abbr class=\"usa-hint usa-hint--required text-no-underline\" title=\"required\"> * </abbr> </label> <input class=\"usa-input collections-action-add-to-new\" id=\"collections-action-dialog-add-to-new\" maxlength=\"\" name=\"add-to-new-collection\" pattern='[^\"&amp;=&lt;&gt;/]*' required=\"\" title='The following characters are not allowed in the Name field: \"&amp;=&lt;&gt;/' type=\"text\"/> </div> <div class=\"action-panel-control-wrap existing-collections-controls\"> <label class=\"usa-label margin-top-0\" for=\"collections-action-dialog-add-to-existing\"> Choose a collection </label> <select class=\"usa-select collections-action-add-to-existing\" id=\"collections-action-dialog-add-to-existing\"> </select> <div class=\"collections-retry-load-on-error usa-input-error-message selection-validation-message\"> Unable to load your collection due to an error <br/> <a href=\"#\"> Please try again </a> </div> </div> </fieldset> <div class=\"display-inline-flex\"> <button class=\"usa-button margin-top-0 action-panel-submit\" type=\"submit\"> Add </button> <button aria-label=\"Close 'Add to Collections' panel\" class=\"usa-button usa-button--outline margin-top-0 action-panel-cancel\" ref=\"linksrc=close_collections_panel\"> Cancel </button> </div> </form> </div> </div> </div> </div> </div> </div> <footer class=\"ncbi-footer ncbi-dark-background\"> <div class=\"ncbi-footer__icon-section\"> <div class=\"ncbi-footer__social-header\"> Follow NCBI </div> <div class=\"grid-container ncbi-footer__ncbi-social-icons-container\"> <a class=\"ncbi-footer__social-icon ncbi-footer__social-icon--gray\" href=\"https://twitter.com/ncbi\" rel=\"noreferrer noopener\" target=\"_blank\"> <svg aria-hidden=\"true\" fill=\"none\" focusable=\"false\" height=\"40\" viewbox=\"0 0 40 40\" width=\"40\" xmlns=\"http://www.w3.org/2000/svg\"> <path d=\"m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z\"> </path> </svg> <span class=\"usa-sr-only\"> NCBI on X (formerly known as Twitter) </span> </a> <a class=\"ncbi-footer__social-icon ncbi-footer__social-icon--gray\" href=\"https://www.facebook.com/ncbi.nlm\" rel=\"noreferrer noopener\" target=\"_blank\"> <svg aria-hidden=\"true\" fill=\"none\" focusable=\"false\" height=\"29\" viewbox=\"0 0 16 29\" width=\"16\" xmlns=\"http://www.w3.org/2000/svg\"> <path d=\"M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z\"> </path> </svg> <span class=\"usa-sr-only\"> NCBI on Facebook </span> </a> <a class=\"ncbi-footer__social-icon ncbi-footer__social-icon--gray\" href=\"https://www.linkedin.com/company/ncbinlm\" rel=\"noreferrer noopener\" target=\"_blank\"> <svg aria-hidden=\"true\" fill=\"none\" focusable=\"false\" height=\"23\" viewbox=\"0 0 26 24\" width=\"25\" xmlns=\"http://www.w3.org/2000/svg\"> <path d=\"M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z\"> </path> <path d=\"M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z\"> </path> <path d=\"M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z\"> </path> </svg> <span class=\"usa-sr-only\"> NCBI on LinkedIn </span> </a> <a class=\"ncbi-footer__social-icon ncbi-footer__social-icon--gray\" href=\"https://github.com/ncbi\" rel=\"noreferrer noopener\" target=\"_blank\"> <svg aria-hidden=\"true\" fill=\"none\" focusable=\"false\" height=\"27\" viewbox=\"0 0 28 28\" width=\"28\" xmlns=\"http://www.w3.org/2000/svg\"> <path d=\"M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z\"> </path> </svg> <span class=\"usa-sr-only\"> NCBI on GitHub </span> </a> <a class=\"ncbi-footer__social-icon ncbi-footer__social-icon--gray\" href=\"https://ncbiinsights.ncbi.nlm.nih.gov/\" rel=\"noreferrer noopener\" target=\"_blank\"> <svg aria-hidden=\"true\" fill=\"none\" focusable=\"false\" height=\"26\" viewbox=\"0 0 27 27\" width=\"26\" xmlns=\"http://www.w3.org/2000/svg\"> <path d=\"M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z\"> </path> <path d=\"M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z\"> </path> <path d=\"M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z\"> </path> </svg> <span class=\"usa-sr-only\"> NCBI RSS feed </span> </a> </div> </div> <div class=\"grid-container ncbi-footer__container\"> <div class=\"grid-row ncbi-footer__main-content-container\"> <div class=\"ncbi-footer__column\"> <p class=\"ncbi-footer__circled-icons-heading\"> Connect with NLM </p> <div class=\"ncbi-footer__circled-icons-list\"> <a class=\"ncbi-footer__social-icon ncbi-footer__social-icon--circled\" href=\"https://twitter.com/nlm_nih\" rel=\"noreferrer noopener\" target=\"_blank\"> <svg aria-hidden=\"true\" fill=\"none\" focusable=\"false\" height=\"32\" viewbox=\"0 0 40 40\" width=\"32\" xmlns=\"http://www.w3.org/2000/svg\"> <path d=\"m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z\"> </path> </svg> <span class=\"usa-sr-only\"> NLM on X (formerly known as Twitter) </span> </a> <a class=\"ncbi-footer__social-icon ncbi-footer__social-icon--circled\" href=\"https://www.facebook.com/nationallibraryofmedicine\" rel=\"noreferrer noopener\" target=\"_blank\"> <svg aria-hidden=\"true\" fill=\"none\" focusable=\"false\" height=\"24\" viewbox=\"0 0 13 24\" width=\"13\" xmlns=\"http://www.w3.org/2000/svg\"> <path d=\"M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z\"> </path> </svg> <span class=\"usa-sr-only\"> NLM on Facebook </span> </a> <a class=\"ncbi-footer__social-icon ncbi-footer__social-icon--circled\" href=\"https://www.youtube.com/user/NLMNIH\" rel=\"noreferrer noopener\" target=\"_blank\"> <svg aria-hidden=\"true\" fill=\"none\" focusable=\"false\" height=\"15\" viewbox=\"0 0 21 15\" width=\"21\" xmlns=\"http://www.w3.org/2000/svg\"> <path d=\"M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z\" fill=\"white\"> </path> </svg> <span class=\"usa-sr-only\"> NLM on YouTube </span> </a> </div> </div> <address class=\"ncbi-footer__address ncbi-footer__column\"> <p> <a class=\"usa-link usa-link--external\" href=\"https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508, -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508! 4d-77.0988323\" rel=\"noopener noreferrer\" target=\"_blank\"> National Library of Medicine <br/> 8600 Rockville Pike <br/> Bethesda, MD 20894 </a> </p> </address> <ul class=\"usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column\"> <li class=\"ncbi-footer__vertical-list-item\"> <a class=\"usa-link usa-link--alt ncbi-footer__link\" href=\"https://www.nlm.nih.gov/web_policies.html\"> Web Policies </a> </li> <li class=\"ncbi-footer__vertical-list-item\"> <a class=\"usa-link usa-link--alt ncbi-footer__link\" href=\"https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office\"> FOIA </a> </li> <li class=\"ncbi-footer__vertical-list-item\"> <a class=\"usa-link usa-link--external usa-link--alt ncbi-footer__link\" href=\"https://www.hhs.gov/vulnerability-disclosure-policy/index.html\" rel=\"noreferrer noopener\" target=\"_blank\"> HHS Vulnerability Disclosure </a> </li> </ul> <ul class=\"usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column\"> <li class=\"ncbi-footer__vertical-list-item\"> <a class=\"usa-link usa-link--alt ncbi-footer__link\" href=\"https://support.nlm.nih.gov/?pagename=cloudpmc-viewer%3Apmc%3Aarticle%3Amanuscript\"> Help </a> </li> <li class=\"ncbi-footer__vertical-list-item\"> <a class=\"usa-link usa-link--alt ncbi-footer__link\" href=\"https://www.nlm.nih.gov/accessibility.html\"> Accessibility </a> </li> <li class=\"ncbi-footer__vertical-list-item\"> <a class=\"usa-link usa-link--alt ncbi-footer__link\" href=\"https://www.nlm.nih.gov/careers/careers.html\"> Careers </a> </li> </ul> </div> <div class=\"grid-row grid-col-12\"> <ul class=\"ncbi-footer__bottom-links-list\"> <li class=\"ncbi-footer__bottom-list-item\"> <a class=\"usa-link usa-link--alt ncbi-footer__link\" href=\"https://www.nlm.nih.gov/\"> NLM </a> </li> <li class=\"ncbi-footer__bottom-list-item\"> <a class=\"usa-link usa-link--alt ncbi-footer__link\" href=\"https://www.nih.gov/\"> NIH </a> </li> <li class=\"ncbi-footer__bottom-list-item\"> <a class=\"usa-link usa-link--external usa-link--alt ncbi-footer__link\" href=\"https://www.hhs.gov/\" rel=\"noreferrer noopener\" target=\"_blank\"> HHS </a> </li> <li class=\"ncbi-footer__bottom-list-item\"> <a class=\"usa-link usa-link--external usa-link--alt ncbi-footer__link\" href=\"https://www.usa.gov/\" rel=\"noreferrer noopener\" target=\"_blank\"> USA.gov </a> </li> </ul> </div> </div> </footer> <div id=\"ZN_dikYWqsjiUWN0Q5\"> </div> <button class=\"back-to-top\"> <label> Back to Top </label> <svg aria-hidden=\"true\" class=\"usa-icon order-0\" focusable=\"false\" role=\"img\"> <use xlink:href=\"/static/img/sprite.svg#arrow_upward\"> </use> </svg> </button> <div class=\"fake-body-scroll\"> </div> <div class=\"fake-body-scroll\"> </div> </body> </html>\n\nand the following known data repositories: bigd.big.ac.cn, massive.ucsd.edu, www.ebi.ac.uk, www.iprox.cn, proteomecentral.proteomexchange.org, www.proteomexchange.org, pdc.cancer.gov, doi.org, www.ncbi.nlm.nih.gov\n\nFor each dataset reference, return the following as a JSON array of objects. Each object must have:\n- `dataset_identifier`: The dataset identifier (which must be a code). If unavailable, set it to \"n/a\".\n- `repository_reference`: The URL or reference to the data repository. If unavailable, set it to \"n/a\".\n\nStrict Instructions:\n- Output must be a valid JSON array of objects.\n- Each object must contain `dataset_id` and `repository_reference`.\n- Any other output will be considered invalid."}]}]